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ABSTRACT 
 
Accurate DNA replication is key to maintaining genome stability in all living 
species. In eukaryotes, the duplication process starts with the formation of the pre-
replicative complex (pre-RC) prior to S phase, followed by the transition to the pre-
initiation complex (pre-IC) that is required for DNA synthesis. The conserved canonical 
model of the pre-RC assembly includes an ordered recruitment of ORC, Cdt1, Cdc6, 
and the helicase MCMs to replication origins, and is strictly governed by replication 
licensing system. As the complexity increases dramatically from yeast to human cells, 
additional replication regulators have been identified in higher eukaryotes. In Chapter I, 
I review how the canonical pre-RC components were identified; what are the novel 
players; and our current understanding of how the replication licensing dictates proper 
DNA synthesis. 
While how ORC is recruited to specific origins has been studied explicitly in 
lower organisms, it remains unclear in higher eukaryotes. To understand whether 
additional factors enable the recruitment of ORC to origins and/or specific chromatin 
sites in human cells, our lab conducted ORC immunoprecipitations followed by mass 
spectrometric analysis in order to find novel ORC interactors. In Chapter II, I describe 
the identification of a highly conserved protein in human cells, leucine-rich repeats and 
WD40 repeat domain-containing protein 1 (LRWD1) or ORC-associated (ORCA). It 
interacts with ORC and modulates its chromatin association. ORCA co-localizes with 
ORC, shows similar cell cycle dynamics, and efficiently recruits ORC to chromatin. 
Depletion of ORCA in human primary cells and embryonic stem cells results in the loss 
of ORC association to chromatin, concomitant reduction of MCM binding, and a 
subsequent accumulation of cells in G1 phase. I therefore propose the model where 
ORCA-mediated association of ORC to chromatin is critical for pre-RC assembly in 
G1. 
In addition to ORC, I describe the interaction of ORCA with replication factor 
Cdt1 and its inhibitor Geminin in Chapter III. I demonstrate the stoichiometry of these 
associations via single-molecule pull-down experiments that each molecule of ORCA 
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can bind to one molecule of ORC, one molecule of Cdt1, and two molecules of 
Geminin. Further, ORCA directly interacts with the N-terminus of Orc2, and this 
association is essential for ORCA stability. ORCA associates with Orc2 throughout the 
cell cycle, with Cdt1 during mitosis and G1, and with Geminin in post-G1 cells. 
Interestingly, overexpression of Geminin results in the loss of interaction between 
ORCA and Cdt1, suggesting that the increased levels of Geminin in post-G1 cells titrate 
Cdt1 away from ORCA. Based on these data, I propose that the dynamic association of 
ORCA with pre-RC components modulates the assembly of its interacting partners on 
chromatin and plays a key role in replication initiation. 
ORCA exhibits cell cycle-regulated protein levels that peak in G1; and it can 
only be stabilized when it is in a complex with Orc2. In Chapter IV, I show that ORCA 
is polyubiquitinated in vivo with elevated ubiquitination observed at the G1/S boundary. 
ORCA utilizes lysine-48 (K48) ubiquitin linkage suggesting that ORCA ubiquitination 
mediates its regulated degradation. Ubiquitinated ORCA is re-localized in the form of 
nuclear aggregates and is predominantly associated with chromatin. I further 
demonstrate that ORCA ubiquitinates at the WD40 repeat domain, the same region 
recognized by Orc2. Moreover, Orc2 associates only with the non-ubiquitinated form of 
ORCA, and Orc2 depletion results in the proteasome-mediated destabilization of 
ORCA. Based on these results, I propose that Orc2 protects ORCA from degradation by 
preventing its ubiquitination within the WD domain. 
In Chapter V, I summarize the significance of my thesis work. With the 
discovery of a novel component of eukaryotic pre-RC, ORCA, we have better 
understanding of the eukaryotic DNA replication machinery. I will point out several 
interesting questions that have emerged from my studies that demand future 
investigation. 
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CHAPTER I. INTRODUCTION 
 
I.1. The assembly of pre-RC in eukaryotic cells 
Well-coordinated DNA replication in S phase and separation of duplicated 
chromosomes into daughter cells in mitosis is paramount to cell survival. Prior to S 
phase, pre-replication complex (pre-RC), a multi-protein complex which dictates when 
and where the DNA replication will initiate, is assembled. The assembly of pre-RC 
involves an ordered recruitment of ORC, Cdc6, Cdt1 and MCM2-7 (Bell, 2002; Bell 
and Dutta, 2002; DePamphilis, 2003; Dutta and Bell, 1997; Kelly and Brown, 2000). In 
this section, I describe the characterization and functional significance of each factor, 
and discuss their similarities and differences in various eukaryotic model organisms. 
 
I.1.1. ORC 
Studies on the unicellular model organism, Saccharomyces cerevisiae, revealed 
conserved replication initiation sites, called origins, which comprise a highly conserved 
autonomously replicating sequence (ARS) (Newlon, 1988). Linker substitution 
mutations across the entire S. cerevisiae chromosomal origin, ARS1, revealed one A 
element and three B elements (B1, B2 and B3) that are essential for origin function 
(Marahrens and Stillman, 1992). Identification of proteins bound to these elements led 
to the discovery of a six-subunit complex, origin recognition complex (ORC) (Bell and 
Stillman, 1992). ORC serves as the initiator to select replication initiation sites (Bell 
and Stillman, 1992). Subsequent studies identified the ORC orthologs in several other 
eukaryotic organisms (Gavin et al., 1995). ORC has been found to be highly conserved 
and its function in the initiation of replication has been demonstrated in various model 
organisms including: Schizosaccharomyces pombe (Gavin et al., 1995; Moon et al., 
1999; Wolf et al., 1996), Drosophila (Gossen et al., 1996; Gossen et al., 1995; Landis et 
al., 1997; Pflumm and Botchan, 2001; Pinto et al., 1999), Xenopus (Carpenter et al., 
Chapter I.4 has been published as: 
Shen, Z., and S.G. Prasanth. 2012. Emerging players in the initiation of eukaryotic 
DNA replication. Cell Div. 7:22. 
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1996; Romanowski et al., 1996; Rowles et al., 1996), and mice as well as human cells 
(Dhar and Dutta, 2000; Dhar et al., 2001b; Gavin et al., 1995; Quintana and Dutta, 1999; 
Quintana et al., 1997; Quintana et al., 1998; Takahara et al., 1996; Tugal et al., 1998; 
Yu et al., 1998). 
Studies using recombinant human ORC proteins provide valuable clues on how 
these subunits form a complex in a stepwise fashion. ORC subunits 2-3-4-5 form a core 
complex, with Orc1 interaction in a cell cycle-regulated manner and Orc6 associating 
with the core ORC in a transient manner. Specifically, Orc2 C-terminus interacts 
directly with Orc3 N-terminus, and Orc3 C-terminus is responsible for ATP-dependent 
Orc4 and Orc5 associations (Dhar et al., 2001a; Radichev et al., 2006; Ranjan and 
Gossen, 2006; Siddiqui and Stillman, 2007; Vashee et al., 2001). In a recent study, the 
stable complex of Orc1-6 can be purified from human cell extracts, and Orc1 and Orc6 
have their own nuclear localization signals that are crucial for nuclear localizations 
(Ghosh et al., 2011). 
Not only for self-assembly, ORC also recognizes origins in an ATP-dependent 
manner (Bell and Stillman, 1992). Orc1-5 all contain potential ATP binding sites 
according to sequence analysis (Speck et al., 2005). In S. cerevisiae and Drosophila, 
only Orc1 binding to ATP is required for its DNA binding function, but not the 
hydrolysis, indicating these are two separate steps and hydrolysis may be key in pre-RC 
assembly (Austin et al., 1999; Chesnokov et al., 2001; Klemm et al., 1997). In S. pombe, 
Orc1, 4, and 5 display ATP binding and hydrolyzing activities (Kong et al., 2003), 
which may only be used during pre-RC assembly, since DNA binding in S. pombe is 
ATP independent (Kong and DePamphilis, 2001). 
The conserved role of ORC is origin binding and serving as a landing pad for 
the assembly of other components that together constitute the pre-RC for the initiation 
of DNA replication.  However, the association of ORC to chromatin varies from one 
organism to another. Even though some specific DNA binding sites have been revealed 
in different eukaryotic organisms, no consensus has been identified other than the ARS 
in the budding yeast (Bell, 2002; Cvetic and Walter, 2005) (Table 1). In S. cerevisiae, 
ORC subunits 1-5 are in close contacts with A and B1 elements, while Orc6 seems to 
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be dispensable for DNA binding (Bell and Stillman, 1992; Lee and Bell, 1997; Rao and 
Stillman, 1995; Rowley et al., 1995). In the fission yeast S. pombe, ORC binds to 
asymmetric AT-rich sequences of the origins via the AT-hook domain of Orc4 (Chuang 
and Kelly, 1999; Kong and DePamphilis, 2001; Kong and DePamphilis, 2002; Lee et 
al., 2001). ChIP analyses show that ORC localizes at the ars2004 and ars3002 origins 
throughout the cell cycle (Ogawa et al., 1999). In Drosophila, ORC is found to bind to 
amplification control elements like ACE3 and ori-β, and all six subunits are required for 
DNA binding (Austin et al., 1999; Chesnokov et al., 2001). In Xenopus, the addition of 
S. pombe Orc4 in egg extracts leads to the chromatin-bound location of AT-rich 
sequences, indicating similar binding mechanism (Kong et al., 2003). Further, most of 
the origins are spaced 5-15 kb apart and are grouped into clusters to fire at the same 
time in S phase, indicating this spacing pattern of origins may provide a potential 
resolution for replication without specific DNA sequence (Blow et al., 2001; Rowles et 
al., 1999). In human cells, only few origins have been identified (Cvetic and Walter, 
2005; Todorovic et al., 1999) including: Lamin B-2 (Abdurashidova et al., 1998), β-
globin (Kamath and Leffak, 2001), c-myc (Waltz et al., 1996), rDNA (Little et al., 
1993). Notably, Epstein-Barr virus replicates from oriP by using human ORC from host 
cells (Chaudhuri et al., 2001; Dhar et al., 2001b; Schepers et al., 2001).  
On the other hand, local chromatin contexts also affect origin selection and 
ORC binding to origins, which will be discussed in the replication licensing section. 
Nevertheless, the exact mechanism of how ORC associates with chromatin is still 
unclear; therefore identification of ORC interacting proteins would be a necessary step. 
 
I.1.2. Cdc6 
Cdc6 was first identified in the screen of cell division cycle (cdc) temperature-
sensitive mutant strains that are not able to synthesize DNA (Hartwell, 1973). In several 
species examined, Cdc6 was confirmed to be downstream of ORC binding to chromatin 
and upstream of MCM loading onto chromatin (Aparicio et al., 1997; Cocker et al., 
1996; Coleman et al., 1996; Liang et al., 1995; Perkins and Diffley, 1998; Tanaka et al., 
1997).   
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Cdc6 belongs to the AAA+ family (ATPases associated with a variety of 
cellular activities), displaying high ATPase activity (Neuwald et al., 1999; Speck et al., 
2005). Structural study from archaeal Cdc6 reveals three distinct domains and sheds 
light on how it functions: two domains form an AAA+ type ATP binding/hydrolysis 
structure; a third winged-helix fold domain, similar to Orc1, is utilized for DNA 
binding (Liu et al., 2000). Most importantly, evidence from mutations of bipartite 
Walker ATP-binding motif (Walker A and B) in S. cerevisiae demonstrates that ATP 
binding/hydrolysis ability significantly regulates Cdc6 activity (Elsasser et al., 1996; 
Perkins and Diffley, 1998; Weinreich et al., 1999). Studies in human cells further 
corroborate this: mutations in the Walker A motif abolish ATP binding, whereas 
mutations in the Walker B motif eliminate ATP hydrolysis (Herbig et al., 1999). 
Cdc6 interacts directly with ORC both in vivo and in vitro (Klemm and Bell, 
2001; Mizushima et al., 2000; Saha et al., 1998; Seki and Diffley, 2000), which 
increases the DNA binding specificity of ORC by reducing the off-rate of ORC from 
origins but not from non-origins. The intact ATP-binding motif is required, as 
mutations of Walker A and Walker B motifs, or ATP-gamma-S impair this function of 
Cdc6 (Mizushima et al., 2000). Single-particle reconstruction of electron microscopic 
images of ORC-Cdc6 in S. cerevisiae shows that the complex forms a ring-shaped 
structure similar to that of the MCM helicase (Speck et al., 2005). 
In S. cerevisiae, the MCM-origin association is dependent on ORC and Cdc6 
(Aparicio et al., 1997; Perkins and Diffley, 1998; Tanaka et al., 1997); and loss of Cdc6 
in G1 by promoter shut-off and thermal inactivation results in post-replicative like 
origins (Cocker et al., 1996). In Xenopus, immunodepletion studies reveal that MCM3 
cannot bind to chromatin lacking Cdc6, while Cdc6 cannot bind to chromatin lacking 
Orc2 (Coleman et al., 1996). Therefore, these data clearly demonstrate a sequential 
association of ORC, Cdc6, and MCM to chromatin. 
 
I.1.3. Cdt1 
Cdt1 was first discovered in the fission yeast S. pombe, where an 
immunoprecipitation-PCR procedure was carried out to isolate genomic DNA 
5 
 
sequences bound by Cdc10, and was regulated in a cdc10-cell cycle-dependent manner 
(Hofmann and Beach, 1994). It was found that Cdt1, as well as Cdc6, are both required 
for loading MCM onto chromatin (Nishitani et al., 2000). Cdt1 accumulates within the 
nucleus and associates with chromatin, with high expression level in G1. 
Overexpression of Cdt1 leads to continuous DNA synthesis and the absence of Cdt1 
prevents the initiation of DNA replication by blocking MCM loading to the chromatin. 
The function of Cdt1 is well conserved in eukaryotes, including in S. cerevisiae 
(Devault et al., 2002), Drosophila (Whittaker et al., 2000), Xenopus (Maiorano et al., 
2000), and human cells (Wohlschlegel et al., 2000). Further, all these investigations 
point out that ORC is required for Cdt1 chromatin association, which in turn facilitates 
MCM loading to chromatin to assemble pre-RC. Because of this vital function, 
misregulation of Cdt1 would show oncogenic potential and genomic instability 
(Arentson et al., 2002; Seo et al., 2005; Tatsumi et al., 2006). 
Extensive biochemical studies have been accomplished to dissect the interaction 
between Cdt1 and its downstream factor, MCM (Ferenbach et al., 2005; Teer and Dutta, 
2008; Wei et al., 2010; Yanagi et al., 2002; You and Masai, 2008). It has been shown 
that Cdt1-MCM2-7 heptamer is loaded onto DNA to form the MCM double hexamer 
(Remus et al., 2009). Further, recent work has demonstrated that Cdt1 facilitates the 
loading of the MCM2-7 by interacting with Orc6 at the Cdt1 N-terminus and interacting 
with MCM6 at the Cdt1 C-terminus (Liu et al., 2011). Moreover, a model has been 
proposed recently that ORC and Cdc6 recruit two Cdt1 molecules to initiate double-
hexamer formation prior to MCM loading, and the replication competence of loaded 
MCM activity is largely influenced by Cdt1 (Takara and Bell, 2011). 
Interestingly, another cell cycle-oscillating protein, Geminin, found only in 
higher eukaryotes, interacts with Cdt1. The interaction between Geminin and Cdt1 and 
how this complex inhibits pre-RC assembly outside of G1 phase will be discussed in the 
following section. 
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I.1.4. MCM 
MCM (minichromosome maintenance) proteins were first isolated in yeast 
mutants that were defective in the maintenance of circular minichromosomes in S. 
cerevisiae (Maine et al., 1984). Biochemical studies from Xenopus egg extracts further 
corroborated this observation (Chong et al., 1995; Kubota et al., 1997; Madine et al., 
1995). MCM proteins 2-7 form a hexameric ring structure and all of the six subunits 
belong to the AAA+ family (Neuwald et al., 1999). The loading of MCM2-7 onto 
chromatin requires the coordinated chromatin association of ORC, Cdc6 and Cdt1 (Bell 
and Dutta, 2002). 
Association of MCM to chromatin serves as the final step in the pre-RC 
assembly. MCM is generally believed to serve as the DNA helicase during replication. 
MCM interacts with replication factors including Cdc45, RPA, RPC, and PCNA 
(Tanaka et al., 1999; Zou and Stillman, 2000). Conditional degron mutants in S. 
cerevisiae demonstrate that depletion of MCM after initiation irreversibly blocks the 
progression of replication forks (Labib et al., 2000). Also, DNA helicase activities have 
been revealed from MCM subunits 4, 6, and 7 (Ishimi, 1997; Lee and Hurwitz, 2000; 
Lee et al., 2001; Sato et al., 2000; You et al., 1999) and 3’ to 5’ helicase activity has 
been proved using reconstituted proteins of the thermophilic archaeon 
Methanobacterium thermoautotrophicum (Chong et al., 2000; Kelman et al., 1999; 
Shechter et al., 2000). Importantly, crystal structure studies from M. 
thermoautotrophicum (Fletcher et al., 2003), Sulfolobus solfataricus (Liu et al., 2008), 
and Methanopyrus kandleri (Bae et al., 2009) and electron microscopy observations 
(Costa and Onesti, 2008; Costa et al., 2006; Gomez-Llorente et al., 2005; Pape et al., 
2003) provide ample information for the hexameric ring structure with DNA passing 
through the central channel, as well as the DNA-binding and ATP- hydrolysis activities 
of MCM proteins as AAA+ family members. 
More direct evidence of the MCM helicase activity came from the observation 
that purified Cdc45/MCM2-7/GINS (CMG) complex from Drosophila embryo extracts 
exhibits an active ATP-dependent DNA helicase activity (Moyer et al., 2006). This core   
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helicase machinery associates with several other factors including MCM10, FACT, 
Ctf4, Mrc1, and Tof1-Csm3 to form the replisome progression complex, which 
functions during eukaryotic DNA replication (Gambus et al., 2006). 
 
I.1.5. Pre-RC assembly 
As described in the above-mentioned paragraph, the general model is: ORC 
recognizes the replication elements and recruits two factors, Cdc6 and Cdt1 
independently. These three components function together to load MCM onto chromatin. 
This pre-RC assembly process takes place as early as late mitosis of the previous cell 
cycle (Mendez and Stillman, 2000). In yeast, at the onset of S phase, Dbf4-dependent 
kinase (DDK) phosphorylation of MCMs and cyclin-dependent kinases (CDKs) 
phosphorylation of Sld2 and Sld3 lead to the assembly of Dpb11, GINS complex, 
MCM10, Cdc45, and DNA polymerase to initiation sites to form the pre-initiation 
complex (pre-IC), which in turn activates the MCM helicase (Bell and Dutta, 2002; 
Dutta and Bell, 1997; Kelly and Brown, 2000; Labib, 2010; Sclafani and Holzen, 2007; 
Tye, 1999). In higher eukaryotes, a similar cascade has been identified, with RecQ4 and 
TopBP1 being orthologs for Sld2 and Dpb11 respectively (Labib, 2010; Sclafani and 
Holzen, 2007). 
ATP plays an important role in the assembly of pre-RC, which can be found in 
three steps. First, the assembly of ORC is an ATP-dependent process. In human cells, 
mutations in the ATP-binding sites of Orc4 or Orc5 impair complex assembly (Siddiqui 
and Stillman, 2007). Next, ORC binding to DNA requires ATP activity as previously 
described in all the model organisms. Further, the loading of AAA+ family proteins 
Cdc6 and MCM adds the third layer of ATP regulation (Seki and Diffley, 2000). 
ORC interacts with Cdc6 directly, and Cdt1 interacts with MCM directly (Bell, 
2002; Bell and Dutta, 2002; Dutta and Bell, 1997; Kelly and Brown, 2000). However, 
several studies in different eukaryotic species have reported that ORC and Cdc6 are 
dispensable once MCM proteins are loaded. For instance, in S. cerevisiae, MCMs   
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remain bound to origins when Cdc6 is degraded (Tanaka and Nasmyth, 1998). In 
Xenopus, no disturbance of replication initiation is detected when ORC and Cdc6 are 
removed from extracts (Hua and Newport, 1998; Rowles et al., 1999; Sun et al., 2002).  
It is of great importance to note that much of the studies on the ordered 
recruitment are based on genetic mutation analyses and biochemical approaches. 
Molecular mechanisms of how these factors are interconnected are still unclear. In 
addition, as the genome complexity increases from yeast to human, several new factors 
may exist that together establish replication initiation and progression.  
 
I.2. Licensing for DNA replication 
The replication origins are recognized by pre-RC, which dictates the firing of 
DNA replication in S phase. In order to maintain proper genome content, replication 
should only take place “once and only once” in each cell cycle and re-replication should 
be strictly prevented (Arias and Walter, 2007). This mission is largely accomplished by 
the CDK regulation of pre-RC components in the form of cellular localization and 
protein stability at the G1/S transition, by local chromatin contexts and by the existence 
of proteins like Geminin to serve as inhibitors for pre-RC formation (Bell, 2002; Bell 
and Dutta, 2002; Kelly and Brown, 2000; Nishitani and Lygerou, 2002). Recently, 
emerging factors have been noticed in this regulation network, which will be discussed 
at the end of this chapter. 
 
I.2.1. Cell cycle-dependent chromatin localizations of pre-RC components 
Of all the ORC subunits, Orc1 and Orc6 show dynamic association patterns with 
the Orc2-5 core complex. In Xenopus, Orc1 can be removed from chromatin in the 
presence of high CDK activity (Rowles et al., 1999). In human cells, Orc1 and Orc6 are 
transported into nuclei independently of the Orc2-5 core complex (Ghosh et al., 2011), 
indicating separate regulations may apply on this complex.   
In human cells, Cdc6 localizes to the nucleus in G1 phase and to the cytoplasm 
during S phase. It can be specifically phosphorylated by the Cyclin A/Cdk2 complex in 
vivo and in vitro, but not Cyclin E or Cyclin B kinase complexes. The phosphorylation 
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was therefore thought to direct the nuclear removal of Cdc6 in a cell cycle-dependent 
manner. This is confirmed by mutagenesis study that the mutant with putative CDK 
phosphorylation sites mutated to alanines is localized predominantly to the nucleus. 
Moreover, overexpression of Cyclin A results in re-localization of Cdc6 from the 
nucleus to the cytoplasm (Delmolino et al., 2001; Herbig et al., 2000; Petersen et al., 
1999).  
MCM proteins also display cell cycle-dependent localizations. In S. cerevisiae, 
CDK is responsible for the nuclear export of MCM proteins (Labib et al., 1999; Nguyen 
et al., 2000)., Phosphorylation of MCM (especially MCM4) by CDKs leads to the 
removal of MCM from chromatin in Xenopus (Coue et al., 1996; Findeisen et al., 1999; 
Hendrickson et al., 1996; Pereverzeva et al., 2000) and in human cells (Fujita et al., 
1998; Ishimi and Komamura-Kohno, 2001). Further, detailed analysis by visualizing 
MCM at different stages of the cell cycle reveals dynamic patterns of MCM proteins 
associating with the chromatin during G1 phase, presumably anticipating replication 
fork movement during the S phase of the cell cycle (Prasanth et al., 2004a). 
 
I.2.2. Proteasome-mediated degradation of pre-RC components at the G1/S 
transition 
Upon phosphorylation by CDK, several pre-RC components are 
polyubiquitinated and undergo proteasome-mediated destruction at the G1/S transition. 
Ubiquitination is one of the most common forms of post-translational modification, 
which makes conjugated polyubiquitin chains to targeted proteins for degradation 
(Hershko and Ciechanover, 1998; Hochstrasser, 1996; Pickart, 2004). Cullin-RING 
dependent ligases (CRLs) are one major group E3 ligase, (Hershko and Ciechanover, 
1998; Hochstrasser, 1996; Petroski and Deshaies, 2005; Pickart, 2001), playing 
essential roles in directing pre-RC components for proteolytic processes. 
Orc1 dissociates from chromatin at the onset of S phase, and is degraded by the 
SCF
 
E3 ligase complex (Kreitz et al., 2001; Mendez et al., 2002; Ohta et al., 2003). SCF 
(Skp1-Cul1-F-box protein), belongs to the Cullin-1 group of the CRL family, with Skp2 
as the F box protein that interacts with Orc1 (Mendez et al., 2002). Cdc6, in contrast to 
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its localization changes in human cells, is regulated by proteolysis in yeast via SCF, 
with Cdc4 as the F-box protein (Calzada et al., 2000; Drury et al., 1997; Drury et al., 
2000; Elsasser et al., 1999; Jallepalli et al., 1998; Perkins et al., 2001; Piatti et al., 1996; 
Wolf et al., 1999). A major quantity of Cdt1 is also degraded by SCF
Skp2
 at the G1/S 
transition (Li et al., 2003; Liu et al., 2004; Nishitani et al., 2006; Sugimoto et al., 2004); 
and additionally, it undergoes degradation in S phase as well as upon DNA damage by 
Cul4-Ddb1-Cdt2, another cullin family complex of the CRLs (Arias and Walter, 2005; 
Arias and Walter, 2006; Higa et al., 2006; Higa et al., 2003; Hu et al., 2004; Kim and 
Kipreos, 2007; Nishitani et al., 2006; Ralph et al., 2006; Zhong et al., 2003). Please 
refer to table 2 for the summary. 
 
I.2.3. Altered local chromatin contexts for origin selection 
Observations from Drosophila (Aggarwal and Calvi, 2004) and Xenopus (Danis 
et al., 2004) showed that histones at the active origins are usually hyper-acetylated and 
acetylation of histones also favors the selection of active origins, indicating that local 
chromatin contexts may affect pre-RC assembly and origin firing. 
First, histone modifications are crucial for origin establishment. In general, 
H3K4 di- and tri-methylation as well as H3 acetylation are enriched closed to 
replication origins in mammalian cells (Karnani et al., 2010). Analysis of histone 
methyltransferase reveals that PR-Set7 degradation during S phase is required for the 
removal of H4K20 mono-methylation at origins and the inhibition of replication 
licensing, whereas expression of a non-degradable form of PR-Set7 mutant results in 
the maintenance of H4K20 mono-methylation and repeated DNA replication at origins 
(Tardat et al., 2010). In addition, Orc1 recognizes histone H4K20 di-methylation via its 
bromo adjacent homology (BAH) domain, which links histone modification to 
replication licensing. On the other hand, analysis of histone acetyltransferase reveals 
HBO1 as an Orc1 interacting protein (Burke et al., 2001; Iizuka and Stillman, 1999), 
and this histone acetylase activity is essential for DNA replication licensing (Miotto and 
Struhl, 2010), which will be discussed in the HBO1 section.  
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Second, nucleosome positioning is another important determinant. In S. 
cerevisiae, ARS when moved into the central DNA region of the core nucleosome 
particle, shows significant decrease in the copy number (Simpson, 1990). High-
throughput sequencing reveals that origin sequences are sufficient to maintain a 
nucleosome-free origin (Eaton et al., 2010). In Drosophila, a “chromatin accessibility 
complex” is able to change the nucleosomal structure at the origins, which allows the 
efficient initiation of replication on SV40 DNA reconstituted chromatin (Alexiadis et al., 
1998). 
Third, DNA methylation is also a crucial factor. ORC does not bind to CpG 
methylated DNA in Xenopus and DNA replication is therefore inhibited (Harvey and 
Newport, 2003). In addition, studies from hamster and human genes also imply that 
CpG islands, free of methylation, are initiation sites for DNA replication (Antequera 
and Bird, 1999; Delgado et al., 1998). 
All these regulations demonstrate that though no consensus sequence has been 
identified for replication initiation in higher eukaryotes, DNA replication is not a 
random event, but instead a well-controlled process. 
 
I.2.4. Existence of the replication inhibitor, Geminin 
Geminin was first identified in Xenopus as an inhibitor of replication. It is 
absent during G1 phase, but accumulates during S-G2-M phases, and is then mitotically 
degraded by APC/C (anaphase promoting complex/cyclosome) (McGarry and 
Kirschner, 1998). Geminin was proposed to function after Cdc6 binding but before 
MCM loading (McGarry and Kirschner, 1998). Based on the mutually exclusive 
expression patterns between Geminin and Cdt1, it was inferred that Geminin functions 
by antagonizing Cdt1 and acts as a Cdt1 inhibitor. This is confirmed by the 
observations from Xenopus (Tada et al., 2001), Drosophila (Mihaylov et al., 2002; 
Quinn et al., 2001), mouse (Yanagi et al., 2002) and human cells (Wohlschlegel et al., 
2000). 
It is clear now that depletion of Geminin or overexpression of Cdt1 can have 
similar effects on the genomic stability, including re-replication and DNA damage 
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(Melixetian et al., 2004; Tachibana et al., 2005; Zhu et al., 2004). On the other hand, 
overexpression of non-degradable Geminin causes cell cycle arrest (Shreeram et al., 
2002; Wohlschlegel et al., 2002b). Taken together, Cdt1-Geminin balance and proper 
regulation are crucial for genomic stability (Saxena and Dutta, 2005). 
From the structural view, Geminin has a destruction box at the N-terminus for 
APC/C mediated degradation, a coiled-coil domain for self-dimerization, and a Cdt1-
binding domain in the central region (Benjamin et al., 2004; Okorokov et al., 2004), and 
utilizes both the dimerized coiled-coil domain and an adjoining portion to interact with 
Cdt1 on two sites in human cells (Saxena et al., 2004). Further, the crystal structure 
studies from several groups have reported the existence of 1×Cdt1: 2×Geminin as the 
licensing permissive heterotrimer as well as 2×(1×Cdt1: 2×Geminin) as the licensing 
inhibitory heterohexamer (De Marco et al., 2009; Lee et al., 2004; Thepaut et al., 2004). 
Therefore, the stoichiometry of the Cdt1-Geminin complex is crucial for licensing 
control (Lutzmann et al., 2006). Interestingly, recent work has demonstrated that 
Geminin can also stabilize Cdt1 in mitosis and thus serve as a positive regulator 
(Ballabeni et al., 2004).   
 
I.3. ORC for non-replication functions 
Other than its classic role in replication initiation, ORC is involved in various 
other cellular events. The most studied aspect is the impact on the chromatin status, for 
example heterochromatin formation and chromosome condensation. How ORC serves 
as a multi-functional complex is not completely clear, and whether additional proteins 
help ORC define its diverse activities is intriguing and needs to be elucidated. It is 
important to note that some of the non-replication functions are indirectly related to its 
primary role in replication initiation, while other functions have been separated out 
from this role. 
 
I.3.1. Transcription silencing and heterochromatin formation 
In S. cerevisiae, genetic mutation analyses of impaired mating type loci (HMR) 
led to the identification of Orc2 involvement in transcriptional repression, which is the 
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first indication of ORC functions in the establishment of silencing (Bell et al., 1993; 
Foss et al., 1993; Micklem et al., 1993). Several pieces of evidence demonstrate that 
this function is genetically separable to its primary role in the origin recognition. First, 
Orc1 is related to different sets of proteins to function separately (Bell et al., 1995; Fox 
et al., 1997). ORC mutants like Orc5 that are defective for silencing but not replication 
have been isolated out (Dillin and Rine, 1997; Fox et al., 1995). Further, established 
silencing is observed in non-replicating extra-chromosomal cassette (Kirchmaier and 
Rine, 2001; Li et al., 2001). It has been found that Sir1 connects ORC (Orc1) and Sir2-4 
at silencers to conduct gene silencing (Bose et al., 2004; Fox et al., 1997; Gardner and 
Fox, 2001; Loo et al., 1995; Triolo and Sternglanz, 1996), and crystal structures have 
revealed that the interaction occurs via the ORC interaction region  (OIR) of Sir1 and 
the N-terminal BAH  domain of Orc1 (Hou et al., 2005; Hsu et al., 2005; Zhang et al., 
2002). Interestingly, this mechanism might become more complicated as new findings 
being added into the model. For instance, ORC may also utilize Sir-independent 
mechanisms at HMR (Sutton et al., 2001). 
In Drosophila, the similar function of ORC in the establishment of 
transcriptionally repressed heterochromatin has also been reported (Huang et al., 1998; 
Pak et al., 1997). Orc2 co-localizes with HP1 at heterochromatic regions, and HP1 
localization into heterochromatin is disrupted in Orc2 mutants. Heterozygous Orc2 
recessive lethal mutations have also been shown to affect the position effect variegation 
(PEV). Interaction analysis reveals that HP1 interacts with the N-terminus of Orc1, 
similar to the interaction of Sir1-Orc1 in S. cerevisiae, indicating the evolutionarily 
conserved function of proteins like Sir1 and HP1 connecting ORC with 
heterochromatin.  
In human cells, ORC co-localizes with HP1 at heterochromatin, and 
immunoprecipitation proves their physical interactions. Orc2 depletion disrupts HP1 
localization and impairs the heterochromatin organization (Prasanth et al., 2004b). Later 
on, multiple ORC subunits are found co-localized with HP1 at the heterochromatic 
regions in a cell cycle-dependent manner (DePamphilis, 2003; DePamphilis, 2005; 
Lidonnici et al., 2004) and with distinct association dynamics (Prasanth et al., 2010). 
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Orc1 and Orc3 directly bind to HP1, and disruption of ORC subunits leads to the 
abnormal distribution of HP1, and vice versa. These all suggest that ORC and HP1 are 
mutually required for each other to bind to heterochromatin (Prasanth et al., 2010). 
 
I.3.2. Chromosome condensation and chromatid cohesion in mitosis 
This function is also first implied by genetic studies from S. cerevisiae where 
ORC mutants displayed defects in M phase (Dillin and Rine, 1998) and could activate 
spindle checkpoint (Gibson et al., 2006). A genetic mutation study on Orc5 and Scc1 
(Suter et al., 2004) strengthens this connection. Importantly, the rescue in sister 
chromatid cohesion impaired cells by expression of Orc2 in late G2/M phase further 
confirms that ORC not only participates in sister chromatid cohesion, but is also 
independent of its replication function (Shimada and Gasser, 2007). 
In Drosophila, mutants of ORC show abnormal chromosome condensation. 
Defects in Orc2 show irregularly condensed chromosomes, with greatest problem in the 
abnormally late replicating regions of chromatin (Loupart et al., 2000). Orc2 and Orc5 
mutants are also reported with defects in metaphase: alignment failures from shorter / 
thicker chromosomes and the poorly assembled spindle (Pflumm and Botchan, 2001). 
In Xenopus, ORC is required at the interphase-mitosis transition for mitotic 
chromosome assembly, independent on DNA replication (Cuvier et al., 2006). Further, 
the recruitment of cohesins to chromosomes requires ORC and other pre-RC 
components in a licensing state (Takahashi et al., 2004), and is inhibited by Geminin 
(Gillespie and Hirano, 2004). 
In human cells, a fraction of Orc2 localizes to centromeres and centrosomes 
throughout the cell cycle. Other than replication effect, depletion of Orc2 also results in 
a population of cells arrested in mitosis with abnormally condensed chromosome, failed 
chromosome congression, and multiple centrosomes (Prasanth et al., 2004b). 
As demonstrated in yeast (Shimada and Gasser, 2007), further investigation in 
higher eukaryotes may be able to differentiate whether the ORC involvement in   
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chromosome condensation and chromatid cohesion in mitosis is due to its intrinsic 
function separable from replication role or due to the indirect effect of abnormal DNA 
replication caused by ORC defects (Chesnokov, 2007; Sasaki and Gilbert, 2007). 
 
I.3.3. Other functions 
Notably, many other functions have been reported in different model organisms, 
involving one or more subunits of the ORC. 
Orc1 controls centriole and centrosome copy number in human cells by 
preventing Cyclin E-dependent reduplication of them in each cell cycle. This 
centrosomes interaction of Orc1 is promoted by Cyclin A (Hemerly et al., 2009). In fact, 
putative cyclin-dependent phosphorylation sites on Orc1 have also been reported in the 
mouse homolog (Zisimopoulou et al., 1998). 
Orc2 can be co-purified from telomere-repeat DNA containing complex, and 
localizes to telomeres, which is recruited by Trf2. Depletion of Orc2 leads to 
dysfunctional telomeres, including telomere-signal-free ends and telomere-repeat-
containing double minutes, and increased telomere circle formation, indicating Orc2 is 
required for telomere integrity (Deng et al., 2007; Tatsumi et al., 2008). 
Orc3, its homolog latheo in Drosophila, was first identified from P element 
mutagenesis as a protein affecting associative learning and/or memory (Boynton and 
Tully, 1992). Orc3 localizes at synaptic connections of the larval neuromuscular 
junction (NMJ), and plays an essential role in regulating Ca
2+
-dependent synaptic 
plasticity (Pinto et al., 1999; Rohrbough et al., 1999). 
ORC core complex has also been reported in adult mouse brain tissues, where it 
localizes to dendrites. Orc3, Orc4 and Orc5 associate with neuronal membranes, and 
individual siRNA or mutant analyses demonstrate Orc3, Orc4, and Orc5 are required 
for proper dendritic growth and branching (Huang et al., 2005). 
Orc6 is involved in cytokinesis. In human cells, Orc6 localizes to kinetochores 
and to a reticular-like structure around the cell periphery during mitosis. In anaphase, 
the reticular structures align along the plane of cell division and Orc6 localizes to the 
midbody. Depletion of Orc6 leads to the formation of multi-nucleated cells (Prasanth et 
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al., 2002). In Drosophila, Orc6 has a large fraction in the cytoplasm near the cell 
membrane (Chesnokov et al., 2001). Further examination reveals that Orc6 localizes to 
the cleavage furrow during cell division and interacts with Pnut, a protein important for 
cell division, and depletion of Orc6 results in the formation of multi-nucleated cells 
(Chesnokov et al., 2003). In addition, mutation analyses suggest that the N-terminal 
domain of Orc6 is responsible for DNA replication function, while the C-terminal 
domain is crucial for the M phase function (Balasov et al., 2009). Analysis on a 
temperature-sensitive degron form of Orc6 that was created based on the Varshavsky’s 
N-end rule demonstrates that Orc6 is essential for symmetric cell division and 
cytokinetic abscission in mitosis, independent from its function in DNA replication 
(Bernal and Venkitaraman, 2011). However, Orc6 is not required for cytokinesis during 
mitosis in yeast (Semple et al., 2006). 
As more non-replication functions are explored, it is of great importance to 
investigate how ORC subunits separate the canonical replication function from these 
diverse cellular pathways and what other factors may play the roles in directing them in 
this complicated network. 
 
I.4. Emerging players in the initiation of replication  
From yeast to human cells, the complexity of the organisms increases 
dramatically. Therefore, additional factors may exist and have been unveiled in the 
involvement and the control of the replication initiation. Geminin, as the pre-RC 
inhibitor, is a good example that can only be found in metazoans (McGarry and 
Kirschner, 1998). In this section, I discuss several factors (from proteins to RNAs) as 
emerging players in the regulation of pre-RC. Interestingly, based on the homology 
analysis, most of them can only be found in higher eukaryotes.  
 
I.4.1. ORC accessory factors 
HBO1. HBO1 (human acetylase binding to Orc1) was originally identified in a 
yeast two-hybrid screen from HeLa cell cDNA library using Orc1 as the bait. The 
histone acetyltransferase activities were found in the HBO1-containing complex, 
17 
 
indicating that an ORC-mediated chromatin acetylation influenced DNA replication 
(Iizuka and Stillman, 1999). In human cells, HBO1 knockdown leads to the MCM 
chromatin loading defect, with no effect on chromatin loading of ORC and Cdc6, 
suggesting HBO1’s involvement at a step after ORC and Cdc6 but upstream of MCM 
loading. In Xenopus egg extracts, immunodepletion of HBO1 also impairs chromatin 
binding of MCM and DNA replication, but this can be restored upon the addition of 
recombinant Cdt1 (Iizuka et al., 2006).  
HBO1 associates with origins in G1 phase, directly interacts with Cdt1, and 
enhances Cdt1-dependent re-replication, therefore acting as the co-activator of Cdt1 
(Miotto and Struhl, 2008). Investigations on the HBO1 acetyltransferase activity reveals 
that HBO1-mediated histone H4 acetylation at origins is required for MCM loading, 
and that Geminin inhibits HBO1 acetylase activity in a Cdt1-dependent manner (Miotto 
and Struhl, 2010). This is consistent with a recent report that Cdt1-HBO1 complex 
promotes MCM loading through acetylation-mediated enhancement of chromatin 
accessibility in G1 phase and is inhibited by Cdt1-Geminin-HDAC11 via deacetylation 
in S phase (Wong et al., 2010). Interestingly, Cdt1-HBO1 interaction is well regulated: 
in response to stress, JNK1 phosphorylates Cdt1 on threonine 29, which results in the 
dissociation of HBO1 from replication origins and consequently results in the inhibition 
of replication initiation (Miotto and Struhl, 2011). Taken together, HBO1 is a key 
molecule that organizes chromatin to facilitate pre-RC assembly and replication 
initiation.  
14-3-3. 14-3-3 protein family comprises a set of ~30 kDa acidic polypeptides. 
These proteins exhibit specific phospho-serine/phospho-threonine binding activities, 
and thus are involved in various cellular pathways, including cell growth, apoptosis, 
cytokinesis, and tumor suppression (Aitken, 2006; Morrison, 2009). In mammalian cells, 
CBP (cruciform-binding protein) belongs to the 14-3-3 family. ChIP experiments reveal 
that CBP associates with monkey replication origins ors8 and ors12, which bear 
inverted repeats and form the cruciform structure. This origin association takes place in 
a cell cycle-dependent manner, with maximal activity at the G1/S boundary (Alvarez et 
al., 2002; Novac et al., 2002; Zannis-Hadjopoulos et al., 2002). Addition of CBP 
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antibodies impairs CBP-cruciform DNA complex formation and inhibits DNA 
replication in vitro (Alvarez et al., 2002; Novac et al., 2002). In Saccharomyces 
cerevisiae, Bmh1 and Bmh2, the 14-3-3 homologs in budding yeast, also have 
cruciform DNA binding activities and bind to replication origin ARS307 in vivo 
(Callejo et al., 2002; Yahyaoui et al., 2007). Recently, the role of 14-3-3 in replication 
initiation has been elucidated. Bmh2 interacts with Orc2 and MCM2, and binds to ARS, 
peaking in G1 phase (Yahyaoui and Zannis-Hadjopoulos, 2009). Utilizing a Bmh2 
temperature-sensitive (bmh2-ts) mutant strain, it has been demonstrated that Bmh2 is 
required for the loading and maintenance of MCM on chromatin during G1 phase, thus 
an essential component for pre-RC formation, DNA replication initiation, and normal 
cell cycle progression (Yahyaoui and Zannis-Hadjopoulos, 2009). 14-3-3 binding to 
cruciform DNA indicates that additional factors may be needed in eukaryotes for 
replication activation at specific DNA structures. 
This site-specific association of ORC accessory factors is also evident at other 
DNA contexts. In Drosophila, the Myb (Myeloblastosis)-containing complex (Myb p85, 
Caf1 p55, p40, p120, and p130) binds in a site-specific manner to the chorion gene 
cluster, ACE3 and ori-β. The Myb complex interacts with ORC, and is essential for 
chorion gene amplification (Beall et al., 2002). Myb may function in converting 
specific inactive replication origins to active ones, possibly by facilitating acetylation at 
origins (Beall et al., 2004; Calvi et al., 2007). In mammalian cells, high mobility group 
(HMG) proteins have the AT-hook motif that binds to the minor groove of the AT-rich 
regions of double-stranded DNA (Reeves and Nissen, 1990). A member of the HMG 
proteins, HMGA1a, associates with ORC in vitro and in vivo (Thomae et al., 2008). 
Targeting HMGA1a to specific DNA sites recruits ORC and creates functional 
replication origins, and the abundance of recruited ORC correlates with the local 
density of HMGA1a. It is therefore proposed that high local concentration of HMGA1a 
may function as a potent, dominant replication origin (Thomae et al., 2008). These 
examples indicate that it will be critical to determine if a defined set of protein 
complexes associates with specific DNA elements that in turn regulates the replication 
initiation at site-specific replication origins. 
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I.4.2. Cdt1-Geminin associated proteins 
HOX. HOX proteins control cell fate determination and patterning specification 
processes during development. They function as transcription factors that bind DNA via 
their homeodomain (Favier and Dolle, 1997; Gehring, 1987; Gehring et al., 1994a; 
Gehring et al., 1994b; Krumlauf, 1994). Through a yeast two-hybrid screen using 
cDNA library from 8.5 days post coitum mouse embryos, Geminin was found to 
associate with HOX proteins, the HOX regulatory DNA elements, as well as the HOX-
repressing polycomb complex (Luo et al., 2004). Geminin inhibits HOX’s function as 
the transcriptional activator, and Geminin-HOX impairs Geminin-Cdt1 interaction (Luo 
et al., 2004). Interestingly, ChIP assay illustrates that HOXD13, HOXD11 and 
HOXA13 bind to human replication origins in vivo, where HOXD13 directly interacts 
with Cdc6 via its homeodomain, promoting pre-RC assembly at origins and 
subsequently stimulating DNA replication (Salsi et al., 2009). Binding of Geminin to 
HOXD13 blocks its pre-RC promoting function; however, exogenous HOXD13 
expression overrides non-degradable Geminin-induced G1 accumulation (Salsi et al., 
2009). A recent study has resolved the solution structure of the homeodomain of 
HOXC9 (HOXC9-HD) in complex with Geminin homeodomain binding region (Gem-
HBR). Interestingly, the C-terminal residue Ser184 of Geminin can be phosphorylated 
by Casein kinase II (CK2), resulting in its higher binding affinity and inhibitory effect 
toward HOX (Zhou et al., 2012). Taken together, these data establish the HOX 
interactions with pre-RC and Geminin as an additional mechanism for controlling pre-
RC assembly and replication initiation.  
Idas. Discovered as a Geminin homolog, Idas shares high similarity with 
Geminin’s central coiled-coil region. The term “Idas” was derived after the name of 
Gemini’s cousin (in ancient Greek mythology). In human cells, Idas localizes in nucleus 
with decreased protein levels in anaphase (Pefani et al., 2011). It forms a complex with 
Geminin, but not Cdt1, and this direct binding prevents Geminin from binding to Cdt1 
and translocates Geminin from cytoplasm to nucleus (Pefani et al., 2011). Depletion of 
Idas leads to the accumulation of cells in S phase and inefficient progression to mitosis 
and G1, whereas overexpression leads to accumulation of multi-nucleated cells (Pefani 
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et al., 2011). In contrast, overexpression of Geminin shows S phase accumulation 
(Shreeram et al., 2002), while depletion of Geminin shows multipolar spindle defects 
(Tachibana et al., 2005). Therefore Idas, possibly by inhibiting Geminin function, may 
provide yet a novel insight to the pre-RC regulation. The recent study has also indicated 
the specific high expression of Idas in the cortical hem and choroid plexus of the 
developing mouse telencephalon, indicating its involvement in developmental control 
(Pefani et al., 2011). 
Geminin has dual functions: replication licensing inhibition and developmental 
control (Kroll, 2007; Luo and Kessel, 2004; Seo and Kroll, 2006). Both HOX proteins 
and Idas affect normal cell cycle proliferation and are also involved in the 
developmental regulation of differentiation. Also notably, they both compete with Cdt1 
for Geminin binding, suggesting that these proteins play crucial roles in pre-RC 
regulation or balancing Geminin’s dual functions along with Cdt1.  
 
I.4.3. MCM related proteins 
MCM8. MCM8 was categorized as a new member of the MCM family based on 
its structural conservation, sharing the conserved MCM helicase ATP binding domain 
as in the MCM2-7 (Gozuacik et al., 2003; Johnson et al., 2003). In human cells, MCM8 
binding to chromatin is cell cycle-regulated (Volkening and Hoffmann, 2005). It 
interacts with Orc2 and Cdc6 (Volkening and Hoffmann, 2005), and co-localizes with 
Cdc6 at c-myc initiation site (Kinoshita et al., 2008). Depletion of MCM8 affects the 
normal G1/S transition and leads to the loading defects of Cdc6 and MCM onto 
chromatin (Volkening and Hoffmann, 2005). In Xenopus, MCM8 has been shown to 
function as a DNA helicase during replication elongation, but not for replication 
initiation (Maiorano et al., 2005). MCM8 is not required for MCM2-7 chromatin 
loading, but instead binds to chromatin at the onset of DNA replication, after replication 
licensing (Maiorano et al., 2005). MCM8 co-localizes with replication foci; with its 
DNA helicase and DNA-dependent ATPase activities, MCM8 regulates the chromatin   
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assembly of DNA polymerase α and RPA34 (Maiorano et al., 2005). In Drosophila S2 
cells, MCM8 depletion diminishes PCNA binding by 30–50%, also indicating the 
involvement of MCM8 in DNA synthesis (Crevel et al., 2007). 
Different cell assay systems and species might explain the differences regarding 
the roles of MCM8 in replication initiation and/or elongation. In Xenopus, Cdc6 
displays reduced chromatin association after replication licensing, and is reloaded onto 
chromatin at the onset of S phase (Oehlmann et al., 2004). In HeLa cells, MCM8 and 
Cdc6 co-localize at the c-myc replication initiation zone during G1 and this association 
continues even after completion of DNA replication (Kinoshita et al., 2008). These data 
indicate that the loss of Cdc6 association to chromatin in MCM8-depleted cells could 
either suggest a role of MCM8 in loading Cdc6 onto chromatin to facilitate pre-RC 
assembly, and/or an independent role in post-G1 phase cells. Moreover, during a small 
time window at the G1/S boundary, the chromatin bound MCM8 also drops to low 
levels, thus manifesting two discontinuous functions of MCM8 and possibly the dual 
role in both DNA replication initiation and elongation (Kinoshita et al., 2008). 
MCM9. MCM9 was identified as another MCM family member by 
bioinformatic approaches (Lutzmann et al., 2005; Yoshida, 2005). In Xenopus, the 
binding of MCM9 onto chromatin is dependent on ORC. Further, MCM9 facilitates the 
loading of MCM2-7 onto chromatin (Lutzmann and Mechali, 2008). In the absence of 
MCM9, pre-RC assembly is hampered and DNA replication halts. Mechanistic analysis 
shows that MCM9 forms a complex with Cdt1, limiting the amount of Geminin that can 
associate with Cdt1 on chromatin during replication licensing. This enables the active 
Cdt1 to load MCM onto chromatin by modulating the ratio of Cdt1 to Geminin 
(Lutzmann and Mechali, 2008; Lutzmann and Mechali, 2009). However, MCM9 is not 
required for pre-RC formation or DNA replication in mice, as no change for chromatin-
bound MCM2/4/7 or Cdt1 were observed upon MCM disruption (Hartford et al., 2011). 
It is possible that these organisms have evolved species-specific and tissue-specific 
requirements. 
Recently, using MCM8 and MCM9 knockout chicken DT40 cell lines as well as 
MCM8-/- and MCM9-/- deficient mice, two groups demonstrate that MCM8 and 
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MCM9 form a complex, distinct from MCM2-7 complex, and they co-regulate their 
stability. Importantly, they are both required for proper homologous recombination 
(Lutzmann et al., 2012; Nishimura et al., 2012). 
MCM10. MCM10 was identified in genetic screens for minichromosome 
maintenance defects and DNA replication defects (Dumas et al., 1982; Maine et al., 
1984; Merchant et al., 1997; Solomon et al., 1992). It does not exhibit sequence 
homology to MCM2-7, but is conserved in most eukaryotes (Liu et al., 2009), and it 
also has the ability to bind both single- and double-stranded DNA (Eisenberg et al., 
2009; Fien et al., 2004; Okorokov et al., 2007; Robertson et al., 2008; Warren et al., 
2009; Warren et al., 2008). In Saccharomyces cerevisiae and Xenopus laevis, MCM10 
can self-assemble into homo-complex, which requires its zinc finger motif (Cook et al., 
2003; Robertson et al., 2008); and in human cells, MCM10 forms a hexameric ring 
structure (Okorokov et al., 2007). MCM10 interacts with MCM2-7, which is essential 
for DNA replication initiation in all eukaryotes examined, including Saccharomyces 
cerevisiae (Gambus et al., 2006; Homesley et al., 2000; Merchant et al., 1997), 
Schizosaccharomyces pombe (Hart et al., 2002; Lee et al., 2003; Liang and Forsburg, 
2001), Xenopus (Zhu et al., 2007), Drosophila (Apger et al., 2010), and human cells 
(Izumi et al., 2000; Zhu et al., 2007). Chromatin loaded MCM2-7 (the inactive form) 
enables the efficient recruitment of MCM10 (van Deursen et al., 2012). MCM10 also 
interacts with DNA polymerase α (Chattopadhyay and Bielinsky, 2007; Fien et al., 
2004; Lee et al., 2010; Ricke and Bielinsky, 2004; Ricke and Bielinsky, 2006; 
Robertson et al., 2008; Warren et al., 2009; Warren et al., 2008; Zhu et al., 2007) and 
recruits DNA polymerase α to replication origins/forks and stabilizes its catalytic 
subunit (Chattopadhyay and Bielinsky, 2007; Ricke and Bielinsky, 2004; Ricke and 
Bielinsky, 2006), functioning together with Ctf4/And-1 (Wang et al., 2010; Zhu et al., 
2007). Taken together, MCM10 may serve as the coordinator for MCM2-7 helicase and 
DNA polymerase, facilitating their roles during replication initiation and elongation. 
MCM10 binds to origins in a TopBP1-dependent manner (Taylor et al., 2011). 
Interestingly, it associates with replication initiation sites before Cdc45, promoting 
Cdc45 chromatin association (Gregan et al., 2003; Sawyer et al., 2004; Wohlschlegel et 
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al., 2002a), as well as after Cdc45 along with DNA polymerase α (Heller et al., 2011; 
Ricke and Bielinsky, 2004). This pre- and post- Cdc45 recruitment of MCM10 is 
intriguing, indicating its complicated but yet uncovered function with CMG. 
Recently, several groups have reported that the origin association of MCM10 is 
independent of CMG assembly, but is essential for DNA unwinding (Kanke et al., 2012; 
van Deursen et al., 2012; Watase et al., 2012). In Saccharomyces cerevisiae, the stable 
CMG complex remains at origins upon the auxin-induced MCM10 degradation 
(mcm10-1-aid) (Watase et al., 2012), and Cdc45-MCM2-7-GINS interactions are not 
impaired upon temperature-induced MCM10 degradation (mcm10-1td) (van Deursen et 
al., 2012), indicating CMG origin assembly is independent of MCM10. However, RPA 
loading is defective in the absence of MCM10 in both studies, suggesting MCM10 
functions in origin DNA unwinding (van Deursen et al., 2012; Watase et al., 2012). 
Parallel observations were also made in Schizosaccharomyces pombe using combined 
promoter shut-off and auxin-induced degradation system (off-aid) (Kanke et al., 2012). 
Moreover, point mutations within the zinc finger motif in fission yeast MCM10 
(MCM10
ZA
) reveals that this motif plays an important role in unwinding origin, though 
it is not essential for MCM10 origin association (Kanke et al., 2012).  
MCM-BP. MCM-BP (MCM-binding protein) was first identified from mass 
spectrometric analyses of TAP (tandem affinity purification) tagged MCM6 and MCM7 
immunoprecipitations (Sakwe et al., 2007). Interestingly, MCM-BP interacts with 
MCM3-7 but not MCM2, indicating MCM-BP and MCM2 form different complexes 
with MCM3-7 (Ding and Forsburg, 2011; Li et al., 2011; Nishiyama et al., 2011; Sakwe 
et al., 2007). Notably, it is reported that MCM-BP may interact with MCM2, but only at 
high protein levels (Nguyen et al., 2012). Further, MCM-BP can interact with the core 
complex MCM4/6/7 in vitro, but does not inhibit the helicase activity (Sakwe et al., 
2007). 
In Arabidopsis thaliana, ETG1 (E2F target gene 1, MCM-BP homolog) is 
required for DNA replication. ETG1-deficient plants display the activation of DNA 
replication stress checkpoint, which is crucial to their survival (Takahashi et al., 2008). 
In Schizosaccharomyces pombe, overexpression of Mcb1 (MCM-BP homolog) disrupts 
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MCM2 association with MCM3-7 complex and causes MCMs dissociation from 
chromatin, leading to DNA replication inhibition, DNA damage and checkpoint 
activation (Ding and Forsburg, 2011; Li et al., 2011). In Xenopus egg extracts, MCM-
BP accumulates in the nucleus in late S phase. Immunodepletion of MCM-BP inhibits 
replication-coupled MCM2-7 dissociation from chromatin, whereas addition of excess 
recombinant MCM-BP disassembles the MCM2-7 complex (Nishiyama et al., 2011). 
Similar observations on these species were also obtained in human cells. MCM-BP 
binds to chromatin in a cell cycle-dependent manner: associating with chromatin in M-
G1-S and dissociating from chromatin in late G2-early M, a pattern slightly later than 
that of MCM2-7 (Sakwe et al., 2007). MCM-BP siRNA knockdown results in the 
reduced dissociation of MCM from chromatin, consistent with its role as the MCM2-7 
unloader from chromatin (Nishiyama et al., 2011). ShRNA prolonged knockdown 
results in G2 checkpoint activation, and raised whole cell levels as well as soluble 
levels of MCM proteins (Jagannathan et al., 2012). Interestingly, yeast two-hybrid 
assay and immunoprecipitation analysis reveal that MCM-BP also interacts with Dbf4. 
However, MCM-BP is not a DDK substrate, but inhibits the phosphorylation of MCM 
by DDK instead, adding another layer of complexity in replication regulation (Nguyen 
et al., 2012). 
Moreover, MCM-BP is also involved in other cellular events. In Arabidopsis 
thaliana, ETG1 is required for the establishment of sister chromatid cohesion 
(Takahashi et al., 2010); in fission yeast, MCM-BP is essential for meiosis (Li et al., 
2011); and in human cells, MCM-BP shRNA knockdown leads to abnormal nuclear 
morphology and centrosomal amplification (Jagannathan et al., 2012). Further 
investigations are needed to distinguish whether these observations indicate its separate 
functions from the DNA replication role or an indirect effect due to aberrant DNA 
replication. 
 
I.4.4. Non-coding RNAs 
Y RNAs. Y RNAs are conserved small stem-loop RNAs, first identified as the 
cytoplasmic RNA components of Ro ribonucleoprotein particles (Ro RNPs) in higher 
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eukaryotes. In human cells, there are 4 types of Y RNAs: Y1, Y3, Y4, and Y5 (Farris et 
al., 1995; Hendrick et al., 1981; Mosig et al., 2007; Perreault et al., 2007; Pruijn et al., 
1990; Pruijn et al., 1993). In human cell free system (late G1 phase nuclei), both 
reconstitution and individual degradation of Y RNAs demonstrate that they are required 
for chromosomal DNA replication, and can substitute for each other (Christov et al., 
2006). However, Y1 RNA binding to Ro60 is not necessary for DNA replication 
(Christov et al., 2006), neither is the Y RNAs containing ribonucleoprotein complex 
(Langley et al., 2010). During the investigation on how Y RNAs are involved in DNA 
replication, DNA combing/fiber fluorescence and nascent-strand analysis were utilized 
to study the effect of Y RNA degradation (Y3) and the supplementation of non-targeted 
Y RNA (Y1), which demonstrated that Y RNAs are required for the initiation rather 
than the elongation of DNA replication (Krude et al., 2009). Interestingly, only 
vertebrate Y RNAs are able to reconstitute chromosomal DNA replication in vitro, 
which led to the discovery of a conserved motif in the double-stranded stem of 
vertebrate Y RNAs that is sufficient for its function (Gardiner et al., 2009). In the recent 
study using fluorescence labeling, it has been shown that Y RNAs associate with 
unreplicated euchromatin in late G1 phase, then disassociate from replicated DNA. 
Pull-down experiments revealed that they interact with ORC and other pre-RC 
components. Therefore, a “catch and release” mechanism was proposed for Y RNAs as 
another licensing factor for replication initiation (Zhang et al., 2011). In addition, 
evidence from Xenopus and zebrafish embryos suggest that Y RNAs may function as a 
developmental control at midblastula transition (MBT) for DNA replication, as Y RNA 
is not required for DNA replication before MBT, but is necessary for replication and 
associates with chromatin in an ORC-dependent fashion after MBT (Collart et al., 
2011). 
G-quadruplex RNA. Epstein–Barr virus (EBV) is an oncogenic herpesvirus 
that can infect human cells and stay in the host as an episome, which replicates once per 
cell cycle. EBV utilizes EBV-encoded protein EBNA1 (Epstein–Barr nuclear antigen 1) 
to recruit host ORC to its origin, oriP, in order to replicate its DNA (Adams, 1987; 
Chaudhuri et al., 2001; Dhar et al., 2001b; Lindner and Sugden, 2007; Schepers et al., 
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2001; Yates and Guan, 1991). The N terminal domain of EBNA1 has two linking 
regions 1 and 2 (LR1 and LR2) that interact with ORC, and deletion of LR1 and LR2 
from EBNA1 eliminates its ORC binding ability (Norseen et al., 2008). Sequence 
analysis of LR1 and LR2 regions shows that they both have arginine- and glycine-rich 
motifs (RG-rich motifs) (Norseen et al., 2008). Substitution of arginines or glycines to 
alanines in LR2 region abolishes ORC association, indicating that the RG-rich motif 
plays a pivotal role in ORC-EBNA1 association (Norseen et al., 2008). Interestingly, 
RNase A but not DNase I disrupts ORC-EBNA1 interaction, suggesting that the 
recruitment of ORC to EBNA1 is RNA dependent (Norseen et al., 2008). EBNA1 
displays RNA binding ability (Lu et al., 2004; Snudden et al., 1994), and has a RG-rich 
motif that is known for its RNA binding activity (Burd and Dreyfuss, 1994). Taken 
together, these indicate an RNA-dependent recruitment of ORC to EBNA1 by the N-
terminal LR1 and LR2 regions of EBNA1.  
Further analyses reveal that this RNA dependency is from the G-quadruplex 
RNA (Norseen et al., 2009; Norseen et al., 2008). A G-quartet is formed by four 
guanines in a square arrangement via hydrogen bonds, and a G-quadruplex is formed by 
two or more stacked G-quartets (Huppert, 2008). The involvement of G-quadruplex 
RNA in ORC-EBNA1 association is demonstrated by introducing a G-quadruplex-
interacting compound, BRACO-19, which abolishes EBNA1 recruitment of ORC and 
inhibits EBNA1-dependent replication of oriP (Norseen et al., 2009). 
The emergence of non-coding RNAs from these studies implies the existence of 
additional factors assisting ORC for origin targeting and replication licensing. 
Intriguingly, upon RNase A treatment, a fraction of ORC is released from chromatin, 
indicating that the ORC association with chromatin can be partially stabilized by RNA 
(Norseen et al., 2008). Therefore, it is highly possible that some structured RNAs 
mediate ORC recruitment to certain origins. These findings reinforce the important role 
of non-coding RNAs in the regulation of replication initiation. 
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I.5. Conclusions 
From the identification of ORC in Saccharomyces cerevisiae in 1992 (Bell and 
Stillman, 1992), enormous achievements have been made in the past two decades in 
dissecting how ORC-mediated assembly of pre-RC regulates the initiation event of 
DNA replication. The ordered assembly of ORC, Cdc6, Cdt1, and MCM has been 
found highly conserved in all the examined model organisms, from budding and fission 
yeast, to Drosophila and Xenopus, and to mammalian cells; and the regulation of pre-
RC has been carried out from multiple layers, including protein localizations, protein 
stabilities, local chromatin contexts, and pre-RC inhibitors. Though these mechanisms 
seem to be redundant, they serve as “guardians” to ensure DNA replication takes place 
“once and only once” in each cell cycle. 
Notably, several novel members have joined the family of pre-RC, mostly 
discovered from proteomic screens/analyses and bioinformatic predictions; at the same 
time, many classic factors, including HBO1, 14-3-3, HOX, MCM10, and Y RNAs, 
were merited with additional roles in replication. However, what we know is probably 
only the tip of the iceberg. For instance, the complete in vitro reconstitution of DNA 
replication initiation machinery or sub-complexes using purified proteins has so far 
been unsuccessful, indicating that there are still important players missing for the 
orchestra. Investigations in other less-studied species may lead us to some valuable 
clues. In Tetrahymena thermophila, ORC has a 26T RNA component that involves in 
ribosomal DNA origin recognition via complementary base pairing (Mohammad et al., 
2007). It will be interesting to find out whether similar functional player exists in other 
model organisms. On the other hand, with the increasing genome size and complexity 
of protein network from lower to higher eukaryotes, how timely control and dynamic 
regulation of replication are achieved also need further elucidation. As reported from a 
recent study using a novel hybrid CHO cell/Xenopus egg extracts, a pre-restriction point 
inhibitor exists for licensing. Other than ruling out pre-RC components, Geminin, 
HBO1 or CDK, the nature of this inhibitor was not characterized (Sasaki et al., 2011).  
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Therefore, exploring new pre-RC association factors (especially from the 
ground level, ORC) may unveil potential questions. In the following chapter, I will 
discuss the characterization and functional studies of a novel ORC association factor, 
ORCA/LRWD1 in the initiation of DNA replication. 
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I.6. Tables 
 
 
 
 
 
 
Table 1. ORC binding sites in different eukaryotic species 
Species Binding Sites References 
Saccharomyces 
cerevisiae 
A and B1 elements 
(Bell and Stillman, 1992; Lee and Bell, 
1997; Rao and Stillman, 1995; Rowley 
et al., 1995) 
Schizosaccharomyces 
pombe 
AT-rich sequences 
ars2004 and ars3002 
(Chuang and Kelly, 1999; Kong and 
DePamphilis, 2001; Kong and 
DePamphilis, 2002; Lee et al., 2001; 
Ogawa et al., 1999) 
Drosophila 
melanogaster 
ACE3 and oriβ 
(Austin et al., 1999; Chesnokov et al., 
2001) 
Xenopus laevis 
AT-rich sequences 
5-15kb apart 
(Blow et al., 2001; Kong et al., 2003; 
Rowles et al., 1999) 
Homo sapiens 
Lamin B-2, β-globin, c-
myc, and rDNA 
(Abdurashidova et al., 1998; Kamath 
and Leffak, 2001; Little et al., 1993; 
Waltz et al., 1996) 
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Table 2. Proteolytic pathways of pre-RC components 
Pre-RC 
Components 
Species 
Cullin 
Family 
RING 
Protein 
Adaptor 
Substrate 
Mediator 
Cell Cycle 
Stage 
Orc1 Homo Sapiens Cul1 Rbx1 Skp1 
Skp2 
(F-box) 
G1/S 
Cdc6 
Saccharomyces 
cerevisiae 
Cdc53 Rbx1 Skp1 
Cdc4 
(F-box) 
G1/S 
Cdt1 Homo Sapiens Cul1 Rbx1 Skp1 
Skp2 
(F-box) 
G1/S 
Cdt1 Homo Sapiens Cul4 Rbx1 Ddb1 Cdt2 
S + 
DNA 
damage 
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CHAPTER II. IDENTIFICATION AND FUNCTIONAL 
CHARACTERIZATION OF A NOVEL ORC INTERACTOR, ORCA/LRWD1 
 
II.1. Introduction 
Origin recognition complex (ORC) proteins are critical for the initiation of DNA 
replication (Bell and Stillman, 1992). Binding of ORC to chromatin serves as a landing 
pad for the assembly of a multi-protein pre-RC at the origins of replication (Bell and 
Dutta, 2002). Studies from different species have shown that ORC is highly dynamic, 
with several ORC subunits getting post-translationally modified by phosphorylation or 
ubiquitination in a cell cycle-dependent manner (DePamphilis, 2005). ORC binding to 
origins is ATP dependent, but the sequence requirement for ORC binding shows 
significant species differences. In S. pombe, Orc4 is known to mediate DNA binding via 
its multiple AT-hooks (Chuang and Kelly, 1999); whereas in Drosophila, Orc6 is 
required for DNA binding by ORC (Balasov et al., 2007). In S. cerevisiae, ORC is 
known to recognize specific ori elements (Bell and Stillman, 1992). In the early 
embryonic cell cycles of Xenopus and Drosophila as well as in replication-competent 
Xenopus egg extracts, the initiation of DNA replication is sequence independent (Blow 
and Laskey, 1986; Hyrien and Mechali, 1993; Sasaki et al., 1999; Walter et al., 1998). 
In human cells, even though certain discrete origins have been identified, no consensus 
DNA sequence has emerged. Using human ORC purified from insect cells, it has been 
demonstrated that ORC stimulates replication initiation from any DNA fragment in 
vitro without any preference for known origin DNA (Vashee et al., 2003). It has been 
suggested that the binding of ORC to specific origin sequences in vivo is attributed to 
the chromatin context (Okuno et al., 2001) or to other proteins that provide specificity 
for chromatin binding, similar to what has been observed for E2F-dependent ORC 
Chapter II has been published as: 
Shen, Z., K.M. Sathyan, Y. Geng, R. Zheng, A. Chakraborty, B. Freeman, F. Wang, 
K.V. Prasanth, and S.G. Prasanth. 2010. A WD-repeat protein stabilizes ORC binding 
to chromatin. Mol Cell. 40:99-111. 
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binding to chorion gene locus or Myb-containing protein complex in site-specific DNA 
replication in Drosophila (Beall et al., 2002; Royzman et al., 1999) or EBNA1-
dependent ORC loading to EBV origin oriP (Dhar et al., 2001). 
In addition to its role in pre-RC assembly, individual subunits of ORC also play 
vital roles in several non-pre-RC functions (Chesnokov, 2007; Sasaki and Gilbert, 
2007). ORC binds to origins as well as to several other chromosomal regions that 
represent repressed chromatin in yeast as well as in metazoans. ORC plays key roles in 
the establishment and spreading of Sir proteins at mating type loci in yeast (Triolo and 
Sternglanz, 1996). Similarly, ORC plays crucial functions in recruiting HP1 and 
eventually in its spreading at heterochromatic loci in metazoans (Prasanth et al., 2010; 
Shareef et al., 2003). Also, in fission yeast S. pombe, ORC interacts with the HP1-
related protein Swi6 that is involved in centromere and mating type gene silencing 
(Matsuda et al., 2007). In all of these events, key chromatin changes accompany ORC 
binding. These data are indicative of the evolutionarily conserved function of ORC in 
gene silencing and heterochromatin organization in addition to their conserved function 
in replication initiation. Even though ORC is highly conserved, how is it recruited to 
origins as well as to heterochromatic sites in post-replicated cells in metazoans and 
what additional factor(s) regulate ORC loading remain to be elucidated. 
In this chapter, I identified and characterized the function of a WD40 repeat-
containing ORC-interacting protein, leucine-rich repeats and WD repeat domain-
containing protein 1 (LRWD1). I henceforth name it ORC-associated (ORCA) in 
human cells. ORCA is highly conserved among higher eukaryotes and interacts with 
ORC, utilizing its WD repeat domain. Further, ORCA associates with chromatin 
predominantly during G1, with levels diminishing during S phase and reloading during 
G2. ORCA co-localizes with ORC at specific chromatin structures, including telomeres 
and centromeres. Tethering of ORCA to an artificially generated chromatin region 
results in the efficient recruitment of ORC to the chromatin site. Finally, depletion of 
ORCA in human primary diploid cells and embryonic stem cells (hESCs) results in loss 
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of ORC and MCM loading to chromatin, resulting in accumulation in G1. Based on 
these data, I propose that ORCA is required for the association of ORC on chromatin 
during G1 to establish pre-RC and to heterochromatic sites in post-replicated cells. 
 
II.2. Materials and methods 
II.2.1. ORCA sequences and plasmid constructs 
Human ORCA cDNA was cloned into pEYFP-C1 with CMV promoter 
(Clontech) and pCGT vector to generate YFP-ORCA and T7-ORCA. ORCA mutants 
were obtained using PCR from ORCA cDNA, (aa positions: 1-127, 1-270, 128-647 and 
270-647) and also cloned into pEYFP or pCGT vectors. After confirmation by 
sequencing, constructs were used for transfection in human cells for 
immunofluorescence or immunoprecipitation experiments. 
pEGFP-Lac repressor vector was a kind gift from Miroslav Dundr (Kaiser et al., 
2008). pEYFP-Lac repressor was constructed by replacing GFP with YFP. pEYFP-
LacI-ORCA was generated by ligating cDNA of ORCA into the pEYFP-LacI vector.  
NCBI accession numbers for ORCA sequences: Homo sapiens (NP_690852.1), 
Pan troglodytes (XP_519556.2), Mus musculus (BAC39318.1), Canis familiaris 
(XP_536851.2), Xenopus laevis (AAH74207.1), Gallus gallus (XP_415759.2), Danio 
rerio (XP_001335047.1), Drosophila melanogaster (NP_723702.1), Nematostella 
vectensis (EDO47466.1). Sequence alignment was conducted using the website 
http://www.ebi.ac.uk/Tools/clustalw/. 
 
II.2.2. Cell culture 
WI38, HeLa, MCF7, and U2OS cells were grown in Dulbecco’s modified 
Eagle’s medium (DMEM) containing high glucose, supplemented with penicillin-
streptomycin and 10% fetal bovine serum (FBS; Hyclone). For transient transfection, 
FuGENE 6 (Roche) and Lipofectamine 2000 (Invitrogen) were used according to the 
manufacturers’ protocols. For generation of stable cell lines, Lipofectamine 2000-
mediated transfection was carried out in U2OS, followed by G418 selection (600 
mg/ml). The U2OS-2-6-3 cells were transfected with a plasmid containing 
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pVITRO2.Cherry.Lac Repressor (LacI) and Tetracyline activator (Tet-On) (kind gift 
from Tetsuya Nakamura) and selected with Hygromycin and G418 to generate 2-6-3 
CLTon cells. 
 
II.2.3. Transfection 
U2OS-2-6-3 CLTon cells were grown in DMEM with 10% Tet system approved 
FBS (Clontech). Cells grown on coverslips to 50%–60% confluency were co-
transfected with 100 ng pEYFP-LacI vector or pEYFP-LacI-ORCA construct along 
with 500 ng various CFP-tagged ORC subunits with Lipofectamine 2000 reagent. 16 to 
24 hrs after transfection, cells were fixed in 2% (w/v) formaldehyde. 
 
II.2.4. Raising ORCA antibodies 
Antibodies against ORCA (S2853, S2854) were raised in rabbits by 
immunization with peptide LSARLLMQRGRPKSDRLGKIR (aa 4–24) and peptide 
LAALKRPDDVPLSLSPSKRA (aa 228–247), respectively (Proteintech Group). 
S2854-1 and S2854-2 were used for immunoprecipitation, S2854-1 affinity purified 
(AP; 1:1000) for immunofluorescence, and S2853-2 AP (1:1500) for immunoblots. 
 
II.2.5. siRNA and shRNA knockdown 
The siRNAs targeting ORCA (ORCA-si1 CCAACCAGGACUACGAAUU, 
ORCAsi2 GUGAAGUGGAAUUCGUCUU) and control luciferase (Elbashir et al., 
2001) were synthesized by Dharmacon. siRNAs were delivered into cells at a final 
concentration of 100 nM, mediated by Oligofectamine or Lipofectamine RNAiMAX 
(Invitrogen), and were delivered twice at a gap of 24 hrs. shRNAs for ORCA (Sigma-
Aldrich; Clone ID, shRNA1 NM_152892.1-465s1c1 and shRNA2 NM_152892.1-
510s1c1) and scramble (plasmid 1864, Addgene) were in pLKO.1. For viral packaging, 
pLKO-shRNA, pCMV-dR8.91, and pCMV-VSV-G were co-transfected into 293T cells 
with FuGENE 6. Viruses were obtained by collecting media at 24 and 48 hrs after 
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transfection. For knockdown of ORCA, cells were infected with the viruses in the 
presence of 8 mg/ml polybrene (Sigma-Aldrich) for 24 hrs and then subjected to 
puromycin selection. 
 
II.2.6. Live cell microscopy 
Human cells stably expressing YFP-ORCA or transiently transfected with 2μg 
pEYFP-ORCA were used for live cell imaging. The cells were transferred to a FCS2 
live cell chamber (Bioptechs Inc.) mounted onto the stage of a Delta Vision optical 
sectioning deconvolution instrument (Applied Precision) on an Olympus microscope 
and kept at 37
o
C in L-15 medium (minus phenol red) containing 30% FBS. Time-lapse 
images acquired with a 63X1.42 N.A. objective lens were captured with a Coolsnap 
CCD camera. 
 
II.2.7. Immunofluorescence and immunoblots  
Cells were either fixed in 2% formaldehyde for 15 min at room temperature and 
then permeabilized by phosphate-buffered saline (PBS) + 0.5% Triton X-100 for 7 min 
on ice, or pre-extracted in CSK buffer (10mM PIPES pH 7.0, 100mM NaCl, 300mM 
sucrose, 3mM MgCl2) + 0.5% Triton X-100 for 5 min on ice and then fixed with 2% 
formaldehyde. Chilled methanol was applied afterwards if needed, according to the 
specific requirement for the antibodies. Cells were then blocked in PBS + 1% normal 
goat serum (NGS), and incubated with primary antibodies in a humidified chamber for 
1 hr and followed by secondary antibody for 45 min. All washes between each step 
were done in PBS + 1% NGS. DNA was stained with DAPI. Cells were mounted in 
Vectashieled (Vector Laboratories Inc.). Cells were examined using a Zeiss Axioimager 
z1 fluorescence microscope (Carl Zeiss Inc.) equipped with Chroma filters (Chroma 
Technology). Axiovision software (Zeiss) was used to collect digital images from a 
Hamamatsu ORCA cooled CCD camera. Cells were also examined on the Delta Vision 
optical sectioning deconvolution instrument (Applied Precision) on an Olympus 
microscope. The antibodies used for immunofluorescence were anti-Orc2 (1:400), anti-
MCM3 (1:400), anti-PCNA mAbPC10 (1:150), anti-HP1 (1:75, Chemicon), anti-
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Centromere AnaC (1:10, Sigma-Aldrich), anti-Trf2 mAb4A794 (1:200, Upstate) and 
anti-CAF1 (p150, ss1, 1:400). For immunoblots, anti-Orc1 mAbpKS1-40 (1:500), anti-
Orc2 pAb205 (1:2000), anti-Orc3 goat pAb (1:500, Abcam), anti-Orc4 goat pAb 
(1:500, Abcam), anti-Orc5 pAb (1:500, BD Pharmingen), anti-Orc6 pAb982 (1:500), 
anti-Cdt1 guinea pig GP47 (1:1000), anti-Geminin (1:1000, Santa Cruz), anti-Cdc6 
mAb37 (1:100), anti-MCM2 (1:1000), anti-MCM3 (1:1000), anti-PCNA mAbPC10 
(1:1500), anti-Cyclin E (1:1000, Upstate), anti-Cyclin B (1:500, Oncogene Ab-3), anti-
MEK2 (1:500, BD Pharmingen), anti-α-tubulin (1:10,000, Sigma-Aldrich) were used. 
 
II.2.8. Nuclear extracts 
Cells were washed with cold PBS and extracted in hypotonic buffer (10mM 
HEPES-NaOH pH 7.9, 10mM KCl, 2mM MgCl2, 0.34M sucrose, 10% glycerol, 0.1% 
Triton X-100) plus a supplement consisting of 1mM DTT, protein phosphatase 
inhibitors (10mM NaF, 1mM Na3VO4, 1mM Na2H2P2O7), protease inhibitor cocktail 
tablets (Roche) at 4
o
C for 5 min. Nuclei were collected by centrifugation (1,500g, 5 
min) and then extracted in nuclear extraction buffer (20mM HEPES-NaOH pH 7.9, 
2mM MgCl2, 1mM EGTA, 25% glycerol, 0.1% Triton X-100) plus a supplement 
consisting of 1mM DTT, protein phosphatase inhibitors, protease inhibitor cocktail 
tablets and 400mM NaCl at 4
o
C for 30 min. The supernatant was collected after high-
speed centrifugation (12,000 rpm, 5 min) and dialyzed in dialysis buffer containing 
150mM NaCl overnight. 
 
II.2.9. Immunoprecipitations 
Nuclear extract was incubated with GammaBind G Sepharose resin (Amersham) 
at 4
o
C for 45 min for pre-clearing. Antibodies were added into the supernatant after the 
removal of the resin, and binding was carried out at 4
o
C overnight. Resin was then 
added for 1 hr to capture the complex, washed three times in nuclear extraction buffer, 
and resuspended in Laemmli buffer for analysis. If elution of the complex was needed, 
extract was incubated with antibody-conjugated resin overnight after pre-clearing. The 
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resin was then washed thrice with TBS and incubated with the appropriate peptide at 
30
o
C for 15 min. The eluate was collected by low-speed centrifugation (5000 rpm, 1 
min) and elution was repeated twice. 
 
II.2.10. Gel filtration and glycerol gradient sedimentation 
Nuclear extract was subject to size exclusion chromatography using a Superdex-
200 column (GE Inc.) at 0.25 ml/min and fractions (600μl each) were collected and 
precipitated by trichloroacetic acid. After centrifugation at 14,000 rpm for 5 min, the 
pellet was washed with acetone twice and resuspended in Tris pH 8.7 and Laemmli 
buffer for immunoblots. For glycerol gradient sedimentation, IP eluate or marker 
(200μl) was layered on 10%-50% glycerol gradient (buffer: 27mM Tris pH 8.0, 100mM 
NaCl, 1mM EDTA, 0.1% NP-40, protease inhibitors). The mixture was centrifuged at 
48,000 rpm for 16 hrs. Fractions (200μl each) were collected and prepared for 
immunoblots as described above. 
 
II.2.11. Synchronization and flow cytometry 
To synchronize cells at G1/S boundary, 2mM thymidine was added. After 24 
hrs, cells were washed thrice with fresh medium, grown for 12 hrs, and incubated with 
2mM thymidine for an additional 24 hrs. Cells were then released, and aliquots were 
taken every 3 hrs for flow cytometry and chromatin fractionation. To arrest cells in 
mitosis, cells were treated with 50ng/ml nocodazole for 14-16 hrs. For flow cytometry, 
cells were collected and washed in cold PBS, resuspended in PBS + 1% NGS, and fixed 
in chilled ethanol overnight. Cells were then washed and resuspended in PBS + 1% 
NGS with 120μg/ml propidium iodide (PI) and 10μg/ml RNase A for 30 min at 37oC. 
DNA content was measured by flow cytometry. 
 
II.2.12.Chromatin fractionation 
Detailed procedure was described previously (Mendez and Stillman, 2000). To 
isolate chromatin, cells were resuspended in buffer A (10mM HEPES-NaOH pH 7.9, 
10mM KCl, 1.5mM MgCl2, 0.34M sucrose, 10% glycerol, 1mM DTT) plus protease 
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inhibitor cocktail tablets and 0.5% Triton X-100 for 10 min on ice and centrifuged 
(1,300g, 5 min). Supernatant (S1) was then centrifuged at a high speed (20,000g, 5 min) 
to get S2. Nuclei (P1) were incubated with micrococcal nuclease (0.5U/ml micrococcal 
nuclease (Sigma-Aldrich) in buffer A plus 1mM CaCl2) for 30 min at 37
o
C and then 30 
min on ice. S3 was collected by low-speed centrifugation. Pellet (P2) was then 
incubated with buffer B (3mM EDTA, 0.2mM EGTA, 1mM DTT) plus protease 
inhibitor cocktail tablets for 30 min on ice, and centrifuged again to get P3. WI38 cells 
were treated with 0.5% Triton-X in CSK for 5 min on ice, and the soluble fraction (S) 
was separated from the pellet (P) by centrifugation. 
 
II.2.13. hES cell culture 
Federally registered hESC line H9 was purchased from WiCell Research 
Institute and routinely maintained under feeder conditions (Thomson et al., 1998). The 
culture medium consists of DMEM/F12 with 20% knockout serum replacement (KSR), 
1 mM glutamine, 1% non-essential amino acid, 0.1 mM β-mercaptoethanol, and 4ng/ml 
bFGF (Invitrogen). For feeder-free cultures, cells are cultured on plates coated with 
Matrigel (BD Biosciences) in the presence of conditioned medium from MEFs, which 
replaces the MEF feeders (Xu et al., 2001). The experiments were conducted with H9 
cells between passage 30 and 40. To infect hESCs, lentiviruses were mixed with MEF-
CM, and the mixture was incubated with H9 cells (approximately 1000,000) for 16 hrs. 
To improve the efficiency of infection, Polybrene (Sigma-Aldrich) was added to the 
infection medium to 6μg/ml. Virus-containing MEF-CM was replaced with complete 
feeder-free growth medium with 1μg/ml puromycin. Cells were continuously cultured 
for 7 days in puromycin containing medium. For proliferation assay the cells after 
selection were plated, and the cell number was counted 6 days after plating. 
 
II.2.14. hES cells chromatin fractionation 
Chromatin fractionation of hESCs was conducted as described previously 
(Nimura et al., 2006) with minor modifications. ES cells were resuspended in nuclear 
isolation buffer (10mM Tris-HCl pH 7.5, 60mM KCl, 15mM NaCl, 1.5mM MgCl2, 
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1mM CaCl2, 0.25M sucrose, 10% glycerol, 1mM DTT) plus protease inhibitors and 
0.15% NP-40 for 10 min on ice and centrifuged (1,300g, 5 min). Supernatant (S1) was 
then centrifuged at a high speed (20,000g, 5 min) to get S2. Nuclear pellets (P1) were 
incubated with 0.5U/ml micrococcal nuclease (Sigma-Aldrich) in nuclear isolation 
buffer with 100mM NaCl for 20 min at 37
o
C and then 10 min on ice. 10mM EDTA was 
then added for 10 min incubation. S3 was separated from P3 by low-speed 
centrifugation. 
 
II.3. Results 
II.3.1. ORCA is conserved among higher eukaryotes 
Our lab has performed biochemical analysis in mammalian cells to identify 
proteins that associate with ORC and play crucial roles in DNA origin specification 
and/or chromatin organization. Immunoprecipitation (IP) with Orc2 monoclonal 
antibody (mAb) from nuclear extracts of asynchronously growing human HeLa cells or 
from nocodazole-arrested mitotic cells was conducted, and the IP material was 
subjected to mass spectrometric analysis. Similarly, IP with T7 antibody from nuclear 
extracts of asynchronously growing T7-Orc2-expressing stable cell line followed by 
mass spectrometry was also conducted. I have identified a protein, ORCA, alias 
LRWD1 (NP_690852, DKFZp434K1815), as one of the ORC interactors in both IP-
mass spectrometric screens. ORCA is composed of 647 aa and motif scan predictions 
suggest that it contains three leucine-rich repeats (LRR) at the N-terminus and five 
WD40 repeats at the C-terminus (Figure 1A). Alignment of ORCA from different 
species, including human, chimpanzee, mouse, dog, zebrafish, chicken, frog, fly, and 
sea anemone, showed very high levels of conservation among higher eukaryotes, with 
maximum homology discernible at the LRR- and WD-containing regions (Figure 1B 
and Figure 2A). 
 
II.3.2. ORCA is an ORC-associating protein 
To validate the IP-mass spectrometric data on the interaction of ORCA with 
ORC, I conducted reverse IP and co-IP experiments. An epitope-tagged version of 
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ORCA, T7-ORCA, was transfected into HeLa cells, and IP was carried out with T7 
monoclonal antibody (mAb). Both human Orc1 and Orc2 co-immunoprecipitated with 
T7-ORCA (Figure 1C). Further, T7-ORCA and HA-Orc2 were co-transfected into 
HeLa cells, and IP with either T7 or HA antibody followed by immunoblot analyses 
further confirmed their interaction (Figure 2B). IP with Orc2 antibody followed by 
immunoblot with ORCA polyclonal antibody (pAb) showed the association of Orc2 
with endogenous ORCA (molecular weight of ORCA ~70kDa; Figure 1D). Finally, 
immunoprecipitation with ORCA pAb in human cells clearly demonstrated the 
association of ORCA with ORC subunits (Figure 1E). Cdt1 and Geminin were also 
associated with ORCA (Figure 1E). Other pre-RC components like Cdc6 or MCMs or 
DNA replication-related proteins PCNA were not part of the ORCA-containing 
complex (Figure 1E). Thus, immunoprecipitation studies using antibodies against 
endogenous proteins as well as tagged versions confirmed the interaction between 
ORCA and ORC. 
To study the complex assembly of ORCA and ORC, I eluted 
immunoprecipitates after ORCA IP with specific peptides, subjected the eluate to 10%–
50% glycerol gradient sedimentation, and examined the fractions by Orc2 and Orc3 
immunoblots (Figure 3A). Co-sedimentation of ORCA and Orc2 and Orc3 (Figure 3A) 
to a position >200 kDa suggested that multiple ORC subunits are present in a complex 
with ORCA. To further investigate the complex assembly of ORCA and multiple ORC 
subunits, I fractionated HeLa nuclear extract on a Superdex-200 gel filtration column. 
The fractions were examined by immunoblots with antibodies against ORCA and 
various ORC subunits (Figure 3B). A significant portion of ORCA was found in 
fractions 5 and 6 (>440 kDa). As reported previously (Thome et al., 2000), Orc2 (66 
kDa) and Orc3 (80 kDa) both co-eluted at ~400 kDa (Figure 3B, fractions 5 and 6). 
Only a small fraction of Orc4 was present in the fraction co-eluting with Orc2 and 
Orc3. The majority of Orc4 was present in apparently monomeric form (Figure 3B, 
fractions 11 and 12). In addition to fractions 4 and 5, Orc1 and ORCA along with Orc2 
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and Orc3 are also present in a higher molecular-weight range. The predicted molecular 
mass of ORCA along with all ORC subunits is ~450 kDa, indicating that ORCA is in 
complex containing multiple ORC subunits in a high-molecular-weight complex. 
 
II.3.3. The binding of ORCA to chromatin is cell cycle dependent 
Intracellular localization and cell cycle distribution of a protein are vital 
indicators of its cellular function(s). To study the distribution of ORCA in human cells, 
I performed immunofluorescence (IF) localization analysis using ORCA antibodies in 
MCF7 (Figure 4A) and U2OS cells (data not shown). ORCA localized predominantly 
in the nucleus of some cells as punctate foci, and several cells showed differential 
staining (Figure 4A), suggesting potential cell cycle-regulated expression of ORCA. 
To investigate the cell cycle-restricted distribution of ORCA, I immunostained 
MCM3 and PCNA in YFP-ORCA-expressing MCF7 (Figure 4B) and U2OS (data not 
shown) cells after pre-extraction with a nonionic detergent, which reflects the fraction 
of proteins that preferentially associates with chromatin. MCM proteins are associated 
with chromatin during G1 and S phase, while PCNA is associated with chromatin only 
during S phase (Prasanth et al., 2004a). Therefore, dual IF of MCM and PCNA 
(following pre-extraction procedures) serves as a tool to identify the cell cycle stage of 
individual cells. Immunolabeling of MCM3 and PCNA in YFP-ORCA-expressing cells 
demonstrated that ORCA was present predominantly in cells that showed homogenous 
MCM labeling and were PCNA negative (Figures 4B and 4C), indicating G1 cells. 
Biochemical fractionation of cells collected at different stages of the cell cycle 
further corroborated that ORCA whole-cell levels and chromatin association are cell 
cycle regulated (Figures 4D and 4E). ORCA was obtained in the nuclear chromatin 
fraction (released into S3 after MNase treatment; Figure 4E), with maximum 
association observed during G1 phase. The levels of ORCA were found to decrease 
during S phase, subsequently beginning to rise during G2, and peaking at G1 (Figure 
4E). 
Time-lapse live cell imaging of YFP-ORCA in human cells further confirmed 
the significant increase of ORCA during G1, after mitotic cell division (Figure 5). 
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Immunofluorescence and biochemical fractionation experiments have clearly indicated 
that ORCA distribution is regulated during the cell cycle. The dynamics of ORCA 
through the cell cycle are reminiscent of ORC dynamics, especially Orc2 (Figure 7B), 
suggesting that ORCA and ORC might cooperate in chromatin association during 
specific cell cycle stages. 
 
II.3.4. ORCA localizes to heterochromatic structures 
Previous studies have shown that multiple subunits of human ORC associate 
with heterochromatic structures (including centromeres and telomeres) and interact with 
the heterochromatin protein, HP1 (Deng et al., 2007; Lidonnici et al., 2004; Prasanth et 
al., 2004b). I observed prominent nuclear foci of YFP-ORCA in MCF7 cells (Figure 
6A). Pre-extraction with detergent was used to remove soluble fraction of YFP-ORCA 
in MCF7 and U2OS cells. Immunolabeling of Orc2 and HP1α in YFP-ORCA-
expressing MCF7 cells showed co-localization of ORCA and ORC at heterochromatic 
foci (Figure 6A). Immunofluorescence staining with ORCA antibody or YFP-ORCA 
localization in MCF7 cells showed distribution of ORCA in heterochromatic foci that 
overlapped with centromeric heterochromatin (AnaC) but not with telomeric sites 
(telomere binding protein; Trf2) (Figure 6B and Figure 7A; pearson coefficient of 
correlation for Figure 6B is provided in Figure 7A). Localization studies of ORCA in 
U2OS cells showed complete co-localization of YFP-ORCA with Orc2 (Figure 6C) and 
ORCA pAb with YFP-Orc1 (Figures 6E and 6F) at specific punctate foci. Detailed 
examination of the punctate foci revealed that in U2OS cells, ORCA overlaps with 
Orc1 and Orc2 at telomeric heterochromatin specifically in interphase cells (Trf2, 
Figures 6D and 6E) but not at centromeres as observed in MCF7 cells (AnaC, Figures 
6D and 6F). ORCA showed similar cell cycle dynamics as that of Orc2; it showed 
punctate homogenous staining during G1 and was restricted to centromeres (MCF7) or 
telomeres (U2OS, Figure 7B) as cells progressed though S phase (monitored by CAF1, 
Figure 7B). But as cells entered mitosis, ORCA and Orc2 re-localized to centromeres in 
all cell lines tested (Figure 7C). The difference in ORCA and ORC distribution between 
MCF7 and U2OS interphase cells was rather striking. Examining several other cell lines 
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including HeLa and IMR-90 (data not shown) revealed that the association of ORCA to 
interphase cell centromeres was restricted to telomerase-positive cells, whereas ORCA 
predominantly localized to telomeres in cells utilizing alternative lengthening of 
telomeres (ALT). Similar observations were made for Orc1 and Orc2 distribution in 
human cells (Figures 6A, 6C, 6E, and 6F). These results indicate that ORCA displayed 
similar localization in cells to that of ORC and also showed complete overlap with ORC 
at heterochromatic sites, including centromeres and telomeres, implying that the 
intracellular distribution of ORCA and ORC are co-regulated. 
 
II.3.5. WD domain of ORCA is required for ORC interaction and chromatin 
association 
Leucine-rich repeats and WD repeats are known to mediate protein-protein 
interactions (Smith, 2008). In order to understand the functional relevance of the 
structural organization of ORCA and to map the region of ORCA that is responsible for 
ORC interaction and association with chromatin, I generated T7- and YFP-tagged 
mutants of ORCA (Figure 8A). T7-tagged full length and mutant ORCA constructs 
were transiently transfected into human cells, and IP was conducted from extracts with 
T7 antibody. Immunoblot analyses with Orc2 antibody revealed that only ORCA 
constructs that contain the WD repeat domain interacted with Orc2 (Figure 8B, 
constructs 128-647, 270-647, and 1-647). Further, to examine the localization of each of 
the ORCA mutants, I utilized YFP-tagged ORCA mutants. YFP-ORCA.1-127 (only 
leucine-rich repeats) showed a homogeneous nuclear and cytoplasmic staining, whereas 
YFP-ORCA.1-270 showed exclusive nuclear pattern in formaldehyde fixed cells 
(Figure 9A). However, detergent pre-extraction procedures showed complete loss of 
YFP-ORCA.1-127 and 1-270 signals, indicating that these ORCA mutants are not 
associated with chromatin (Figure 8C). This was corroborated by biochemical approach 
where only ORCA mutants containing WD repeat associated with chromatin (Figure 
8D). Similarly, YFP-ORCA.128-647 and YFP-ORCA.270-647 (mutants containing 
WD domain) showed predominantly nuclear staining (Figure 8C) with prominent 
heterochromatic foci co-localizing with HP1α and Orc2 upon pre-extraction (Figure 8E 
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and Figure 9B). WD40 repeat domain-containing proteins are known to bind histones 
and nucleosomes and have been suggested to be important players in chromatin 
modifying complexes (Suganuma et al., 2008). These results demonstrate that WD 
domain of ORCA is critical for ORC interaction and chromatin binding and suggest that 
ORCA interaction with ORC is critical for their stable association/recruitment onto 
chromatin. This is corroborated by the fact that ORCA interaction with Orc2 was 
significantly reduced in DNase I pretreated extracts, demonstrating that the ORC-
ORCA interaction is stabilized on the chromatin (Figure 9C). 
 
II.3.6. ORCA tethers ORC to heterochromatin 
Since the ORC-ORCA interaction was stabilized on chromatin, I was interested 
to address the role of ORCA in ORC recruitment/tethering to chromatin. I have utilized 
a modified version of the in vivo cell system originally generated by David Spector’s 
group, where a 200 copy transgene array has been integrated into chromosome 1 in 
human U2OS cell as a single heterochromatic locus (U2OS-2-6-3) (Janicki et al., 2004). 
Each transgene copy has 256 copies of Lac operator. Our lab has stably integrated 
Cherry-LacI (Lac operator repressor) and rtTa (tet-activator) in 2-6-3 cells, so that the 
locus containing the transgene array can be readily visualized in living cells by the 
presence of Cherry-LacI (U2OS-2-6-3 CLTon (Figure 10A, Figure 11A)). A triple-
fusion protein expressing YFP-LacI-ORCA was generated so that ORCA could be 
directly targeted to the stably integrated chromatin locus in 2-6-3 CLTon via a Lac 
operator-repressor interaction. By targeting ORCA to the locus, I examined the 
recruitment of various ORC subunits to the chromatin locus using CFP-tagged versions 
of ORC. Targeting of YFP-LacI-ORCA to the locus resulted in the specific recruitment 
of all the ORC subunits to the chromatin locus, with Orc2 (Figure 10B) and Orc3 
(Figure 11C) being recruited most efficiently in majority of the cells. Similar results 
were obtained for Orc5 (Figure 11D) as well as Orc4 and Orc6 (data not shown). 
Interestingly, CFP-Orc1 is recruited in only 63% of YFP-LacI-ORCA-positive cells (n 
= 650, three independent experiments; Figure 11B). Immunolabeling of these cells with 
either MCM or PCNA suggested that ORCA brings Orc1 to the locus specifically 
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during G1 phase or at the G1/S boundary of the cell cycle (YFP-LacI-ORCA + CFP-
Orc1; whenever CFP-Orc1 is at the locus, 100% cells show MCM-positive staining; n = 
50; data not shown). 
Similar recruitment assays with YFP-LacI-ORCA mutants, including YFP-LacI-
ORCA.1-127, YFP-LacI-ORCA.1-270, YFP-LacI-ORCA.128-647, and YFP-LacI-
ORCA.270-647, demonstrated that only the mutants that possess the WD domain 
recruit ORC to chromatin (Figure 10C and Figure 11E). YFP-LacI alone does not 
recruit any of the ORC subunits to the chromatin locus (Figure 10B and Figures 11B-
11D). These data clearly demonstrate that ORCA can recruit ORC or stabilize the 
association of ORC to a chromatin region and WD repeat is essential for the ORC 
recruitment to chromatin. 
Further, when YFP-LacI-ORCA was tethered to the locus, robust accumulation 
of MCM was observed at the locus (44.4% ± 0.8% cells showed MCM3 at the locus), 
demonstrating that the ORC bound to the locus is functional (Figure 10D and Figure 
11F). These results are similar to what I see for Orc1 recruitment, suggesting that Orc1 
loading may be critical for MCM loading and that only in the cells where Orc1 is 
recruited, MCM could load. 
 
II.3.7. Depletion of ORCA results in loss of ORC binding to chromatin 
To gain an insight into the functional significance of the ORCA-ORC 
interaction and to unravel the cellular function of ORCA, I used RNA interference 
(RNAi)-mediated knockdown of ORCA with two small interfering RNA (siRNA) 
oligonucleotides and two short hairpin RNAs (shRNAs; Figure 13Aa) in human 
Osteosarcoma U2OS cells and primary diploid fibroblast WI38 cells (Elbashir et al., 
2001). Transfection of ORCA siRNA (two independent siRNA oligonucleotides, 
ORCA-si1 and ORCA-si2) twice with a gap of 24 hrs resulted in significant loss of 
ORCA in U2OS cells, YFP-ORCA stable cell line, and primary fibroblasts (Figures 
12A and 12C and Figures 13Ab, 13B, 13C, and 13D). Immunoblots on whole-cell 
extracts demonstrated that total levels of ORC proteins were unaltered in cells lacking 
ORCA (Figure 12C and Figure 13Ab). Immunoprecipitation with Orc2 antibodies in 
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ORCA-depleted cells showed that even though negligible ORCA is left behind, it is in 
complex with ORC, suggesting that ORCA-ORC complex is highly stable (Figure 
13E). Interestingly, chromatin fractionation after ORCA depletion in U2OS cells clearly 
demonstrated that ORC proteins, including Orc1, Orc2, Orc3, and Orc4 (see 
arrowheads), showed significant reduction in chromatin fraction (P3) and redistribution 
to the cytosolic fraction (S2), with most pronounced effects on Orc2 (Figure 12B). 
Similar results were obtained from chromatin fractionation of U2OS cells that stably 
express shRNAs against ORCA (Figure 13F). However, no significant changes in the 
chromatin association of other pre-RC proteins, including MCMs, were discernible in 
ORCA depleted human cancer cell lines. Similarly, previous results have demonstrated 
that depletion of human Orc2 and Orc3 in human cancerous cells results in increase in 
mitotic population without any obvious defects in loading of MCM proteins onto the 
chromatin (Prasanth et al., 2004b). I believe that after ORCA depletion, even the low 
levels of ORCA or ORC associated with chromatin in human cancerous cells are 
sufficient to load MCMs. 
To address this, I performed siRNA depletion of ORCA in primary diploid 
fibroblasts, WI38 (46XX normal diploid female). Greater than 90% knockdown of 
ORCA was achieved via the siRNA approach (Figure 12C). In ORCA-depleted primary 
cells, significant accumulation of p21 and Cyclin E and reduction of Cyclin B was 
observed, all indicative of G1 arrest (Figure 12C). 
Proliferation assay in ORCA-depleted primary cells showed significant 
proliferation defect (Figure 13G). Further, FACS analysis showed prominent G1 
accumulation upon ORCA depletion (Figure 12D; 70.2% in G1 compared to 46.8% in 
control cells). Immunofluorescence staining with PCNA antibodies showed significant 
decrease in PCNA labeling (Figure 12F and Figure 13H; 38.8% ± 3.1% in control 
versus 22.5% ± 3.5% in ORCA-depleted cells), corroborating the FACS data. 
Chromatin fractionation in ORCA-depleted primary cells showed reduction in 
ORC subunits (Figure 12H and Figure 13H; seen both with cell biological and 
biochemical approaches) and also reduced MCM on chromatin (Figure 12H). In 
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summary, depletion of ORCA in human primary cells results in reduced ORC loading 
to chromatin with a concomitant defect in chromatin loading of MCM, resulting in cells 
accumulating in G1 phase. 
I have also conducted stable shRNA-mediated depletion of ORCA in hESCs 
(Figures 12E and 12G and Figures 13I–13L). The key difference between somatic and 
hESCs is the short G1 phase in hESCs, with most of the cells being in active 
proliferation phase (S phase) (Becker et al., 2006). hESCs are phenotypically and 
karyotypically normal cells that can proliferate in culture almost indefinitely. They are 
similar to pluripotent cell lines derived from the post-implantation epiblast, making 
studies on them physiologically relevant (Brons et al., 2007; Tesar et al., 2007). Most 
strikingly, the hESCs like primary cells lacking ORCA proliferated very slowly 
compared to the control (Figure 13I), and FACS analyses clearly showed increase in G1 
population as also evident by an increase in total Cyclin E levels (Figure 12E and 
Figure 13K). ORCA-depleted hESCs also showed fewer PCNA-positive cells, 
indicating reduced number of S phase cells (Figure 12G). Oct4, a well-established 
marker for pluripotency of hESCs, remained unaltered in ORCA-depleted hESCs, 
suggesting that ORCA depletion reduces proliferation without impairing pluripotency 
(Figure 13K). Further, immunofluorescence studies in detergent pre-extracted cells 
revealed loss of ORC association to chromatin in ORCA-depleted hESCs (Figure 13J). 
Similar observations on the loss of Orc1 and Orc2 binding to chromatin in ORCA-
depleted hESCs (P3) were seen by chromatin fractionation procedures (Figure 13L). 
This observation was similar to what I found in human cancerous cell lines as well as in 
primary cells. 
Taken together, these data demonstrate that ORCA is an essential protein that is 
required for loading or stabilizing ORC to chromatin. Future studies will focus on the 
mechanistic insights on how ORCA recruits ORC specifically to origins and to 
heterochromatic regions. 
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II.4. Discussion 
ORC is critical for the establishment of pre-RCs during G1 phase of the cell 
cycle (Bell and Dutta, 2002). Apart from pre-RC function, recent evidence in different 
model organisms has pointed to the role of ORC in transcriptional silencing, 
heterochromatin formation, and position effect variegation (Sasaki and Gilbert, 2007; 
Shimada and Gasser, 2007). In yeast, the differential binding affinity of ORC to HMRa 
locus determines their function either for DNA replication or for heterochromatin 
establishment (Palacios DeBeer et al., 2003). In yeast, ORC binds adjacent to 
replication start point, suggesting that ORC directs the pre-RC to a distinct chromatin 
site (Das-Bradoo and Bielinsky, 2009). While ORC binds specific DNA sequences in 
yeast, metazoans do not show sequence-specific association of ORC at origins (Cvetic 
and Walter, 2005). Though the replication initiation events are nonrandom in 
metazoans, the mechanism or factors that recruits ORC or specifies ORC binding to 
specific chromatin sites remains elusive. In this chapter, I have identified an ORC-
interacting protein, ORCA that associates and co-localizes with ORC. Another study 
also reported that ORCA (LRWD1) is an ORC interactor (Vermeulen et al., 2010). I 
demonstrate that ORCA is critical for loading ORC to the chromatin and/or stabilizing 
the complex on chromatin. Furthermore, by using an artificial gene locus system, I have 
shown that ORCA regulates the association of ORC to chromatin sites. Recent work has 
demonstrated that recruitment of ORC or Cdc6 to DNA is sufficient to create an 
artificial origin of replication in mammalian cells using pre-RC components fused to the 
GAL4 DNA-binding sites (Takeda et al., 2005). Similar to their observations, I now 
show that tethering ORCA to a chromatin locus results in efficient recruitment of ORC 
to chromatin and robust accumulation of MCM, suggesting that this system like the 
artificial origin developed by Dutta and coworkers is functional and provides a useful 
tool to study pre-RC function. 
DNA replication must occur once and only once in each cell cycle and pre-RC 
components are key players in this regulation. In S. cerevisiae, ORC remains associated 
with the chromatin throughout the cell cycle, although phosphorylation plays a key role 
in regulating ORC activity (Diffley et al., 1994; Liang and Stillman, 1997; Nguyen et 
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al., 2001). Recent work in yeast has demonstrated that ORC, Cdc6, and Cdt1 are 
required for loading but not for maintaining MCM at the origins of replication 
(Tsakraklides and Bell, 2010). In S. pombe, ORC association to chromatin increases 
during mitosis and peaks at M/G1 (Wu and Nurse, 2009). In Xenopus, ORC is not 
associated with chromatin during S phase and is absent from the mitotic chromatin 
(Hua and Newport, 1998; Romanowski et al., 1996; Rowles et al., 1999; Sun et al., 
2002). In Drosophila, Orc1 is degraded at the end of M phase by the anaphase-
promoting complex activated by Fzr/Cdh1 (Araki et al., 2005). In contrast, in human 
cells, Orc1 dissociates from chromatin, is ubiquitinated, and then is degraded during the 
G1 to S phase transition and reloaded at the M-G1 transition when new pre-RCs are 
formed (Kreitz et al., 2001; Mendez et al., 2002; Siddiqui and Stillman, 2007; Tatsumi 
et al., 2003). Human Orc2 and Orc3 associate predominantly with centric and 
pericentromeric heterochromatin during the end of S phase, G2, and mitosis (Prasanth 
et al., 2004b). A key molecule regulating replication licensing is Cdt1, which 
accumulates during M and G1 and is degraded during S phase by SCF
Skp2
-mediated 
proteolysis through CDK phosphorylation and replication-coupled proteolysis by 
Cullin4-Ddb1
Cdt2
 ubiquitin ligase and PCNA (Fujita, 2006; Tada, 2007). In addition, 
Geminin, a protein expressed in cells from S phase through early mitosis, controls the 
levels of Cdt1 (McGarry and Kirschner, 1998; Wohlschlegel et al., 2000). I demonstrate 
that ORCA modulates ORC loading and shows cell cycle dynamics similar to that of 
human ORC, with maximum expression during G1 and then sequential release from 
most sites, except at heterochromatic sites during the post-G1 part of the cell cycle. 
These data suggest that ORCA gets modified (presumably ubiquitinated), since 
immunoblots with ORCA antibody that were exposed for longer duration show a smear 
in the high molecular weight region (molecular weight of ORCA ~70 kDa, Figures 13B 
and 13C). It is a possibility that once ORCA accomplishes the loading of ORC, it is 
released from the chromatin, gets ubiquitinated, and finally is degraded during the G1/S 
boundary. Interestingly, epitope-tagged ORCA (YFP as well as T7) also shows this 
modification, suggesting that this is a highly coordinated post-translational event. The 
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association of ORCA with ORC, Cdt1, and Geminin suggests that this might be a key 
component that regulates timely association of each of these components to chromatin 
to ensure ‘‘once per cell cycle’’ replication. 
The association of ORCA and ORC to centromeres and telomeres in post-
replicated cells suggests that this complex plays a key role in chromatin organization at 
heterochromatic structures. Recent work has established that ORC interacts with the 
Shelterin complex, as well as the RNA component, TERRA, and plays important roles 
in structural integrity of telomeres and chromatin structure therein (Deng et al., 2009; 
Tatsumi et al., 2008). Proper organization of ORC and its associated proteins at 
heterochromatic sites are critical for cell cycle progression (Pflumm and Botchan, 2001; 
Prasanth et al., 2004b). ORCA and ORC bind to centromeres throughout the cell cycle 
in human MCF7, HeLa, and IMR-90 cells but associate predominantly with telomeres 
during interphase and to centromeres in mitotic cells in the Osteosarcoma U2OS cells. 
These data imply that ORCA and ORC co-localize to heterochromatic structures in all 
human cell lines examined. In support of this observation, a recent proteomic screen has 
also identified ORCA and ORC as components of human telomeres (Dejardin and 
Kingston, 2009). MCF7 breast epithelial cells and HeLa cells use telomerase to perform 
RNA-dependent DNA replication at telomeres to maintain telomere length (Counter et 
al., 1992), whereas U2OS cells use the mechanism called ALT, which is mediated by 
DNA recombination (Reddel, 2003). The specific association of ORCA and ORC at 
telomeres only in ALT+ cells implies that these proteins might also be involved in DNA 
repair/recombination. Interestingly, ORCA has recently been identified as a target of 
ATM and ATR in a screen to identify substrates modified by these kinases (Matsuoka 
et al., 2007). Further, transcription microarray data as well as other recent data have 
provided evidence for significant enrichment of ORCA in adult testis, a tissue that is 
highly recombinogenic (Teng et al., 2010). The binding of ORCA to telomeres in cells 
that use recombination-mediated ALT supports this hypothesis. Recent evidence has 
also pointed out that centromeres are highly recombinogenic, and recombination occurs 
at higher frequency at centromeres than at telomeres, implicating the multiple roles of 
ORCA at heterochromatic sites (Jaco et al., 2008). 
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Work in yeast has demonstrated that ORC is critical to maintain the 
nucleosomal configuration adjacent to origins (Lipford and Bell, 2001). Interestingly, 
disruption of nucleosomal arrangement at an origin has been shown to affect replication 
initiation, suggesting that ORC is critical not only for replication initiation, but also for 
altering the local chromatin environment to facilitate origin function (Lipford and Bell, 
2001). In yeast, origin sequences have been shown to be sufficient for maintenance of 
nucleosome-free origin, whereas ORC is needed for accurate nucleosome position 
flanking origin (Eaton et al., 2010). In Drosophila, open chromatin seems to be a 
critical feature that governs ORC binding (MacAlpine et al., 2010). Recent work has 
indicated that chromatin proteins like HMGa can specifically target ORC to specific 
sites on DNA, which in turn is crucial for specification of origins (Thomae et al., 2008). 
My data provide evidence that the binding of ORCA stabilizes ORC binding to 
chromatin, presumably to origins in G1 and to heterochromatin in post-replicated 
human cells. Based on these data, I propose that the WD40 repeat-containing ORCA is 
a critical factor that is required for loading/stabilizing ORC to chromatin. 
 
II.5. Contributions of co-workers  
Dr. Brian Freeman contributed Figure 3B; Dr. Kizhakke M. Sathyan contributed 
Figure 10B-C, 11B-E; Yijie Geng and Dr. Fei Wang contributed Figure 12E, 12G, 13I-
L. 
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II.6. Figures 
 
 
 
 
 
 
 
Figure 1. ORCA is a highly conserved ORC-binding protein. (A) Schematic 
representation of ORCA domain structure. Simple Modular Architecture Research Tool 
(SMART)-based domain predictions reveal three leucine-rich repeats at the N-terminus 
and five WD repeats at the C-terminus. (B) Sequence alignment shows high 
conservation of ORCA among higher eukaryotes. The top block represents alignment of 
LRR-3 (90-113aa human) and the lower block is WD40 repeat-1 (390-430aa human). 
Note that on the basis of bioinformatics prediction, only a conserved WD40-containing 
protein was found as a possible ortholog in Drosophila. (C) ORCA associates with 
ORC. Immunoprecipitation with T7 mAb in cells transfected with T7-ORCA followed 
by immunoblots with antibodies against T7, Orc1, Orc2, and MCM2 reveals specific 
interaction of T7-ORCA with Orc1 and Orc2. Mouse IgG (mIgG) was used as the 
control. (D) Reverse IP with Orc2 mAb shows Orc2 can efficiently pull down 
endogenous ORCA from human cells. (E) ORCA interacts with multiple components of 
pre-RC. IP with ORCA antibody shows the interaction with ORC subunits, Cdt1, and 
Geminin. 
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Figure 2. ORCA is a highly conserved, novel ORC-binding protein. (A) Percentage 
identity and percentage similarity of ORCA between humans and other organisms 
based on protein alignment. (B) ORCA and ORC interact with each other. T7-ORCA 
and HA-Orc2 were co-transfected in human cells for co-IP experiments. IP using T7 
antibody could efficiently pull down Orc2 and similarly IP using HA antibody could 
bring down T7-ORCA.  
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Figure 3. ORCA exists in multiple sub-complexes in the cell. (A) Glycerol gradient 
sedimentation analysis of ORCA complex on material immunoprecipitated with ORCA 
antibodies. The corresponding molecular weight markers are labeled. Note that ORCA, 
Orc2, and Orc3 co-sediment in fractions 12-14. (B) Association of ORCA with ORC in 
human cells. HeLa nuclear extract fractionated over a Superdex-200 gel filtration 
column and fractions analyzed for ORCA and various ORC subunits by immunoblot. 
Molecular weight markers are labeled on top of the panel. Note the multiple peaks of 
ORCA corroborating its existence in multiple sub-complexes. 
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Figure 4. ORCA association with chromatin is cell cycle regulated. (A) 
Immunostaining of human cells with ORCA-specific antibody shows differential 
staining of ORCA, with some cells showing strong staining, while others lacking it. (B) 
YFP-ORCA-expressing MCF7 cells were pre-extracted and immunostained with 
MCM3 and PCNA. Note that the YFP-ORCA-expressing cells show punctate labeling 
of MCM3 and lack of PCNA, pointing to the presence of ORCA protein in G1 cell 
population. DNA is counterstained with DAPI (blue). Scale bars in (A) and (B) 
represent 10 µm. (C) Statistical analysis of MCM/PCNA profile in YFP-ORCA-
expressing MCF7 cells. Note that ORCA is predominantly present in cells that show 
MCM+/PCNA- (60.3% ± 6.1%), representing G1 cells. ORCA-expressing, 
MCM+/PCNA+ cells denoting cells in S phase is 11.8% ± 8.2%, and MCM-/PCNA- is 
27.9% ± 8.1%. The graph represents mean values plus standard deviation from four 
independent experiments (n = ~100 cells in each experiment). (D) Levels of ORCA 
during the cell cycle. ORCA immunoblot of whole-cell extract from cells synchronized 
during specific stages of the cell cycle. Note the increase in ORCA during G1 phase. 
(E) Biochemical fractionation of ORCA. Chromatin fractionation from cells 
synchronized during different stages of the cell cycle show accumulation of ORCA in 
G1 cells (S3 fraction) and decrease during G1/S and S. ‘‘*’’ denotes a cross-reacting 
band of ORCA pAb. Note that the cross-reacting band appears in the cytosolic fraction 
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Figure 4 (cont.) and is therefore not found in any of the experiments where nuclear 
extracts were used (Figure 1 and Figure 3). MEK2 is shown as a control for chromatin 
fractionation. Flow cytometry profiles are shown on top of the panel. S2 represents 
cytosolic fraction, S3 nuclear soluble and MNase-released nuclear fraction, and P3 the 
insoluble and MNase-resistant nuclear fraction. Bar diagrams in (Db) and (Eb) 
represent the relative abundance of ORCA throughout the cell cycle (level in G1 is 
being considered 100%). 
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Figure 5. ORCA is highly dynamic. Time-lapse live cell imaging of YFP-ORCA in 
MCF7 cells. The images were obtained using a Delta Vision optical sectioning 
deconvolution instrument (Applied Precision) on an Olympus microscope with a 
63X1.42NA objective. The scale bar represents 10 µm. 
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Figure 6. ORCA co-localizes with ORC at heterochromatic structures. (A) IF with 
Orc2 pAb and HP1α antibodies after pre-extraction procedure in YFP-ORCA-
expressing MCF7 cells reveals co-localization of ORCA with Orc2 and HP1α at 
heterochromatic regions. (B) Triple immunolabeling with antibodies against ORCA, 
telomere binding protein Trf2, and centromere protein AnaC shows co-localization of 
ORCA with centromeric and pericentromeric heterochromatin in MCF7 cells. (C) 
Immunostaining of Orc2 and HP1α in YFP-ORCA-expressing stable U2OS cells shows 
the complete overlap of ORCA and Orc2. (D) Immunostaining of Trf2 and AnaC in 
YFP-ORCA-expressing stable U2OS cells shows co-localization of YFP-ORCA at 
telomeres but not at centromeres. (E and F) Similar overlap of endogenous ORCA and 
YFP-Orc1 in U2OS cells at telomeres (E) but not at centromeres (F). The scale bar 
represents 10 µm.  
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Figure 7. ORCA localizes to centromeres. (A) Immunolabeling using antibodies 
against centromere protein AnaC shows co-localization with YFP-ORCA at 
centromeric heterochromatin in MCF7 cells. Figure 6B is shown again (lower panel) 
with pearson co-efficient of correlation demonstrating significant co-localization. (B) 
Dynamics of YFP-ORCA and Orc2 during G1 and S phase in human U2OS cells. 
CAF1 (p150) is shown as an S phase marker. (C) YFP-ORCA localizes to centromeres 
during mitosis. DNA was stained with DAPI (blue). The scale bar represents 10µm. 
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Figure 8. WD40 repeat of ORCA mediates ORC and chromatin association. (A) 
Schematic representation of various truncation mutants of ORCA. Each of the mutants 
contains an epitope tag-T7 or YFP-at their N-terminus for IP or IF analyses, 
respectively. (B) IP in cells expressing various T7-ORCA mutants with T7 antibody 
and analysis of Orc2 by immunoblot. Note that only ORCA constructs possessing the 
WD40 domain efficiently interact with Orc2 (T7-ORCA.128-647; 270-647; 1-647). (C) 
YFP-tagged truncated ORCA constructs and their chromatin binding as detected by 
detergent pre-extraction procedure followed by formaldehyde fixation. Note that only 
the constructs having WD repeat domain associate with chromatin. DNA was stained 
with DAPI (blue). The scale bar represents 10 µm. (D) Immunoblot analysis of YFP-
tagged truncated ORCA constructs shows association of FL (1-647) and WD-containing 
fragments (128-647 and 270-647) with chromatin (P). YFP-ORCA mutant constructs 
lacking WD (1-127 and 1-270) appear in non-chromatin-associated detergent-extracted 
supernatant (S) fraction. (E) YFP-ORCA.270-647 localizes to heterochromatin as 
evident by co-localization with HP1α and Orc2. The scale bar represents 10 µm. 
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Figure 9. The WD domain of ORCA is essential for chromatin binding. (A) 
Expression analysis of YFP-ORCA mutants in human cells following formaldehyde 
fixation shows the punctate localization of ORCA in cells containing an intact WD 
domain. (B) YFP-ORCA.128-647 localizes to heterochromatin as evident by immuno-
localization with HP1α. DNA was stained with DAPI (blue). The scale bar represents 
10 µm. (C) IP using Orc2 mAb in extracts treated with (+) or without (-) DNase I. Note 
the reduction of ORCA and Orc3 interaction with Orc2 in DNase I-treated samples. 
Longer exposure of ORCA immunoblot is shown for input. ‘*’ denotes the cross-
reacting band. 
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Figure 10. ORCA tethers ORC to chromatin. 
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Figure 10 (cont.) (A) Schematic representation of the 2-6-3 CLTon locus in human 
U2OS cells (adapted and modified from (Janicki et al., 2004)). The chromatin locus is 
visualized by Cherry-LacI staining. (B) Cells were co-transfected with YFP-LacI and 
CFP-Orc2 or with YFP-LacI-ORCA and CFP-Orc2. YFP-LacI does not recruit CFP-
Orc2 to the locus, whereas YFP-LacI-ORCA can efficiently recruit CFP-Orc2 to the 
chromatin locus. (C) Cells co-transfected with YFP-LacI-ORCA.1-270 or YFP-LacI-
ORCA.270-647 and CFP-Orc2 show that only YFP-LacI-ORCA.270-647 recruits Orc2 
to the locus. (D) Cells transfected with YFP-LacI-ORCA and not YFP-LacI alone show 
accumulation of MCM3 to the locus, demonstrating that ORC binding to this locus is 
functional. Scale bars represent 10 µm. 
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Figure 11. ORCA tethers ORC to chromatin. 
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Figure 11 (cont.) (A) The artificially generated chromatic locus in 2-6-3 CLTon cells is 
heterochromatic and shows accumulation of HP1α. ORCA recruits various ORC 
subunits to heterochromatic locus (B) Orc1, (C) Orc3 and (D) Orc5. (E) Co-transfection 
of YFP-LacI-ORCA.1-127 or YFP-LacI-ORCA.128-647 with CFP-Orc2 shows that 
YFP-LacI-ORCA.128-647 recruits Orc2 to the locus. (F) Tethering YFP-LacI-ORCA to 
the locus results in accumulation of MCM. Note the bottom cell (cell number 1) lacking 
YFP-LacI-ORCA does not show the presence of MCM3 at the locus. DNA was stained 
with DAPI (blue). The scale bar represents 10 µm.  
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Figure 12. ORCA is required for loading ORC to chromatin. (A) Immunoblot 
analysis after siRNA depletion of ORCA with two independent siRNA oligonucleotides 
shows >90% depletion in U2OS cells. ‘‘*’’ denotes the cross-reacting band. Tubulin 
was used as the loading control. (B) Chromatin fractionation in ORCA-depleted U2OS 
cells and immunoblot analysis. Note that in the ORCA siRNA-treated cells, there is a 
significant reduction of Orc2 from P3 fraction and a concomitant accumulation in S2. 
Similar reduction is apparent for Orc1, Orc3, and Orc4. MEK2 was used as a control for 
chromatin fractionation. SF2/ASF, a splicing factor, is used as the loading control. (C) 
Immunoblot analysis after depletion of ORCA in human primary diploid fibroblasts 
WI38. Note the increase in levels of p21 and Cyclin E and decrease in Cyclin B upon 
ORCA depletion. (D and E) Cell cycle profile by flow cytometry of WI38 cells and 
hESCs depleted of ORCA shows increased accumulation in G1 phase. (F and G) 
Percentage of PCNA-positive cells (by immunofluorescence) in control and ORCA-
depleted WI38 and hESCs. The graphs represent mean values plus standard deviation 
from three independent experiments (n = ~400). (H) Chromatin fractionation in ORCA-
depleted WI38 cells and immunoblot analysis. Note the significant reduction of Orc2 
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Figure 12 (cont.) and Orc3 and MCM2, MCM3, and MCM5 on chromatin (P) and the 
increase in p21 in ORCA-depleted cells. ‘‘%’’ on the right side of (B) and (H) denotes 
the amount of protein left on chromatin after ORCA depletion. 
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Figure 13. ORCA is required for loading ORC to chromatin. 
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Figure 13 (cont.) (A) a. Schematic representation of the location of short hairpin-1 and 
-2 and siRNA oligo-1 and -2 against ORCA used in the present study. b. siRNA 
oligonucleotide treatment of human cells using a pool of ORCA-1 and -2 oligos in 
YFP-ORCA cells shows the efficient depletion of ORCA. Note that Orc2 whole-cell 
levels remain unchanged. (B and C) Immunoblot using ORCA antibody in YFP-ORCA 
cells or U2OS cells treated with ORCA-1 and -2 siRNAs show significant depletion of 
endogenous as well as YFP-ORCA from human cells. Note the disappearance of high-
molecular-weight modifications of ORCA upon ORCA siRNA. (D) Knockdown of 
ORCA shows reduced ORCA in human cells as evident by immunofluorescence 
analysis. The scale bar represents 10 µm. (E) Orc2 IP in ORCA-depleted cells. Note the 
residual ORCA presents in ORCA-depleted extracts forms complex with ORC. (F) 
Chromatin fractionation in control and ORCA shRNA-1-treated U2OS cells. Note that 
in ORCA-depleted cells, Orc2 shows reduced binding to chromatin and a concomitant 
increase in S2 fraction. (G and I) Depletion of ORCA in WI38 as well as hESCs shows 
dramatically reduced proliferation rates. The error bar (Figure 13G) represents standard 
deviation from three independent experiments. (H) Orc2 and PCNA 
immunofluorescence in control and ORCA siRNA-treated WI38 cells. (J) 
Immunofluorescence following detergent pre-extraction using Orc2 antibody in control 
and ORCA shRNA-treated hESCs shows reduced levels of chromatin associated Orc2 
in ORCA-depleted hESCs. (K) Immunoblot analysis following depletion of ORCA 
using shRNA in hESCs. Note the increase in Cyclin E levels. (L) Chromatin 
fractionation in ORCA-depleted hESCs and immunoblot analysis of ORC and MCM. 
Note the significant reduction of Orc1 and Orc2 and reduced MCM3 in P3 in ORCA-
depleted cells. SF2/ASF, a splicing factor is shown as the loading control. Note that 
ORCA is found predominantly in the P3 fraction (chromatin/nuclear insoluble) in 
hESCs, whereas it is enriched in S3 (chromatin soluble) in human cancer cells, 
suggesting that ORCA is more strongly associated with the chromatin in hESCs. DNA 
was stained with DAPI (blue). Scale bars represent 10 µm. 
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CHAPTER III. UNDERSTANDING THE ROLE OF ORCA/LRWD1 IN DNA 
REPLICATION INITIATION 
 
III.1. Introduction 
In eukaryotes, initiation of DNA replication requires the assembly of the pre-RC 
in late mitosis and G1, with the sequential loading of ORC, Cdc6, Cdt1 and MCM2-7 
onto replication origins (Bell and Dutta, 2002). The Cdt1-mediated recruitment of the 
helicase MCM2-7 to chromatin additionally requires MCM9 (Lutzmann and Mechali, 
2009). At the G1/S transition, pre-RC is converted to pre-IC when MCM proteins are 
activated by the CDK and DDK. CDK and DDK dependent phosphorylation activities, 
in addition to molecules like MCM10, enable the recruitment of Cdc45 and GINS onto 
MCM2-7 in order to activate the helicase (Gambus et al., 2006; Moyer et al., 2006; 
Pacek and Walter, 2004; Truong and Wu, 2011; Wohlschlegel et al., 2002). Upon the 
initiation of DNA replication, the pre-RC is disassembled, and Cdt1 and Cdc6 are 
released from the origins thereby preventing re-replication (Diffley, 2010). 
Several mechanisms ensure that replication occurs “once and only once” during 
each cell cycle (Arias and Walter, 2007; Thommes and Blow, 1997). This “licensing” 
process is well coordinated and the loss of licensing causes DNA re-replication, 
genomic instability and tumorigenesis (Arias and Walter, 2007). The regulation of the 
licensing factors Cdt1 and Cdc6 during the cell cycle is a crucial regulatory mechanism 
to prevent DNA re-replication (Arias and Walter, 2007; Blow and Dutta, 2005; Cook, 
2009; Fujita, 2006). In S. cerevisiae, Cdc6 is degraded whereas Cdt1 is exported out of 
the nucleus at the end of G1 (Drury et al., 1997; Mimura et al., 2004; Wilmes et al., 
2004). In S. pombe, both Cdc6 and Cdt1 are subject to proteolytic degradation in post-
G1 cells (Gopalakrishnan et al., 2001; Hu and Xiong, 2006; Jallepalli and Bogyo, 1997; 
Jallepalli et al., 1997; Ralph et al., 2006). In mammalian cells, multiple parallel 
Chapter III has been published as: 
Shen, Z., A. Chakraborty, A. Jain, S. Giri, T. Ha, K.V. Prasanth, and S.G. Prasanth. 
2012. Dynamic association of ORCA with prereplicative complex components 
regulates DNA replication initiation. Mol Cell Biol. 32:3107-3120. 
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mechanisms operate to prevent Cdc6 and Cdt1 activity in post-G1 phase: nuclear export 
of Cdc6 (Kim and Kipreos, 2008); cleavage of Cdc6 (Pelizon et al., 2002); SCF
Skp2
and 
Cul4/Ddb1-mediated degradation of Cdt1 (Nishitani et al., 2001; Zhong et al., 2003); 
presence of the Cdt1 inhibitor Geminin (McGarry and Kirschner, 1998). Geminin is 
predominantly present in post-G1 cells and is degraded by APC
Cdh1
 during late mitosis 
to enable Cdt1 to assemble on chromatin (Bastians et al., 1999; Li and Blow, 2004; Li 
and Blow, 2005; Tada et al., 2001; Wohlschlegel et al., 2000). Recent studies have also 
indicated that Geminin promotes the Cdt1-dependent loading of MCM2-7 in G1, 
though the molecular nature of this Geminin-Cdt1 complex remain to be understood 
(Lutzmann et al., 2006). It has been suggested that the stoichiometry of Cdt1 and 
Geminin in the cells during different cell cycle stages determine the recruitment of 
MCM2-7 for licensing or inhibiting pre-RC assembly (De Marco et al., 2009; Lutzmann 
et al., 2006) and that a fine-tuned balance between Cdt1 and Geminin is crucial for 
genomic stability (Saxena and Dutta, 2005). Surprisingly, overexpression of Cdt1 
mutants that lack the MCM binding domain can still induce re-replication by de-
repressing endogenous Cdt1 by titrating the levels of PCNA and Cyclin (Teer and 
Dutta, 2008). Using quantitative fluorescent microscopy, it has been demonstrated that 
Cdt1 can associate with Geminin as well as chromatin simultaneously, and that these 
dynamic associations provide spatial-temporal control of licensing (Xouri et al., 2007). 
In Chapter II, I report that ORCA/LRWD1 is a novel ORC-associated protein 
that binds to ORC, Cdt1 and Geminin (Bartke et al., 2010; Shen et al., 2010; Vermeulen 
et al., 2010). In this chapter, I demonstrate that the cellular as well as chromatin-bound 
Orc2 levels are several folds higher than ORCA in human cells. Using single-molecule 
pull-down experiments, I demonstrate that one molecule of ORCA is bound to one 
ORC, one Cdt1 and two Geminin, suggesting that an ORCA-independent ORC 
complex exists in cells. I show that ORCA directly interacts with Orc2 and that the 
binding of Orc2 to ORCA stabilizes cellular ORCA. ORCA associates with Orc1 
during G1; with Orc2 throughout the cell cycle; with Cdt1 during G1; with 
phosphorylated Cdt1 during mitosis; and with Geminin in post-G1 cells. 
Overexpression of Geminin results in the loss of Cdt1 association with ORCA, 
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suggesting that the increased levels of Geminin titrate ORCA away from Cdt1. Based 
on these results, I propose that at the end of G1 phase when the levels of Geminin begin 
to elevate, ORCA binding to Cdt1 is lost resulting in the disassembly of pre-RC. 
Collectively these results suggest a crucial role for ORCA in pre-RC assembly and 
replication initiation. 
 
III.2. Materials and methods 
III.2.1. Cell culture and transfection 
HeLa, U2OS, MCF7 and WI38 cells were grown in Dulbecco’s Modified Eagle 
Medium (DMEM) containing high glucose, supplemented with penicillin-streptomycin 
and 10% fetal bovine serum (FBS) (Hyclone). Lipofectamine 2000 (Invitrogen) and 
lipofectamine RNAiMAX (Invitrogen) were used for transient transfections and RNAi 
respectively according to the manufacturers’ protocols. 
 
III.2.2. Plasmids and antibodies 
Human Orc2, Cdt1, Geminin cDNAs were cloned into pCGT vector and 
pEYFP-C1 with CMV promoter (Clontech) to generate T7-Orc2, T7-Cdt1, T7-Geminin 
and YFP-Geminin. Truncated mutants were obtained using PCR from Orc2, Cdt1 and 
Geminin cDNAs and also cloned into pCGT vector.  
The following antibodies were used for immunoprecipitations and immunoblots 
as indicated: ORCA pAb (2853-2, 2854-1), Orc1 mAb (pKS1-40), Orc2 pAb (205), 
Orc3 pAb (Abcam), Orc4 pAb (Abcam), Orc5 pAb (BD Pharmingen), Orc6 pAb (982), 
Cdt1 pAb (Dr. Yue Xiong Lab), Geminin pAb (Santa Cruz Biotechnology), Tubulin 
mAb (Sigma-Aldrich), T7 mAb (Novagen), GFP mAb (Covance). 
 
III.2.3. Insect cell culture and baculovirus expression 
For the expression analysis, the full-length human ORCA was first cloned in 
pFastBac HT-B (Invitrogen) vector and later was amplified along with poly-histidine 
tag using pFastBac HT-B-ORCA as template. Similarly, the ORFs of human ORC 
subunits, Cdt1 and Geminin were also amplified by PCR. The PCR product of human 
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ORCA was first cloned in pFastBac-Dual vector at BssHII and SpeI sites followed by 
the cloning of human ORC subunits or Cdt1 or Geminin individually in the same 
backbone so that each subunit of ORC or Cdt1 or Geminin will be expressed along with 
ORCA from the same virus. Similarly, viruses expressing individual proteins as 
histidine tag were also generated. DNA sequencing was performed to confirm the 
constructs and recombinant baculoviruses were produced as per the manufacturer’s 
protocol (Bac-to-Bac® Baculovirus Expression System, Invitrogen). Hi5/Sf9 insect 
cells were either infected with baculoviruses expressing ORCA and individual subunits 
of ORCs/Cdt1/Geminin or in a combination of different viruses, each at a multiplicity 
of infection of 5-10 and incubated at 28˚C for 60-72hr. Nuclear extracts were prepared 
in PK50 buffer (in the presence or absence of 2mM ATP) and proteins were 
precipitated by saturation at 45% ammonium sulfate (Siddiqui and Stillman, 2007). The 
reconstituted proteins in PK50 buffer were immunoprecipitated using anti-ORCA 
antibody followed by immunoblotting using anti-ORC or Cdt1 or Geminin antibody. 
 
III.2.4. Immunoprecipitation 
Nuclear extracts or whole-cell lysates were incubated with GammaBind G 
Sepharose resin (Amersham) at 4
o
C for 45 min for pre-clearing. Antibodies were added 
into the supernatant after the removal of the resin, and binding was carried out at 4
o
C 
overnight. Resin was then added for 1 hr to capture the complex, washed three times in 
nuclear extraction buffer, and resuspended in Laemmli buffer for immunoblot analysis. 
If elution of the complex was needed, extracts were incubated with antibody-conjugated 
resin overnight. The resin was then washed and incubated with appropriate peptides 
thrice at 30
o
C for 15 min. The eluate was then collected by low-speed centrifugation. 
 
III.2.5. Single-molecule pull-down (SiMPull) 
SiMPull experiments were carried out on methoxy polyethylene glycol (mPEG) 
passivated quartz slides doped with biotin PEG as described previously (Jain et al., 
2011). Antibodies were immobilized on NeutrAvidin (Thermo) coated flow chambers 
either by incubating with biotinylated T7 antibody (Novagen) for 10 min or incubating 
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with biotinylated anti-rabbit IgG secondary antibodies for 10 min followed by ORCA 
antibody for 20 min. RIPA buffer lysed samples were then incubated in the chamber for 
20 min and washed twice with the buffer (10mM Tris-HCl pH 8.0, 50mM NaCl 
0.1mg/ml BSA). Single-molecule data were acquired by a prism type total internal 
reflection fluorescence (TIRF) microscope and analyzed using scripts written in Matlab.  
For ORCA-Orc1 SiMPull analyses, lysates were made from the YFP-Orc1 stable cell 
line (U2OS cells) where T7-ORCA was transiently transfected. For ORCA-Cdt1 
SiMPull analysis, lysates were made from U2OS cells where T7-ORCA and YFP-Cdt1 
were transiently transfected. Similarly, for ORCA-Geminin SiMPull analysis, lysates 
were prepared from cells transiently transfected with T7-ORCA and YFP-Geminin. 
 
III.2.6. Gel filtration and glycerol gradient sedimentation 
Nuclear extracts were subject to size exclusion chromatography using a 
Superdex-200 column (GE Inc.) at 0.25 ml/min and fractions (600µl each) were 
collected and precipitated by trichloroacetic acid (TCA). After centrifugation at 14,000 
rpm for 5 min, the pellet was washed with acetone twice and resuspended in Tris pH 8.7 
and Laemmli buffer for immunoblots. 
For glycerol gradient sedimentation, IP eluate or marker (200µl) was layered on 
10-50% glycerol gradient (buffer: 27mM Tris pH 8.0, 100mM NaCl, 1mM EDTA, 
0.1% NP-40, protease inhibitors). The mixture was centrifuged at 48,000 rpm for 16 
hrs. Fractions (200µl each) were collected and prepared for immunoblots as described 
above. 
 
III.2.7. Synchronization 
To synchronize cells at G1/S boundary, 2mM thymidine was added. After 24 
hrs, cells were washed thrice with fresh medium, grown for 12 hrs, and incubated with 
2mM thymidine for an additional 24 hrs. Cells were then released and aliquots were 
taken at 4 hrs and 8 hrs for S and G2 cells. For M and G1 populations, cells that had  
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been released from the double thymidine block for 8 hrs were further treated with 50 
ng/ml nocodazole for 14-16 hrs to arrest them in mitosis, and were released for 5-6 hrs 
into G1 phase. 
 
III.3. Results 
III.3.1. ORCA is required for the G1/S transition 
I previously demonstrated that depletion of ORCA in human primary diploid 
fibroblasts results in cells accumulating in G1 phase of the cell cycle (Chapter II and 
(Shen et al., 2010)).  However, it remained to be determined whether ORCA depletion 
results in a delay in G1 progression or an arrest in the G1 phase of the cell cycle. To 
resolve these possibilities, WI38 diploid fibroblasts cells were serum starved and then 
treated with control or ORCA-specific siRNAs. Cells were then released from the arrest 
and harvested at 12 and 24 hrs for immunoblot and flow cytometry analysis (Figure 
14Aa). The control and ORCA siRNA-treated cells at 12 hrs post release looked 
identical. However in 24 hrs post release, control cells efficiently entered the cell cycle 
and progressed through S and G2/M, whereas the ORCA siRNA-treated cells failed to 
enter S-phase with 67.7% cells in G1 as compared to 25.9% in control cells (Figure 
14Ac). The appearance of a population of cells in S phase in ORCA-depleted cells 
could either denote incomplete depletion of ORCA or an extremely slow progression 
through S phase. Further, chromatin fractionation and immunoblot analysis revealed 
decreased ORC (25.3% of Orc2 on chromatin) as well as MCM (43.3% of MCM3 on 
chromatin) loading onto chromatin suggesting that the pre-RC checkpoint had been 
activated because of defects in loading MCM onto chromatin (Figure 14Ad). Reduced 
levels of Geminin are consistent with cells accumulating in the G1 phase of the cell 
cycle.  These results suggest that in the absence of ORCA, the transition from G1 to S 
phase is affected. 
I have previously demonstrated that ORCA interacts with ORC, Cdt1 and 
Geminin. In order to test the cellular levels of ORCA protein relative to Orc2, Cdt1 and 
Geminin in human U2OS cells, cell lysates were prepared and immunoblots using 
antibodies against ORCA, ORC, Cdt1 and Geminin were conducted. The relative 
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stoichiometry of ORCA and various ORC subunits were normalized using standard 
curves with purified protein that were in the linear detection range. Silver staining was 
used to quantify the purified 6×histidine tagged recombinant protein that were 
expressed in SF9 cells, purified on Talon column, or GST-fusion proteins purified from 
bacterial cells. Based on these calculations, human Orc2 was found to be 10-fold more 
abundant than ORCA in asynchronously growing human cells (Figure 14B).   
ORCA is highly dynamic through the cell cycle with elevated protein levels 
during G1 and subsequent decrease during the G1/S boundary, and presents 
predominantly at heterochromatic sites in post-G1 cells (Shen et al., 2010). I next 
examined the relative abundance of ORCA compared to ORC subunits during G1 phase 
of the cell cycle. Cells synchronized at G1 were used for conducting immunoblot 
analysis to ascertain the levels of ORCA, ORC, Cdt1 and Geminin. Consistent with 
previous studies, ORCA, Orc1 and Cdt1 levels were increased in G1 compared to Orc2, 
which was found to be unaltered. Geminin levels were negligible during G1 (Figure 
14C). To calculate the relative levels of chromatin-associated pool of ORCA and ORC 
(asynchronous as well as G1), I performed chromatin fractionation and quantitated the 
levels of ORC, ORCA, Cdt1 and Geminin (Figure 14D). Similar to Orc1 and Cdt1, both 
the total and chromatin-bound levels of ORCA showed increase during G1 phase of the 
cell cycle (around 2-fold increase in G1 samples compared to asynchronous samples). 
Orc1 and Orc2 were found to be equimolar on the G1 chromatin consistent with a 1:1 
ratio of Orc1 to Orc2. Orc1 and Orc2 levels were found to be 3-fold higher than ORCA 
on the G1 chromatin, suggesting that either multiple ORC proteins associate with 
ORCA or that ORCA-independent ORC complex exists in G1 cells. To further address 
these two possibilities, I evaluated the relative stoichiometry of ORCA bound to ORC, 
Cdt1 and Geminin using single-molecule analysis.  
 
III.3.2. Single-molecule pull-down (SiMPull) analyses of the stoichiometry of 
ORCA and pre-RC 
To further probe the stoichiometry between ORCA and pre-RC components, 
single-molecule pull-down (SiMPull) assays were performed (Jain et al., 2011). 
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SiMPull combines conventional pull-down assay with single-molecule fluorescence 
microscopy. Cellular protein complexes are pulled down from cell lysate on to a 
passivated surface at a low density (0.1-0.2 molecules-µm
-2
) and then imaged with 
single fluorophore sensitivity. When the proteins are stoichiometrically labeled with 
fluorophores such as genetically-encoded fluorescent proteins, single-molecule 
photobleaching analysis can reveal the stoichiometry of the proteins constituting the 
complex (Jain et al., 2011; Means et al., 2011). Lysates from cells co-expressing T7-
ORCA and YFP-Orc1 (as the representative of ORC) were added to surface coated with 
T7 antibody (Figure 15A). After washing away the unbound proteins, the surfaces were 
imaged for YFP fluorescence under a single-molecule total internal reflection 
fluorescence microscope. Figure 15Bb depicts representative single-molecule 
fluorescence images. The lysate that only expressed YFP-Orc1 served as the control 
and exhibited a 5-fold reduced binding (Figure 15Bb-c). Photobleaching of individual 
YFP molecules is a discrete phenomenon and the number of photobleaching steps 
provides information about the stoichiometry of the labeled protein (Figure 15Ab-c) 
(Jain et al., 2011; Ulbrich and Isacoff, 2007). Nearly 80% (864 out of 1075) of pulled 
down YFP-Orc1 molecules bleached in a single step (Figure 15Bd-e), indicating that 
each complex has one molecule of Orc1. Similar analysis was performed on lysates 
expressing T7-ORCA and YFP-Cdt1; ~82% of the YFP-Cdt1 fluorescence spots 
showed one photobleaching step (Figure 15C) indicating that each ORCA-Cdt1 
complex has one molecule of Cdt1. Next, I examined the stoichiometry of Geminin in 
ORCA-Geminin complexes. Biotinylated anti-rabbit IgG secondary antibody was 
immobilized onto the chamber, followed by ORCA antibody or rabbit IgG (Figure 
15Da). Cell lysates expressing T7-ORCA and YFP-Geminin were incubated in the 
chamber. There was a 5-fold enrichment of YFP spots in the anti-ORCA coated 
chamber as compared to the control (Figure 15Db-c). Photobleaching analysis 
demonstrated that 54% of YFP molecules displayed two photobleaching steps, while 
43% molecules exhibited one-step photobleaching (Figure 15Dd-e). This is consistent 
with two Geminin molecules per complex given the ~75% active fraction of YFP (Jain 
et al., 2011; Ulbrich and Isacoff, 2007). These results demonstrate that each molecule of 
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ORCA can interact with one ORC, one Cdt1 and/or two Geminin.  Future work would 
be to use SiMPull technology to study complex assembly and also stoichiometry of 
multiple components within the complex. This would entail using multiple fluorescent 
tags and requires further technical advancements. 
 
III.3.3. Cell cycle-dependent association of ORCA with ORC, Cdt1 and Geminin 
Since ORCA interacts with ORC, Cdt1 and Geminin, I examined if they exist in 
one complex or are present in independent complexes. HeLa nuclear extracts were 
fractionated on a Superdex-200 gel filtration column and examined the fractions by 
immunoblots (Figure 16A). As reported previously, ORCA and Orc2 co-fractioned in 
the range >440 kDa (Figure 16A, fraction 5-6), with some present at higher molecular 
weight (>669 kDa), indicating that ORCA along with all ORC subunits (predicted MW 
450kDa) exists in mammalian cells (Shen et al., 2010). Cdt1 was present in higher 
molecular weight range. In contrast, Geminin was only enriched in fractions 4-8 in a 
smaller molecular weight complex with negligible monomeric form in fractions 12-13 
(Figure 16A). These data suggest that distinct complexes may exist in human cells. 
Pre-RC components are highly dynamic with Orc1, Cdc6 and Cdt1 being cell 
cycle regulated to ensure that replication occurs only once through the cell cycle.  The 
levels of ORCA are elevated during G1 phase of the cell cycle and drop as the cells 
enter S phase. To address if the existence of ORCA with ORC, Cdt1 and Geminin in 
different sub-complexes reflected its cell cycle-regulated association with each of these 
components, I performed immunoprecipitation using ORCA antibody during different 
cell cycle stages (Figure 16Ba). ORCA associated with Orc2 throughout the cell cycle. 
ORCA associated with Orc1 predominantly during G1 phase of the cell cycle, and with 
lesser affinity to the phosphorylated form of Orc1 during mitosis. ORCA associated 
with Cdt1 in G1 and Geminin from G1/S to G2 predominantly, and interacted with both 
Cdt1 and Geminin in M phase regardless of the phosphorylation status (Figure 16Ba).  
Treatment of extracts with phosphatase demonstrated that Orc1 (data not shown), Cdt1 
and Geminin (Figure 16Bb) are phosphorylated during mitosis. 
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To further evaluate the composition of the ORCA-containing complexes with 
ORC, Cdt1 and Geminin during different stages of the cell cycle, I performed 
immunoprecipitation of ORCA, followed by peptide elution and subjected the eluate to 
10%–50% glycerol gradient sedimentation in asynchronous (Figure 16C), G1 extracts 
(Figure 16D) and mitotic extracts (Figure 16E). Immunoblot analysis from 
asynchronous cells revealed that Orc2 co-sedimented with ORCA at the molecular 
weight >200 kDa (Figure 16C). Cdt1, in addition to being a monomer (fraction 9), was 
also present in the higher molecular weight range. Geminin was present in fraction 7 in 
a smaller molecular weight complex and also in a much larger complex (Figure 16C, 
Fraction 13-15). The glycerol gradient analysis suggests the existence of a large 
complex composed of ORCA-ORC-Cdt1-Geminin. Immunoprecipitation and 
sedimentation analysis from G1 extracts (Figure 16D) revealed the co-existence of 
ORCA, Orc2 and Cdt1 but not Geminin (in fraction 11). In mitotic extracts, ORCA, 
Orc2, Cdt1 and Geminin were found to co-sediment (fraction 10, Figure 16E). 
Similarly, gel filtration analysis of ORCA immunoprecipitates from mitotic extracts 
further corroborated the existence of ORCA-ORC-Cdt1-Geminin complex (Figure 16F, 
fraction 8). To confirm the presence of ORCA-Orc2-Cdt1-Geminin during mitosis, I 
conducted sequential immunoprecipitation. ORCA immunoprecipitates were peptide-
eluted and the eluate was subject to Cdt1 immunoprecipitation. The presence of 
Geminin was evaluated in this assay. Sequential immunoprecipitation clearly revealed 
the existence of an ORCA complex consisting of Orc2, Cdt1 and Geminin (Figure 
16G). These results suggest the existence of ORCA-ORC-Cdt1 complex during G1 and 
an ORCA-ORC-Cdt1-Geminin during mitosis.  
 
III.3.4. ORCA associates with Orc2 directly  
In Chapter II, I report ORCA was originally identified in an Orc2 
immunoprecipitation-mass spectrometry screen, and was also found to co-
immunoprecipitate with all ORC subunits, Cdt1 and Geminin. However, whether 
ORCA displays direct interaction with any of these components had remained to be 
elucidated. To address this possibility, our lab generated baculoviruses expressing each 
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of the ORC subunits, ORCA, Cdt1 and Geminin for expression in insect cells. Insect 
cells were either infected with baculoviruses expressing ORCA and individual subunits 
of ORCs/Cdt1/Geminin or in a combination of different viruses, each at a multiplicity 
of infection of 5-10 and incubated at 28˚C for 60-72 hrs. Whole-cell extracts or nuclear 
extracts were prepared (see materials and methods) and immunoprecipitation was 
carried out using the ORCA antibody (Figure 17A). Orc2 bound ORCA directly in 
whole-cell extracts (Figure 17Ab) as well as nuclear extracts (data not shown) by this 
assay. Immunoprecipitation using Orc2 antibody on purified Orc2 and ORCA proteins 
further confirmed direct interaction between Orc2 and ORCA (Figure 17B). Orc1 and 
Orc3 showed weak interactions with ORCA only when nuclear extracts were used (data 
not shown).  
Several studies have successfully reconstituted the ORC complex in vitro using 
the baculovirus expression system (Dhar et al., 2001; Siddiqui and Stillman, 2007; 
Vashee et al., 2001).  I examined whether ORCA could be efficiently incorporated into 
the ORC complex in vitro. Co-infection of viruses expressing ORCA and ORC subunits 
followed by immunoprecipitation of Orc2 (Figure 17C) or ORCA (Figure 17D) clearly 
demonstrated that ORCA could be efficiently incorporated into the ORC complex, 
suggesting that ORCA is an integral component of this multi-protein complex. 
To address the functional relevance of ORCA binding to Cdt1 and Geminin, I 
first addressed in vitro binding of ORCA to Cdt1 and Geminin. Using binary infections 
in insect cells, I demonstrate that ORCA can associate with Cdt1 (Figure 17E) as well 
as Geminin (Figure 17F) in vitro.  
 
III.3.5. ORCA utilizes its WD domain to bind to ORC, Cdt1 and Geminin 
I previously demonstrated that the WD domain of ORCA is required for 
chromatin association of ORCA and for binding of ORCA to ORC. To map the region 
of ORCA that associates with Cdt1 and Geminin, I tagged different domains of ORCA 
expressing leucine rich repeat (LRR, 1-127aa), LRR+linker (1-270aa), WD alone (270-
647aa) and WD+linker (128-647aa) (Figure 17G) and performed co-
immunoprecipitation experiments to determine which domains were sufficient to 
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interact with Cdt1 and Geminin. Immunoprecipitation was carried out using T7 
antibody and the interaction of ORCA with Cdt1 and Geminin was assessed by 
immunoblot analysis. Like Orc2, Cdt1 as well as Geminin interacted with the WD 
domain of ORCA (Figures 17H and 17I). Based on bioinformatics predictions, ORCA 
has 5 discernible WD domains (Simple Modular Architecture Research Tool, SMART). 
Deletion of even a single WD domain resulted in complete loss of interaction between 
ORCA and ORC, Cdt1 as well as Geminin (data not shown). These results demonstrate 
that the entire WD domain of ORCA is critical for its interaction with pre-RC 
components as well as for its association to chromatin. 
 
III.3.6. Orc2 is required for stabilization of ORCA 
In order to map the region of Orc2 that is critical for binding to ORCA, I 
generated several truncation mutants of Orc2 with T7 tag (Figure 18A). Each of these 
mutants was transfected into human cells and immunoprecipitations were conducted 
using T7 antibody and immunoblotted for ORCA and Orc3 to address which domains 
of Orc2 are sufficient for interaction with ORCA and Orc3. These results demonstrate 
that the N-terminal fragment of Orc2 (1-240aa) binds to ORCA efficiently, whereas the 
Orc2 fragment (227-451aa) is sufficient to associate to Orc3 (Figures 18A and 18B). 
Further fine mapping of the N-terminal fragment demonstrated that the first 100aa of 
Orc2 are sufficient to bind to ORCA (Figure 18C). I previously demonstrated that 
ORCA is required for ORC binding to chromatin. I now addressed the impact of Orc2 
depletion on ORCA stability and observed that the human cancerous U2OS cells 
(Figure 18D) as well as primary diploid fibroblasts (Figure 18E) lacking Orc2 showed 
destabilization of cellular ORCA levels, similar to what has been reported for Orc3 
(Prasanth et al., 2004). No obvious changes were observed for Orc1 levels in cells 
lacking Orc2. Similarly, depletion of Orc1 did not affect the cellular levels of Orc2 as 
well as ORCA (Figures 18D and 18E).  To address if expression of the N-terminal half 
(1-240aa) of Orc2 that showed robust binding to ORCA can rescue the ORCA 
destabilization in Orc2-depleted cells, I utilized 2 different siRNAs against Orc2, so that 
only the endogenous Orc2 is depleted without affecting the exogenously expressed 
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Orc2 truncation mutants (oligo 2.1 in cells expressing MT3 227-577aa and oligo 2.6 in 
cells expressing MT1 1-240aa) (Figure 18F). Rescue assays revealed that only MT1 
domain but not MT3 rescued the ORCA degradation in the absence of endogenous 
Orc2. These results clearly demonstrated that Orc2 is required for the stability of ORCA 
in mammalian cells suggesting that ORCA is always in a complex with Orc2.  
 
III.3.7. ORCA binds to distinct domains of Geminin and Cdt1 
ORCA associates with Geminin during post-G1 and with Cdt1 predominantly in 
G1 phase of the cell cycle. During mitosis, ORCA along with ORC associates with both 
Geminin and Cdt1. To address whether a quaternary complex consisting of ORCA-
Cdt1-Geminin exists in cells during defined periods of the cell cycle, I mapped the 
interaction sites between ORCA-Cdt1 and ORCA-Geminin. Several Geminin mutants 
with the T7 tag (Figure 19A) were transfected into human cells and T7 
immunoprecipitations followed by immunoblot analysis with Cdt1 were carried out. 
The results are consistent with previously published observations that showed that the 
central region of Geminin is responsible for the Cdt1-Geminin association (Ballabeni et 
al., 2004; Saxena et al., 2004). I found that the 80-160 fragment of Geminin (G3) is 
sufficient to associate with Cdt1 (Figure 19B). In contrast, ORCA 
immunoprecipitations from the cell lysates expressing T7-tagged Geminin mutants 
showed that the C-terminus of Geminin is required for the ORCA binding (Figure 19C). 
The absence of ORCA association with the fragment 80-160aa of Geminin suggested 
that the binding site of ORCA within Geminin is between 160-209aa. I made smaller 
truncation mutations spanning 92-140, 92-160 and 161-209aa, but all these mutants 
failed to associate with ORCA, possibly due to loss of conformation of the mutant 
proteins. Based on these mapping analyses, I propose that ORCA binds to the C-
terminal end of Geminin and Cdt1 interacts with the central region of Geminin (Figures 
19B and 19C), consistent with the possibility that ORCA, Cdt1 and Geminin co-exist 
simultaneously in one complex. It remains to be determined if the phosphorylation of 
Geminin and Cdt1 facilitates the quaternary complex with ORCA and ORC.   
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To address if ORCA can associate with Cdt1 and Geminin in a single complex, I 
further mapped the interaction domain of Cdt1 to ORCA and Geminin. T7-tagged Cdt1 
mutants (Figure 19D) were transfected in human cells and immunoprecipitation was 
carried out using the T7 antibody. The C-terminal fragment of Cdt1 368-546aa (MT 
C5) could interact with ORCA but not with Geminin. However, 1-368aa interacted with 
ORCA as well as Geminin, suggesting that ORCA can bind to multiple domains within 
Cdt1 (Figures 19E and 19F). While there is at least one distinct domain within Cdt1 that 
can associate with ORCA but not with Geminin, it supports the existence of a 
quaternary complex within human cells. It has previously been demonstrated that the C-
terminal end consisting of the last 377 residues of Xenopus Cdt1 are essential for 
licensing and the very C-terminus is responsible for MCM binding (Ferenbach et al., 
2005).  Similarly, C-terminal 392-471aa of human Cdt1 has been shown to interact with 
MCM6 (Zhang et al., 2010). To fine map the C-terminal region of Cdt1 that associates 
with ORCA, I generated C-terminal mutants including 451-546, 401-546, and 368-
546aa. The fragment 451-546aa of Cdt1 showed robust interaction with ORCA (Figure 
19G).  
 
III.3.8. Overexpression of Geminin results in the loss of ORCA-Cdt1 interaction 
To gain an insight into the functional significance of ORCA binding to Cdt1 and 
Geminin, I addressed how changing the expression of Geminin affects the interaction 
between ORCA and Cdt1. In mammalian cells, Geminin levels begin to increase during 
the G1/S boundary, coincident with a decrease in the levels of ORCA and Cdt1. I 
therefore asked if the balance between each of these components is critical for entry 
into S phase and to prevent re-licensing. Geminin was overexpressed in human cells 
and immunoprecipitation using ORCA antibody was performed. In untransfected cells, 
ORCA interacted efficiently with endogenous Geminin as well as Cdt1 (Figure 20A). In 
cells transfected with 2µg of Geminin, ORCA interacted with endogenous as well as 
T7-Geminin. Interestingly, in the presence of overexpressed Geminin, ORCA failed to 
show any interaction with Cdt1 (Figure 20A), suggesting that excess quantities of 
Geminin titrated all the Cdt1 away from ORCA. Alternatively, all of the ORCA was 
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bound to Geminin; as a result, no free ORCA molecules were left behind to interact 
with Cdt1. To address each of these possibilities, I overexpressed T7-Geminin mutant 
(1-160aa) that can associate with Cdt1 but not with ORCA. Immunoprecipitation with 
ORCA in these cells showed that even though ORCA cannot associate with the 
overexpressed Geminin, the binding of ORCA to Cdt1 is lost (Figure 20B). 
Overexpression of ORCA did not perturb the Cdt1 binding to Geminin (Figure 20C) 
indicating that Geminin has a higher affinity to Cdt1 over ORCA. The above results 
indicated that the excess Geminin inhibited the ORCA-Cdt1 interaction. It is 
paradoxical to the fact that during mitosis a quaternary complex consisting of ORCA-
ORC-Geminin-Cdt1 exists in cells. One possibility could be that the various cell cycle-
specific post-translational modifications on each of these components might influence 
the complex assembly. For instance, the hyper-phosphorylation of Cdt1 as well as 
Geminin during mitosis may facilitate the complex assembly. I propose that ORCA 
binding to Cdt1 and Geminin at the end of G1 adds another layer of complexity in 
regulating licensing and preventing re-replication. 
 
III.4. Discussion 
DNA replication is a highly coordinated processes and its intricate regulation is 
crucial for maintaining genomic integrity. The involvement of ORCA in DNA 
replication and chromatin organization is beginning to be appreciated. I demonstrate 
that ORCA levels peak during G1 phase of the cell cycle, with ORC being several-fold 
excess in asynchronous as well as in G1 phase cells. However, single-molecule pull-
down (SiMPull) analyses demonstrate that ORCA and ORC are stoichiometric and that 
a single ORCA molecule could associate with a single ORC, one Cdt1 and two 
Geminin molecules. The excess of ORC in cells over ORCA suggests that ORCA-
independent ORC complexes exist in cells. It remains to be determined whether the 
ORCA bound to ORC defines specific origins. Whether ORCA recruits ORC to a 
specific set of origins, for example, late origins that are enriched in heterochromatic 
regions, or facilitates loading of ORC to all origins remains to be elucidated. It has 
previously been demonstrated that in yeast, origin-bound ORC along with Cdc6 recruits 
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two Cdt1, which in turn initiates the loading of double hexamer of the Mcm2-7 helicase 
(Takara and Bell, 2011). One possibility is that the ORCA-independent ORC associates 
with multiple Cdt1 molecules. It is also possible that the scenario in human cells is 
different from that in yeast, since there is no evidence as yet for an ORCA ortholog in 
yeast. 
ORCA associates with Orc2 directly, and Orc2 in turn is required for the 
stability of cellular ORCA. This suggests that ORCA is always in a complex with Orc2 
in human cells. My results demonstrate the existence of an ORCA-ORC-Cdt1 complex 
during G1, ORCA-ORC(2-5)-Geminin complex in S phase, and an ORCA-ORC(2-5)-
phosphorylated Cdt1-phosphorylated Geminin in mitotic cells (Figure 21). The 
phosphorylated Orc1 present during mitosis fails to associate with ORCA, suggesting 
that the binding of Orc1 to the ORCA-ORC(2-5) is an obligatory step to establish the 
pre-RC. It is interesting to note that the phosphorylated Cdt1 binds to ORCA very 
efficiently during mitosis.   
Replication licensing is a key mechanism that ensures that DNA replication 
occurs once and only once each cell cycle. Loss of licensing control is therefore 
deleterious to a cell and results in re-replication and genomic instability (Arias and 
Walter, 2007). Cells regulate this by modulating the levels and cellular distribution of 
pre-replicative complex proteins including Cdt1 and Cdc6 in a cell cycle-dependent 
manner. Cdt1 interacts with MCM2-7 DNA helicase complex and loads this complex 
onto chromatin (Evrin et al., 2009; Nishitani et al., 2000; Remus et al., 2009). At the 
beginning of S phase, CDK and DDK activate these replication origins (Diffley, 2010; 
Heller et al., 2011; Tanaka and Araki, 2010). Upon initiation of DNA replication, Cdc6 
and Cdt1 are released from origins and degraded by proteasomes and/or exported out 
from the nucleus (Aparicio et al., 1997; Arias and Walter, 2007; Blow and Dutta, 2005; 
Truong and Wu, 2011). In higher eukaryotes, Geminin inhibits Cdt1, thereby 
preventing the association of MCM2-7 with Cdt1 or preventing the loading of MCMs 
during S and G2 phases of the cell cycle (Lee et al., 2004; Maiorano et al., 2004; Tada 
et al., 2001; Wohlschlegel et al., 2000). Recent studies suggest that Geminin and Cdt1 
form a complex that is competent for licensing that in turn is competent for loading 
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MCM2-7 on chromatin (Lutzmann et al., 2006). How the Cdt1-Geminin complex 
permits licensing as well as prevents licensing remains to be elucidated. It has been 
suggested that the stoichiometry of the Cdt1-Geminin complex plays a key role in 
determining these activities (De Marco et al., 2009; Lutzmann et al., 2006). 
Accordingly, it has been suggested that the heterotrimer, where Cdt1 has exposed 
surfaces that enables loading of MCM, represents a ‘licensing permissive’ state even in 
the presence of Geminin. The inhibitory complex is hetero-hexameric, possibly due to 
an increased local concentration of Cdt1 and Geminin (De Marco et al., 2009). While 
Geminin can associate with Cdt1 at a different stoichiometry and dictate the ability to 
license or prevent it, how this stoichiometry is achieved at the end of G1 phase remains 
to be determined. In Xenopus egg extracts, Geminin has been shown to associate with 
chromatin in a Cdt1-dependent manner at the G1/S boundary when the pre-IC is formed 
(Maiorano et al., 2004). MCM9 has recently been shown to bind to Cdt1 and modulate 
the Cdt1-Geminin ratio to enable licensing (Lutzmann and Mechali, 2008). ORCA 
associates with Cdt1 primarily during the G1 phase of cell cycle, whereas it binds to 
Geminin in post-G1 cells. Overexpression of Geminin results in the loss of ORCA 
association to Cdt1.  However, overexpression of a Geminin mutant that can associate 
with Cdt1 but not ORCA still inhibits the binding of ORCA to Cdt1. These results 
suggest that at the G1/S boundary, increased binding of Geminin to Cdt1 could decrease 
the affinity of ORCA to Cdt1.  The loss of interaction between ORCA and Cdt1 might 
be a key step in disassembling pre-RC at the end of G1 phase. In late G1, as the level of 
ORCA is reduced, and Geminin level begins to elevate, more Geminin is available to 
bind to Cdt1 that in turn prevents licensing. A quaternary complex consisting of ORCA-
ORC-Cdt1-Geminin exists in mitotic cells where both Geminin and Cdt1 are heavily 
phosphorylated. It is a possibility that the phosphorylation of Cdt1 and Geminin (during 
mitosis) facilitates this complex assembly, whereas the dephosphorylated Geminin (at 
the G1/S boundary) inhibits ORCA-Cdt1 association. This will be tested in future 
experiments.  
The presence of WD repeats on ORCA, which are required for chromatin 
association, as well as the requirement of the WD to enable the association with ORC, 
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Cdt1 and Geminin suggests that ORCA is a key chromatin-associated protein that can 
mediate the assembly of proteins to chromatin that in itself do not have the ability to 
associate with chromatin or DNA. Mouse Cdt1 has been reported to be capable of 
binding DNA in a sequence-, strand- and conformation-independent manner. This DNA 
binding domain of Cdt1 overlaps with the Geminin binding domain, suggesting that the 
association of Cdt1 to DNA was inhibited by the presence of Geminin (Yanagi et al., 
2002). However, recent reports have demonstrated that Cdt1 can simultaneously 
associate with Geminin and chromatin in vivo, and this in turn facilitates the recruitment 
of Geminin to chromatin (Xouri et al., 2007).  
We demonstrate that the C-terminus of Cdt1 that has been previously shown to 
bind MCM2-7 also harbors the ORCA binding domain. Though the C-terminus of Cdt1 
binds to MCM2-7, the essential N-terminal of Cdt1 has been shown to be critical for 
loading MCM2-7 along with Cdc45 and GINS that stimulate the helicase activity 
(Takara and Bell, 2011). Recent solution structure of the C-terminal domain of Cdt1 
(450-557aa and 420-557aa of mouse Cdt1) by X-ray crystallography and NMR 
revealed the presence of a winged-helix domain that could possibly interact with MCM 
(Jee et al., 2010; Khayrutdinov et al., 2009). Similarly, NMR studies have revealed the 
interaction between human Cdt1 (410-440aa) and MCM6 (708-821aa) (Liu et al., 
2011). It is possible that the binding of ORCA to Cdt1 facilitates the loading of MCM2-
7 similar to the chromatin remodeler SNF2H that has been proposed to promote MCM 
loading via its interaction to Cdt1 (Sugimoto et al., 2011). Alternatively, the ORCA 
binding to the C-terminal of Cdt1 inhibits the interaction of Cdt1 and MCM in G1 cells. 
Only when Geminin levels begin to elevate, the binding of Geminin to Cdt1 (resulting 
in the loss of ORCA-Cdt1 interaction) permits the efficient association of MCM to the 
exposed domain of Cdt1. This model is supported by previous data that the Cdt1-
Geminin complex and not free Cdt1 is the MCM2-7 loader (Lutzmann et al., 2006). 
This active complex is inactivated by the addition of more Geminin after origin firing. 
My results demonstrate that the binding of ORCA to Cdt1 and Geminin is yet another 
way of ORCA functioning in replication initiation and cell cycle entry. 
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III.6. Figures 
 
 
Figure 14. ORCA is required for entry into the cell cycle. (A) a. Scheme of the 
experiment in WI38 cells. Cells were serum starved for 5 days. ORCA or control 
siRNA was transfected thrice at a gap of 24 hrs starting day 3. On day 6, cells were 
released from arrest for FACS or immunoblot analysis.  b. Immunoblot showing 
efficient knockdown of ORCA. c. FACS analysis at 12 hrs and 24 hrs post release in 
control and ORCA siRNA-treated cells. Note the efficient release of cells into the cell 
cycle in 24 hrs FACS profile for control but a G1 arrest in ORCA-depleted cells. d. 
Chromatin fractionation in control and ORCA siRNA-treated cells and immunoblotting 
with Orc2, MCM3 and Geminin. SRSF1 and MEK2 are shown as loading controls for 
chromatin (P) and cytosolic (S) fractions, respectively. (B) Relative levels of ORCA, 
Orc1, Orc2, Cdt1 and Geminin in asynchronously growing human U2OS cells. GST-
tagged ORCA, His-tagged Orc1, Orc2, Cdt1 and Geminin were loaded as indicated (ng) 
for quantitation. (C) Relative levels of ORCA, Orc1, Orc2, Cdt1 and Geminin in G1 
phase of U2OS cells. Note that ORCA, Orc1 and Cdt1 levels are high during G1, 
whereas Geminin levels are negligible in G1. (D) Relative abundance of ORCA, Orc1, 
Orc2, Cdt1 and Geminin on chromatin (P) during G1 in human U2OS cells. “*” denotes 
the cross-reacting band. 
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Figure 15. The stoichiometry of ORCA bound to ORC, Cdt1 and Geminin using 
single-molecule pull-down (SiMPull) analyses (A) a. Schematic representation of the 
SiMPull assay. Representative single-molecule fluorescence time trajectories of YFP-
Geminin molecules that exhibit (b) one-step and (c) two-step photobleaching. (B) 
ORCA-Orc1 pull-down a. Schematic, b. TIRF images of YFP molecules pulled down 
from U2OS cell lysates expressing T7-ORCA and YFP-Orc1 using biotinylated T7 
antibody. The lysate expressing YFP-Orc1 only serves as the control. c. Average 
number of YFP fluorescent molecules per imaging area, 2500 µm
2
. d. Photobleaching 
step distribution for YFP-Orc1 bound to T7-ORCA. e. Fluorescence intensity 
distribution of YFP molecules, exhibiting 1 and 2 photobleaching steps. Nearly 15% of 
the molecules could not be unambiguously scored and were discarded; the discarded 
molecules show no enrichment of the intensity. (C) ORCA-Cdt1 pull-down. YFP 
molecules pulled down from U2OS cell lysates expressing T7-ORCA and YFP-Cdt1 
using biotinylated T7 antibody. The same lysate incubated with the biotinylated Flag 
antibody serves as the control. (D) ORCA-Geminin pull-down. YFP molecules pulled 
down from U2OS cell lysates expressing T7-ORCA and YFP-Geminin using 
biotinylated anti-rabbit IgG and ORCA antibody were analyzed. The same lysate 
incubated with the biotinylated anti-rabbit IgG and rabbit IgG serves as the control. The 
fluorescence intensity of molecules bleaching in two steps was nearly twice that of 
molecules bleaching in a single step.  
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Figure 16. ORCA association with ORC, Cdt1 and Geminin is cell cycle regulated. 
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Figure 16 (cont.) (A) Association of ORCA with ORC, Cdt1 and Geminin in human 
cells.  HeLa nuclear extract fractionated over a Superdex-200 gel filtration column and 
fractions analyzed for ORCA, Orc2, Cdt1 and Geminin by immunoblot. Molecular 
weight markers are labeled on top of the panel. (B) a. ORCA immunoprecipitation 
during different stages of the cell cycle. ORCA associates with Orc2 throughout the cell 
cycle. ORCA associates with Orc1 during G1 but not efficiently with the 
phosphorylated Orc1 during mitosis. ORCA associates with Cdt1 during G1 as well as 
robustly with phosphorylated Cdt1 during mitosis. ORCA associates strongly with 
Geminin from G1/S to mitosis. B. Immunoblot analysis of whole-cell extract from 
nocodazole-arrested mitotic extracts treated with and without phosphatase. Note the 
phosphorylated form of Cdt1 and Geminin collapses on phosphatase treatment. (C) 
Glycerol gradient sedimentation analysis of ORCA complex on material (asynchronous 
sample) immunoprecipitated using ORCA antibodies. The corresponding molecular 
weight markers are labeled. Note that ORCA and Orc2 co-sediment in fractions 11-15; 
ORCA and Cdt1 co-sediment in fraction 11-14; ORCA and Geminin co-sediment in 
fraction 8, and 13-15. Fraction 13-14 contains ORCA, Orc2, Cdt1 and Geminin, 
suggesting the existence of a quaternary complex as well. (D and E) Glycerol gradient 
sedimentation analysis of ORCA-containing complex from G1 extracts (D) and mitotic 
extracts (E). Note co-sedimentation of ORCA-Orc2-Cdt1 (Fraction 10) in G1 extracts 
and ORCA-Orc2-Cdt1-Geminin (Fraction 9-10) in mitotic extracts. (F) Gel filtration 
analysis of ORCA-containing complex during mitosis. (G) Sequential 
immunoprecipitation of ORCA followed by Cdt1 from mitotic extracts. Immunoblot 
analysis of Geminin corroborates the presence of ORCA-Orc2-Cdt1-Geminin complex 
in mitotic extracts. 
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Figure 17. ORCA associates with Orc2 directly and utilizes WD to associate with 
ORC, Cdt1 and Geminin. (A) Binary infections using ORCA baculovirus in 
combination with (a) Orc1, (b) Orc2, (c) Orc3, (d) Orc4, (e) Orc5 and (f) Orc6 in insect 
cells followed by immunoprecipitation using ORCA antibody from whole-cell extracts. 
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Figure 17 (cont.) Note the prominent interaction between Orc2 and ORCA. (B) Direct 
interaction between ORCA and Orc2. His-ORCA and His-Orc2 were purified on Talon 
column and the two proteins were incubated following which immunoprecipitation was 
carried out using Orc2 antibody. (C and D) Reconstitution of the ORCA-ORC complex. 
Co-infection of ORCA+Orc1-5 baculovirus in insect cells and immunoprecipitation 
with Orc2 (C) or ORCA (D) antibody of whole-cell extracts. (E and F) Binary infection 
using ORCA baculovirus in combination with Cdt1 (E) and Geminin (F) in insect cells 
followed by immunoprecipitation using ORCA antibody from nuclear extracts. (G) 
Schematic representation of various truncation mutants containing T7 epitope tag at 
their N-terminus of ORCA. (H) IP in U2OS cells expressing various T7-ORCA mutants 
and Flag-Cdt1 using T7 antibody and analysis of Cdt1 by immunoblot. (I) IP in U2OS 
cells expressing various T7-ORCA mutants and YFP-Geminin using T7 antibody and 
analysis of Geminin by GFP immunoblot. Note that only ORCA constructs possessing 
the WD40 domain efficiently interact with Cdt1 and Geminin (T7-ORCA.128-647; 
270-647; 1-647). “*” denotes the cross-reacting band. 
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Figure 18. ORCA requires Orc2 for its stability. (A) Schematic representation of 
various truncation mutants containing T7 epitope tag at the N-terminus of Orc2 (MT1-
MT4). (B) IP using T7 antibody in U2OS cells expressing various mutants of T7-Orc2 
and analysis of ORCA and Orc3 by immunoblot. Note that the fragment 1-240aa (MT1) 
associates with ORCA, and 227-577aa (MT3) but not 452-577aa (MT4) binds to Orc3. 
(C) Schematic representation of smaller truncation mutants of Orc2 within the N-
terminal 240aa (MT1-1 to MT1-4) and their interaction status with ORCA. 1-100aa of 
Orc2 efficiently shows ORCA binding. (D and E) Depletion of Orc2 but not Orc1 
results in destabilization of cellular ORCA in human cancerous U2OS and WI38 cells. 
(F) Transient expression of MT1 (1-240aa) or MT3 (227-577aa) in U2OS cells depleted 
of endogenous Orc2 and immunoblot analysis using ORCA antibody. Note that the 
expression of MT1 can rescue the destabilization of ORCA. “*” denotes the cross-
reacting band. 
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Figure 19.  ORCA interacts with C-terminus of Geminin and C-terminus of Cdt1. 
(A) Schematic representation of various truncation mutants containing T7 epitope tag at 
the N-terminus of Geminin (MT-G1 to MT-G7). (B) IP in U2OS cells expressing 
various T7-Geminin mutants using T7 antibody and analysis of Cdt1 by immunoblot. 
Note that 80-160aa of Geminin is sufficient to bind Cdt1. (C) IP in U2OS cells 
expressing various T7-Geminin mutants using ORCA antibody and analysis of T7-
Geminin by immunoblot. Note that ORCA associates with the C-terminal end of 
Geminin. (D) Schematic representation of various truncation mutants containing T7 
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Figure 19 (cont.) epitope tag at their N-terminus of Cdt1 (MT-C1 to MT-C5). “+” 
denotes the extent of interaction based on the  immunoblots shown in (E) and (F). (E) 
IP in U2OS cells expressing various T7-Cdt1 mutants using T7 antibody and analysis of 
Geminin by immunoblot. (F) IP in U2OS cells expressing various T7-Cdt1 mutants and 
HA-ORCA using T7 antibody and analysis of ORCA by immunoblot. Note that the 
368-546aa fragment of Cdt1 associates with ORCA but not with Geminin. (G) IP in 
U2OS cells expressing T7-tagged C-terminus mutants of Cdt1 and HA-ORCA using T7 
antibody and analysis of ORCA by immunoblot. Note that 451-546aa fragment of Cdt1 
efficiently associates with ORCA. 
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Figure 20. Overexpression of Geminin disrupts the ORCA-Cdt1 interaction. (A) 
ORCA immunoprecipitation in U2OS cells transiently overexpressing T7-Geminin 
followed by ORCA, Geminin, Orc2 and Cdt1 immunoblots. Note the loss of ORCA-
Cdt1 but not ORCA-Orc2 interaction in cells overexpressing Geminin. Arrowheads 
denote endogenous and overexpressed Geminin. (B) ORCA immunoprecipitation in 
U2OS cells transiently overexpressing T7 vector (VT), T7-Geminin (full-length, FL) or 
T7-Geminin 1-160aa (G2, that only associates with Cdt1 but not ORCA), followed by 
Geminin, ORCA, Cdt1 and T7 immunoblots. Note that overexpression of full-length 
Geminin as well as truncated Geminin disrupts the ORCA-Cdt1 binding. (C) Geminin 
immunoprecipitation in U2OS cells transiently overexpressing T7-ORCA, followed by 
Geminin, T7, Cdt1 and Orc2 immunoblot. Note that the overexpression of ORCA does 
not affect the Cdt1-Geminin complex formation. 
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Figure 21. Model depicting the ORCA association with the pre-RC components in 
a cell cycle-regulated manner. In late M-G1, ORCA associates with ORC and Cdt1. 
Along with Cdc6, pre-RC are assembled at origins. ORCA is abundant in G1 phase. 
One prediction would be that ORCA acts as a scaffold and facilitates the assembly of 
Cdt1 during M and G1 and that of Geminin at the end of G1 on the chromatin. At the 
end of G1, Geminin levels begin to elevate. The balance in the Cdt1-Geminin ratio at 
this time point favors replication licensing. At the G1/S boundary, as Geminin levels 
begin to increase significantly, and ORCA levels begin to decrease, ORCA-Cdt1 
interaction is lost and Geminin titrates all the Cdt1 away from ORCA and hence from 
the origins. This makes the complex licensing inactive, following which Cdt1 is 
ubiquitinated and degraded. During G2, ORCA-ORC(2-5)-Geminin complex prevents 
licensing. During mitosis ORCA-ORC(2-5)-phosphorylated Cdt1-phosphorylated 
Geminin complex exists, and at the end of mitosis Geminin gets degraded and Orc1 is 
dephosphorylated and thus a functional pre-RC is assembled. 
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CHAPTER IV. UNDERSTANDING THE BIOLOGICAL RELEVANCE OF 
ORCA/LRWD1 UBIQUITINATION 
 
IV.1. Introduction 
DNA replication must occur once and only once in each cell cycle and the 
components of pre-RC coordinate this process. This is accomplished by ensuring that 
the pre-RC components are inactivated during S phase and their reassembly on the 
chromatin is prevented until the end of mitosis (DePamphilis, 2005; Feng and Kipreos, 
2003; Woo and Poon, 2003). Thus, the regulation of replication licensing factors during 
the cell cycle is crucial to preventing re-replication. 
Studies in different model organisms have shown that ORC is highly dynamic; 
with several ORC subunits getting post-translationally modified by phosphorylation or 
ubiquitination in a cell cycle-dependent manner (DePamphilis, 2005; Feng and Kipreos, 
2003; Woo and Poon, 2003). In S. cerevisiae, ORC is associated with the chromatin 
throughout the cell cycle, although phosphorylation regulates ORC activity (Diffley et 
al., 1994; Liang and Stillman, 1997; Nguyen et al., 2001). In S. pombe, ORC 
association to chromatin increases during mitosis and peaks at M/G1 (Wu and Nurse, 
2009). In Xenopus, ORC is not associated with chromatin during S phase and is also 
absent from the mitotic chromatin (Hua and Newport, 1998; Romanowski et al., 1996; 
Rowles et al., 1999; Sun et al., 2002). In Drosophila, Orc1 is degraded at the end of M 
phase by the Fzr/Cdh1 activated anaphase-promoting complex (Araki et al., 2003). In 
human cells, however, Orc1 dissociates from chromatin, is ubiquitinated and then 
degraded during the G1/S transition, and is reloaded at the M/G1 transition when new 
pre-RCs are formed (Kreitz et al., 2001; Mendez et al., 2002; Siddiqui and Stillman, 
2007; Tatsumi et al., 2003). Human Orc2 and Orc3 associate predominantly with 
centric and pericentromeric heterochromatin during the end of S phase, G2 and mitosis 
(Prasanth et al., 2004). A key molecule regulating replication licensing is Cdt1, which 
Chapter IV has been published as: 
Shen, Z., and S.G. Prasanth. 2012. Orc2 protects ORCA from ubiquitin-mediated 
degradation. Cell Cycle. 11:3578-3589. 
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accumulates during M and G1, and is degraded during S phase (Fujita, 2006; Tada, 
2007). In addition, Geminin, a protein expressed in cells from S phase through early 
mitosis, controls the levels of Cdt1 (McGarry and Kirschner, 1998; Saxena and Dutta, 
2003; Wohlschlegel et al., 2000; Xouri et al., 2007). Interestingly, Geminin is degraded 
during mitosis, thus restricting origin licensing to the end of mitosis and beginning of 
G1 when CDK/DDK activity is kept low (Diffley, 2004). In the previous chapters, I 
have demonstrated that ORCA modulates ORC loading, shows cell cycle dynamics 
similar to that of human ORC with highest levels observed during G1 and then 
sequential release from most sites, except at heterochromatic sites during the post-G1 
part of the cell cycle (Shen et al., 2010). 
Ubiquitination modulates protein function in multiple ways, including signaling 
a protein for destruction by proteasomes; organelle biogenesis; chromatin modification; 
DNA repair function; signal transduction in immune system (Chen and Sun, 2009; 
Kirkin et al., 2009; Weake and Workman, 2008). Ubiquitin is transferred to the lysine 
residues of the target protein by the action of E1 activating, E2 conjugating and E3 
ubiquitin-ligase enzymes (Cardozo and Pagano, 2004; Hershko and Ciechanover, 1998; 
Hochstrasser, 1996; Petroski and Deshaies, 2005; Pickart, 2001). The type of E3 ligase 
in a particular conjugation complex defines the specificity for substrate recognition. The 
Cullin-RING dependent E3 ligases (CRLs), as the major E3 ligase group, play essential 
roles in directing several pre-RC components for destruction (Hershko and 
Ciechanover, 1998; Hochstrasser, 1996; Petroski and Deshaies, 2005; Pickart, 2001). 
During the G1/S transition, the SCF E3 ligase complex (Skp1-Cul1-F-box protein) 
degrades Orc1 (Mendez et al., 2002). During S phase, Cdt1 undergoes degradation by 
SCF
Skp2
 mediated proteolysis through CDK phosphorylation (Li et al., 2003; Liu et al., 
2004; Nishitani et al., 2006; Sugimoto et al., 2004), as well as replication-coupled 
proteolysis by Cul4-Ddb1
Cdt2
 ubiquitin ligase and PCNA (Arias and Walter, 2006; Higa 
et al., 2006a; Hu et al., 2004; Ralph et al., 2006; Zhong et al., 2003). Upon mitosis, 
Geminin is degraded by anaphase-promoting complex, another E3 CRL ligase that 
recognizes its target through the destruction box (D-box) sequence (McGarry and 
Kirschner, 1998). Typically, the polyubiquitinated chain of a protein is recognized by 
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the proteasome which ultimately degrades the tagged protein (Komander, 2009). 
Ubiquitin-binding proteins comprise an ubiquitin-binding domain that can interact with 
an ubiquitin moiety or to an ubiquitinated protein. Ubiquitin-binding proteins might 
also be regulated by ubiquitination (Hicke et al., 2005). Recent evidence has shown that 
a large subset of WD repeat β-propellers are a novel class of ubiquitin-binding domains 
and their binding to ubiquitin is important for their function in vivo (Pashkova et al., 
2010). In this chapter, I investigate if the significant reduction of ORCA levels at the 
end of G1 are mediated by post-translational modifications, primarily through 
ubiquitination-mediated degradation, and if the reduction in ORCA levels in post G1 
cells is another mechanism cells utilize to ensure that the replication occurs once and 
only once during each cell division cycle.  
I demonstrate that ORCA is polyubiquitinated in human cells with an elevated 
ubiquitination at the G1/S boundary, in agreement with the reduction of ORCA levels at 
the end of G1. The ubiquitinated ORCA utilizes K48 linkage, consistent with the role of 
ubiquitin-mediated proteolysis of ORCA. Ubiquitination of ORCA occurs at the WD 
repeats, a domain required for chromatin association and ORC binding. Ubiquitinated 
ORCA is chromatin-bound and showed negligible turnover. Further, depletion of Orc2 
in human cells causes destabilization of cellular ORCA. However, the presence of a 
proteasome inhibitor MG132 in Orc2-depleted cells prevents the degradation of ORCA, 
but not Orc3. Furthermore, Orc2 associates only with non-ubiquitinated form of ORCA, 
demonstrating that Orc2 association with ORCA prevents its ubiquitin-dependent 
proteolytic degradation. Finally, I demonstrate that ORCA associates with the E3 
ubiquitin ligase Cul4A-Ddb1. I speculate that once ORCA accomplishes the loading of 
ORC, it dissociates from ORC, gets ubiquitinated, resulting in the reduced levels of 
ORCA at the G1/S boundary. I suggest that Orc2 protects ORCA from degradation by 
preventing the association of E3 ligases as well as the ubiquitination within the WD 
domain.  
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IV.2. Materials and methods 
IV.2.1. Cell culture and RNA interference 
U2OS and WI38 cells were grown in Dulbecco’s Modified Eagle Medium 
(DMEM) containing high glucose, supplemented with penicillin-streptomycin and 10% 
fetal bovine serum (FBS) (Hyclone). When indicated, cells were incubated with DMEM 
+ 20µM MG132 for proteasome inhibition. Lipofectamine 2000 (Invitrogen) was used 
for transient transfections as per the manufacturers’ protocols. Orc2 siRNAs (Prasanth 
et al., 2004) and Ddb1 siRNAs (Hu et al., 2004) were delivered by lipofectamine 
RNAiMAX (Invitrogen) as a final concentration of 100nM for three times at a gap of 
24 hrs. 
 
IV.2.2. Plasmids and antibodies 
Human ORCA cDNA was cloned into pCGT, pCGN and pEYFP-C1 vectors 
with CMV promoter (Clontech) to generate T7-ORCA, HA-ORCA and YFP-ORCA. 
Truncated mutants were obtained using PCR from the ORCA cDNA and also cloned 
into the pCGT vector. Site-directed mutagenesis (Stratagene) was carried out to make 
the lysine (K) to arginine (R) mutants using standard protocols. Flag-Ub and His-Ub 
were kind gifts from Dr. Jie Chen, and Cul4A-Ddb1 constructs were from Dr. Yue 
Xiong. 
The following antibodies (pAb: polyclonal antibodies; mAb: monoclonal 
antibodies) were used for immunoprecipitations and immunoblots as indicated: ORCA 
pAb (2853-2, 2854-1), Orc2 pAb (205), Orc3 pAb (Abcam), Myc mAb (9E10), Lys48-
Ub mAb (Millipore), Lys63-Ub mAb (Millipore), alpha-Tubulin mAb (Sigma-Aldrich), 
T7 mAb (Novagen), GFP mAb (Roche and Covance). 
 
IV.2.3. Immunoprecipitation and immunofluorescence  
Nuclear extracts were prepared first in hypotonic buffer (10mM HEPES-NaOH 
pH 7.9, 10mM KCl, 2mM MgCl2, 0.34M sucrose, 10% glycerol, 0.1% Triton X-100) 
plus a supplement consisting of 1mM DTT, protein phosphatase inhibitors (10mM NaF, 
1mM Na3VO4, 1mM Na2H2P2O7), protease inhibitor cocktail tablets (Roche), followed 
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by nuclear extraction buffer (20mM HEPES-NaOH pH 7.9, 2mM MgCl2, 1mM EGTA, 
25% glycerol, 0.1% Triton X-100) plus a supplement consisting of 1mM DTT, protein 
phosphatase inhibitors, protease inhibitors. And whole-cell lysates were made in the 
RIPA buffer (without DNase I or MNase treatment). Extracts were first pre-cleared by 
GammaBind G Sepharose resin (Amersham) and then incubated with antibodies at 4
o
C 
overnight. Resin was then added into extracts for 1.5 hrs, washed three times and 
resuspended in Laemmli buffer for immunoblot analysis. To make cell lysates for 
immunoprecipitations under the denaturing condition, cells were precipitated with 10% 
trichloroacetic acid (TCA) and washed twice with acetone. The dried pellets were then 
incubated with urea-cracking buffer (50mM Tris pH7.5, 8M Urea, 1% SDS) for 10min 
at 65
o
C, and diluted with 10 volumes of Tween-20 buffer (50mM Tris pH7.5, 150mM 
NaCl, 0.5% Tween-20, 0.1mM EDTA). 
Immunofluorescence studies were carried out as described previously (Sathyan 
et al., 2011). The YFP-ORCA expressing cell line was either fixed in 2% 
paraformaldehyde for 15 min at room temperature and then permeabilized by PBS + 
0.5% Triton X-100 for 7 min on ice, or pre-extracted in CSK buffer (10mM PIPES pH 
7.0, 100mM NaCl, 300mM sucrose, 3mM MgCl2) + 0.5% Triton X-100 for 5 min on 
ice and then fixed with 2% paraformaldehyde. Cells were then blocked in PBS + 1% 
normal goat serum (NGS), and incubated with primary antibodies for 1 hr and 
secondary antibodies for 45 min.  DNA was stained with DAPI. Cells were examined 
on the DeltaVision optical sectioning deconvolution instrument (Applied Precision) on 
an Olympus microscope. 
FRAP experiments were performed on the DeltaVision microscope (Applied 
Precision) using a 63×NA 1.4 Planapochromat oil-immersion objective (Olympus) with 
a 488-nm laser line. Required regions were photobleached for 250–300 ms with laser, 4 
pre-bleach and 50 post-bleach frames were recorded for each series. Quantification of 
fluorescence intensities were conducted in 30 nuclei for each condition. T (1/2) times of 
recovery and maximum recovery fraction were calculated from the curves. 
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IV.2.4. Synchronization 
To synchronize U2OS cells at the G1/S boundary, 2mM thymidine was added. 
After 24 hrs, cells were washed three times with fresh medium, grown for 12 hrs, and 
incubated with 2mM thymidine again for 24 hrs. A portion of thymidine released cells 
were further treated with 50ng/ml nocodazole to be arrested in mitosis, and were then 
released into G1 phase. For proteasome inhibition treatments, MG132 was added to 
double thymidine-blocked cells in the presence of 2mM thymidine (G1/S) for 6 hrs, or 
added to 3 hrs post nocodazole release cells (G1) for 6 hrs. Equal amount of DMSO 
was used as the control. 
 
IV.3. Results 
IV.3.1. ORCA is polyubiquitinated 
Immunoblot analysis on U2OS whole-cell lysate using ORCA antibody that 
were exposed for longer duration showed a smear in the high molecular weight region, 
suggesting the prevalence of post-translational modification, predominantly 
ubiquitination, of ORCA (molecular weight of ORCA ~70kDa, Figure 22A) at the 
endogenous level. Interestingly, epitope-tagged ORCA (T7- as well as YFP-tagged) 
also showed this modification, suggesting that this is a post-translational event (Figure 
22B and data not shown). Further, co-transfection of T7-ORCA and Flag-Ub followed 
by Flag immunoprecipitation clearly pointed to the fact that a fraction of ORCA is 
polyubiquitinated (Figure 22C). Note that the arrowhead (Figure 22C) denotes the 
ORCA that has at least one ubiquitin attached since it was immunoprecipitated using 
Flag in cells expressing Flag-Ub.  It is also likely, that the overabundance of 
unmodified ORCA is pulled down non-specifically. Similarly, T7-ORCA was co-
transfected with varying concentrations of 6×His-Ub in U2OS cells. His-tag pull-down 
confirmed the ubiquitination of ORCA (Figure 22D). HA immunoprecipitation of 
U2OS whole-cell lysates co-expressing HA-ORCA and Flag-Ub under the denaturing 
condition further confirmed ubiquitination of ORCA (Figure 22E). 
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IV.3.2. ORCA ubiquitination is elevated at the G1/S boundary 
I have previously demonstrated that the total levels as well as chromatin-
associated levels of ORCA are cell cycle regulated with maximum levels observed at 
G1, decreasing during S phase and being retained predominantly at the heterochromatic 
foci during most of S phase, G2 phase and mitosis (Shen et al., 2010). In order to test 
whether endogenous ORCA levels are regulated by ubiquitin-mediated degradation 
preferentially at the G1/S boundary, U2OS cells synchronized at G1 or G1/S were 
treated with MG132 for 6 hrs to block the ubiquitin-mediated degradation. Whole-cell 
lysates from these cells were analyzed by immunoblots using antibodies against ORCA. 
Ubiquitination of ORCA was low in G1, as there was no dramatic accumulation of the 
ubiquitinated form of ORCA (high-molecular-weight smear) upon MG132 treatment 
compared to the DMSO control (Figure 23). In contrast, ORCA displayed increased 
accumulation of the ubiquitinated form upon MG132 treatment at the G1/S boundary, 
indicating elevated ORCA ubiquitination at the end of G1 (Figure 23). 
 
IV.3.3. Ubiquitination of ORCA occurs on the WD repeat-containing domain 
The WD domain of ORCA mediates its chromatin association as well as its 
ORC binding (Shen et al., 2010).  To map the domain that is responsible for ubiquitin 
binding as well as to identify the ubiquitination sites on ORCA, I generated several T7-
tagged truncation mutants of ORCA expressing leucine-rich repeat (LRR, 1-127aa), 
LRR + linker (1-270aa), WD alone (270-647aa) and WD + linker (128-647aa) (Figure 
24A). Immunoprecipitations were carried out using T7 antibody and the samples were 
analyzed by immunoblotting. Only the WD-containing ORCA fragments (128-647aa, 
270-647aa and full length) showed prominent high-molecular-weight smear 
characteristic of ubiquitination (Figure 24B), which is consistent with recent 
observations that WD-repeat propellers serve as ubiquitin-binding domains (Higa et al., 
2006b). The WD domain of ORCA is not only critical for mediating the association of 
ORCA to chromatin and pre-RC components, but also for modulating its ubiquitin 
association. 
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Further, to define the lysine residues in the WD domain of ORCA that are 
linked to ubiquitin, I generated single point mutations as well as multiple point 
mutations spanning the entire WD domain of ORCA. Fourteen lysine residues (K) that 
were present within the WD region (270-647aa) were mutated to arginine residues (R) 
in various permutations and combinations. Cells were transfected with T7-ORCA, T7-
ORCA.270-647 or the mutants T7-ORCA.K-R, T7-ORCA.270-647.K-R, where all of 
the lysine residues were substituted by the arginine residues within the WD domain 
(Figure 24C). While T7-ORCA as well as T7-ORCA.270-647 fragments showed robust 
ubiquitination (Figures 24D and 24E), none of the single point mutations were able to 
abolish the ubiquitination (data not shown). The mutants T7-ORCA.K-R as well as T7-
ORCA.270-647.K-R, where all of the lysines were substituted by arginine showed 
marginally reduced ubiquitination (Figures 24D and 24E) but not complete loss of 
ubiquitination. It is possible that non-lysine residues are utilized for ubiquitin linkage as 
has been observed in case of mammalian substrates for endoplasmic reticulum-
associated degradation (Shimizu et al., 2010). 
  
IV.3.4. K48 ubiquitin linkage on ORCA targets it for proteasome-mediated 
degradation 
We have demonstrated that ORCA gets polyubiquitinated. The most abundant 
polyubiquitin chain has been demonstrated to be the lysine-48 (K48) linkage, which 
signals the target protein for degradation via the proteasome pathway (Woelk et al., 
2007). The other common linkage is lysine-63 (K63) that plays a role in mediating 
various cellular functions including DNA repair, signal transduction, transcription and 
endosomal trafficking (Hoege et al., 2002; Hofmann and Pickart, 1999; Spence et al., 
2000; Vong et al., 2005). In order to test the ubiquitin linkage on ORCA, I conducted 
immunoblot analysis using either K48-specific or K63-specific ubiquitin antibodies. 
T7-ORCA-expressing cells showed increased K48 linkage compared to the control 
(Figure 25A, short, non-saturated exposure; and Figure 25B, long, saturated exposure), 
and exhibited further accumulation upon MG132 treatment (Figure 25B), consistent 
with ORCA being targeted for ubiquitin-mediated proteasomal degradation. 
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Immunoprecipitation of ORCA using HA antibodies in cells co-transfected with Flag-
Ub and HA-ORCA, followed by immunoblot analysis with K48 antibody (Figure 25C) 
or K63 antibody (Figure 25D), clearly demonstrated K48 linkage in ORCA. These 
results demonstrate that ORCA poly-ubiquitination is primarily K48, suggesting that 
ORCA ubiquitination is required for its degradation via the proteasomal machinery. 
Though the protein levels of ORCA are cell cycle regulated, its transcript levels did not 
show any significant variation as detected by quantitative real-time PCR during 
different stages of the cell cycle (data not shown).   
 
IV.3.5. Orc2 protects ORCA from ubiquitin-mediated proteolysis 
I have recently demonstrated that ORCA is required for ORC binding to 
chromatin (Shen et al., 2010). Similarly, Orc2 is required for the cellular stability of 
ORCA (Bartke et al., 2010; Shen et al., 2012) and Orc3 (Figures 26A and 26B) 
(Prasanth et al., 2004). I have also carried out depletion of ORCA as well as Orc2 in 
YFP-ORCA-expressing stable cell line. YFP-ORCA labeling was significantly 
decreased in Orc2-depleted cells corroborating the immunoblot analysis that ORCA 
levels are destabilized upon Orc2 depletion (Figure 26C). ORCA and ORC associate 
with heterochromatic structures including at telomeres and centromeres (Shen et al., 
2010). Immunofluorescence analysis using Trf2 antibody in YFP-ORCA-expressing 
cells showed no significant changes in Trf2 labeling at telomeres in ORCA siRNA and 
Orc2 siRNA-treated cells (Figure 26C). Next, I addressed if the ORCA destabilization 
was due to ubiquitin-mediated degradation of ORCA. The presence of a proteasome 
inhibitor MG132 in Orc2-depleted cells partially rescued ORCA, but not Orc3 levels 
(Figure 26A, U2OS osteosarcoma cells; and Figure 26B, WI38 primary diploid 
fibroblasts). MG132-treated control cells also showed further stabilization and 
increased accumulation of ubiquitinated forms of ORCA (Figure 26B). 
Polyubiquitinated form of ORCA was apparent in control and MG132-treated control 
and Orc2 siRNA-treated cells. Stabilization of Cdt1 upon MG132 is shown as the 
positive control. It is interesting to note that Orc2 associates with the WD domain of 
ORCA, the domain that shows ubiquitination. Based on these data, I hypothesize that 
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Orc2 by interacting with ORCA prevents the proteasome-mediated degradation of 
ORCA, possibly by preventing ubiquitin linkage within the WD domain. This would 
suggest that Orc2 associates with the non-ubiquitinated form of ORCA. To address this, 
I carried out immunoprecipitation of Orc2 in T7-ORCA-expressing cells and examined 
if Orc2 can associate with ubiquitinated as well as non-ubiquitinated forms of ORCA. It 
was evident that Orc2 associated only with the non-ubiquitinated ORCA, and the 
ubiquitinated ORCA was not found to be associated with Orc2 (Figure 26D). 
Furthermore, in the unbound fraction (following the Orc2 immunoprecipitation), the 
non-ubiquitinated ORCA (arrowhead) was depleted whereas the ubiquitinated form of 
ORCA was enriched, suggesting that Orc2 associated predominantly with the non-
ubiquitinated form of ORCA. Immunoprecipitation using T7 antibody in T7-ORCA-
expressing cells clearly showed the presence of ubiquitinated ORCA (Figure 26D).  
Similar results were obtained, when HA-Orc2 and T7-ORCA were co-expressed and 
immunoprecipitation using HA antibody was carried out. Orc2 associated only with 
non-ubiquitinated form of ORCA but not with ubiquitinated ORCA, demonstrating that 
Orc2 binding to ORCA prevents ubiquitination of ORCA (Figure 26E).   
 
IV.3.6. Ubiquitinated ORCA is associated with nuclear sub-structures and bound 
to nuclear insoluble chromatin fraction 
I have thus far demonstrated that ORCA gets polyubiquitinated in the WD 
domain; this polyubiquitination is elevated at the G1/S boundary and targets it for 
degradation; and Orc2 binding to ORCA protects it from ubiquitin-mediated 
proteolysis. I then examined how the localization of ORCA is affected when cells are 
treated with MG132, so that ORCA can be ubiquitinated but not degraded.  In control 
cells (DMSO treated), upon paraformaldehyde (PF) fixation, ORCA (as visualized by 
YFP-ORCA in a stable cell line expressing this fusion protein) showed diffuse nuclear 
staining (Figure 27A). In MG132-treated cells, ORCA showed large nuclear aggregates 
that were primarily located in DAPI-less regions (Figure 27A). In order to remove the 
soluble proteins, cells were detergent pre-extracted (PE) before PF fixation. In DMSO 
treated interphase cells, the punctate patterns of ORCA binding to telomeres (Figure 
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27A) was discernible (Shen et al., 2010); however in MG132-treated cells, ORCA 
continued to show nuclear aggregates in DAPI-less regions (Figure 27A). 
Immunofluorescence using antibodies detecting K48 polyubiquitin chains showed co-
localization of ORCA with K48Ub in these foci (Figure 27B), suggesting that upon 
MG132 treatment, polyubiquitinated ORCA binds to nuclear sub-structures that are 
resistant to detergent extraction. Recent studies have demonstrated that ubiquitin and 
ubiquitin-like proteins are present in the nucleoli, some of which play crucial roles in 
the ribosome biogenesis (Shcherbik and Pestov, 2010). The functional relevance of the 
nucleolar accumulation of ubiquitinated proteins remains to be understood. To address 
if the nuclear sub-structures decorated by ORCA in MG132-treated cells represent 
nucleoli, I carried out immunostaining using Fibrillarin antibody.  The ubiquitinated-
ORCA-containing nuclear foci did not co-localize with nucleoli, but were generally 
localized adjacent to nucleoli (Figure 27C). 
Biochemical fractionations of DMSO-treated and MG132-treated YFP-ORCA-
expressing cells were carried out to ascertain the association of ORCA to chromatin. 
ORCA was present in the pellet fraction (P) suggesting that ORCA is associated with 
nuclear insoluble/chromatin fraction. In MG132-treated cells, the majority of the 
ubiquitinated ORCA was in the pellet fraction (P), suggesting that ubiquitinated ORCA 
is bound to nuclear insoluble matrix/chromatin (Figure 27D).   
I next conducted Fluorescence Recovery After Photobleaching (FRAP) analysis 
to study the dynamics of ORCA and ubiquitinated ORCA in YFP-ORCA-expressing 
stable cells. The YFP signal of a defined region in the nucleus was irreversibly 
bleached, and the recovery kinetics of fluorescence intensity into the bleached region 
was assessed (Figure 27E). ORCA showed extremely fast and almost complete 
recovery kinetics with a T(1/2) = 0.3 ± 0.07s (mobile fraction 0.93 ± 0.04) (Figure 27F). 
In contrast, ubiquitinated ORCA (MG132-treated) failed to recover (less than 20% 
recovery, Figure 27F), suggesting that ubiquitinated ORCA did not exchange and was 
largely immobile. 
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IV.3.7. Cul4A-Ddb1 E3 ligase associates with ORCA 
A recent study has demonstrated that Cul4-Ddb1 ligase interacts with multiple 
WD-containing proteins including WDR5, Cdt2 and EED and that Cul4-Ddb1 ligase 
regulates histone methylation (Higa et al., 2006b). Several groups have also reported 
that WD-repeat proteins directly bind Ddb1 and serve as the substrate-recruiting 
module of E3 (Angers et al., 2006; Jin et al., 2006). It has also been shown recently that 
WD propellers define an ubiquitin-binding domain that regulated the turnover of F-box 
proteins (Pashkova et al., 2010). Multiple pre-RC components are degraded by the 
ubiquitin-mediated degradation pathway during the G1/S boundary in order to prevent 
re-replication (Drury and Diffley, 2009). I tested if Cul4/Ddb1 associates with ORCA 
and if this in turn modulates ORCA ubiquitination. Immunoprecipitation using ORCA 
antibody in cells transiently expressing T7-ORCA and Myc-Cul4A demonstrated that 
ORCA interacts with Cul4A (Figure 28A). Similarly, co-transfection of T7-ORCA and 
Myc-Cul4A, followed by T7 IP confirmed the interaction between ORCA and Cul4A 
(Figure 28B).  Moreover, co-transfection of T7-ORCA with Myc-Ddb1, followed by 
ORCA IP, demonstrated that ORCA associates with Ddb1 as well (Figure 28C). 
Reverse IPs using Myc antibody in cells transiently expressing Myc-Cul4A or Myc-
Ddb1 further confirmed the association of ORCA with this E3 ligase complex (Figure 
28D). Finally, I mapped the domains of ORCA to which Cul4A and Ddb1 bind. 
Different truncation mutants of T7-ORCA (Figure 24A) were co-transfected with Myc-
Cul4A, and immunoprecipitations using T7 antibody were carried out. Only the WD 
repeat-containing domain showed interaction with Cul4A and the endogenous Ddb1 
(Figure 28E).  
To address if Cul4A-Ddb1 mediates the ubiquitination and degradation of 
ORCA, I depleted Cul4A and Ddb1 from human cells as well as in combination with 
Orc2 (Figure 28F and data not shown). I assessed if ORCA levels could be stabilized in 
the absence of Cul4A-Ddb1 individually or in combination with Orc2. No significant 
stabilization of ORCA was found under these conditions, suggesting that multiple E3 
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ligases may be targeting ORCA for ubiquitination (Figure 28F). It is equally likely that 
ORCA is a DCAF (Ddb1- and Cul4-associated factor) that along with Cul4A-Ddb1 
provides the substrate specificity for this E3 ligase.  
 
IV.4. Discussion 
In eukaryotes, initiation of DNA replication requires the assembly of pre-RC in 
late mitosis and G1, with the sequential loading of the ORC, Cdc6, Cdt1 and MCM2-7 
onto replication origins (Bell and Dutta, 2002). In order to prevent re-replication and 
control replication licensing, several factors including Orc1, Cdt1, and its inhibitor 
Geminin, exhibit cell cycle-regulated protein levels via ubiquitination-mediated 
proteasome degradation. I have shown that ORCA modulates ORC loading, binds to 
Cdt1 and Geminin, shows maximum levels during G1 and gets sequentially released 
from most sites, presumably by ubiquitination-mediated degradation, except at 
heterochromatic sites during the post-G1 part of the cell cycle (Shen et al., 2010). 
ORCA binds to Cdt1 and Geminin; and the timely association of ORCA with ORC, 
Cdt1 and Geminin, and the binding of each of these components to chromatin dictated 
by ORCA ensures “once per cell cycle” replication (Shen et al., 2012). 
In this chapter, I demonstrate that ORCA is polyubiquitinated in vivo with 
elevated ubiquitination and degradation at the G1/S boundary and is stabilized when 
cells are treated with the proteasome inhibitor MG132. Orc2, the direct binding partner 
of ORCA stabilizes ORCA by preventing its proteasomal degradation. The WD domain 
of ORCA is responsible for ORC binding as well as chromatin association (Shen et al., 
2010). The WD repeats are organized to form a -propeller fold of 6-8 blades that 
together form an interaction scaffold (Li and Roberts, 2001; Migliori et al., 2012; Neer 
et al., 1994; Smith et al., 1999). Recent work has shown that WD-repeat propellers are a 
novel class of ubiquitin-binding domains (Pashkova et al., 2010). I have observed that 
ORCA gets ubiquitinated at its WD repeat-containing domain.  Interestingly, the WD-
repeat domain is also required for the association of ORCA to Cdt1 and Geminin as 
well as to the E3 ligase Cul4A-Ddb1. Smaller truncation mutants of the ORCA WD 
domain have failed to provide any useful information, since the entire -propeller 
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structure seems to be required for association of ORCA to ORC as well as to chromatin.  
Determination of the crystal structure of ORCA is critical to understanding how ORCA 
can interact with several different proteins, as well as to chromatin utilizing its WD 
domain. However, one prediction would be that binding of Orc2 to ORCA prevents 
ubiquitin linkage formation on the WD domain. It is also equally likely that binding of 
Orc2 causes steric hindrance and does not allow the association of E3 ligases like 
Cul4A-Ddb1, thereby stabilizing ORCA. Future structure-function analyses would 
answer these questions. 
I have observed that the polyubiquitination of ORCA occurred on chromatin, as 
ORCA was resistant to detergent extraction (Figures 27A and 27D). It has been 
suggested that the ubiquitin-proteasome machinery is active in nuclear domains and this 
in turn governs crucial cellular processes including DNA repair and gene regulation 
(von Mikecz, 2006). Fibrillarin immunostaining showed ubiquitinated ORCA localized 
adjacent to nucleoli; however, the functional relevance of this localization remains 
unclear.  
The chromatin-mediated polyubiquitination of ORCA is similar to what has 
been reported for mammalian Orc1, Xenopus Cdt1 and Xenopus p27 (Arias and Walter, 
2005; Furstenthal et al., 2001; Mendez et al., 2002). It has been proposed that Orc1 
polyubiquitination acts as a dual-switch, whereby ubiquitination first serves as a signal 
to initiate DNA replication, following which the protein is targeted for degradation 
(Mendez et al., 2002). Interestingly, Cdt1 is also ubiquitinated on chromatin and 
requires DNA replication to be initiated (Arias and Walter, 2005). Just like the pre-RC 
components Orc1 and Cdt1, ORCA shows cell cycle regulation with maximum levels at 
G1 and a significant reduction during the G1/S boundary. It is possible that Orc2 by 
interacting with ORCA prevents the proteasome-mediated degradation of ORCA, 
presumably at origins during G1. The loss of Orc2 from origins and retention only at 
heterochromatic structures in post-G1 cells suggest that ORCA may be degraded from 
origins in post-G1 cells by ubiquitin-mediated proteolysis, which is consistent with the 
elevated ORCA ubiquitination at the G1/S boundary. ORCA accomplishes the loading 
of ORC during G1. At the end of G1, Orc2 is released from origins; the residual ORCA 
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without Orc2 (especially from origins) during the G1/S boundary is degraded by 
ubiquitination. This suggests that when signals dictate ORC to come off the chromatin 
or undergo destruction, cells also instruct ORCA to undergo rapid degradation to 
prevent ORC from being re-stabilized on the chromatin. This could be yet another 
mechanism ensuring that replication occurs only once during each cell division cycle. 
Our lab has previously demonstrated that Orc2 is highly dynamic on chromatin 
(Prasanth et al., 2010), and therefore the prediction is that every time Orc2 is released 
from chromatin, ORCA is targeted for degradation.  
My results demonstrate that ORCA interacts with Cul4A-Ddb1 and its 
proteolysis could be mediated by the Cul4A-Ddb1 pathway. Cul4 associates with Ddb1 
to form an E3 ubiquitin ligase that constitutes a large family of the Cullin-RING ligases 
(CRLs) and targets substrate proteins for proteasome-mediated degradation (McCall et 
al., 2005). The Cul4-Ddb1 is involved in various cellular events, including DNA 
replication and repair (Bondar et al., 2004; Chen et al., 2001; Groisman et al., 2003; 
Higa et al., 2006a; Higa et al., 2003; Hu et al., 2004; Kapetanaki et al., 2006; McCall et 
al., 2005; Nag et al., 2001; Sugasawa et al., 2005; Wang et al., 2006), histone 
methylation (Higa et al., 2006b), and transcription (Wertz et al., 2004). It has also been 
shown that Cul4-Ddb1 interacts with WD-containing proteins including WDR5, EED 
and RBBP5, and associates with methylated H3. Further, inactivation of Cul4 and Ddb1 
abolishes the H3K4 mono- and tri-methylation (Higa et al., 2006b). Cul4-Ddb1 may 
also function via the WD-containing adaptors to affect histone methylation. ORCA has 
been shown to bind to repressive histone marks (Bartke et al., 2010; Chan and Zhang, 
2012; Vermeulen et al., 2010). The interaction of ORCA with Cul4A-Ddb1 may not be 
solely for its degradation, but may also mediate other important regulatory pathways. 
Several studies have shown that WD-containing proteins serve as the substrate-
recognition subunits of the Cul4-Ddb1 ubiquitin ligase (Higa et al., 2006b; Higa and 
Zhang, 2007). Recently, a set of WD repeats containing proteins that interact with Cul4-
Ddb1 ligase has been identified based on the structural studies, and these have been 
termed DCAFs (Ddb1- and Cul4-associated factors), or CDWs (Cul4- and Ddb1-
associated WD-repeat proteins). Ddb1, comprising three β-propeller structures, uses one 
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β-propeller to interact with Cul4A, and uses the other double β-propellers to bind the 
WD-containing protein (Angers et al., 2006; Higa et al., 2006b; Jin et al., 2006; Lee and 
Zhou, 2007). From this view, the WD containing proteins serve as the substrate-
specifying and recruiting adaptors for downstream effectors, or the substrates 
themselves to fit into the structure. I have demonstrated that ORCA associates with 
Cul4-Ddb1 and it is the WD domain of ORCA that mediates this interaction. When I 
knockdown both Cul4 and Ddb1 in cells, I do not observe any significant stabilization 
of ORCA protein levels (Figure 28F). This implies that other E3 ligases might be 
involved in ORCA degradation. It is also likely that ORCA serves as an adaptor to 
recruit substrates to the Cul4A-Ddb1 E3 ligase. Future work on the identification of 
ORCA interacting partners will provide more insights into this. 
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IV.5. Figures 
 
 
Figure 22. ORCA is polyubiquitinated in vivo. (A) Immunoblot analysis of U2OS 
whole-cell lysates using antibodies against ORCA. The arrowhead indicates unmodified 
ORCA, and the bar indicates the high-molecular-weight smear. The asterisk denotes the 
cross-reacting band. (B) Immunoblot analysis of the whole-cell lysates of U2OS cells 
transfected with T7-tagged ORCA (+) or control vector (-) using antibodies against T7. 
Note the high-molecular-weight smear in (+). (C) Flag immunoprecipitation of U2OS 
cells co-expressing T7-ORCA and Flag-Ub. Note the polyubiquitinated T7-ORCA as 
denoted by the high-molecular-weight smear. Cells only transfected with T7-ORCA 
were used as the immunoprecipitation control. (D) Affinity pull-down in cells 
expressing T7-ORCA and varying amount of 6×His-Ub (0, 1, 2µg). Polyubiquitinated 
T7-ORCA was pulled down by His tag. (E) HA immunoprecipitation of U2OS cells co-
expressing HA-ORCA and Flag-Ub under the denaturing condition. Mouse IgG 
immunoprecipitation serves as the control. 
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Figure 23. Ubiquitination of ORCA is elevated at the G1/S boundary. U2OS cells 
were synchronized at G1 or G1/S boundary and treated with DMSO or MG132 for 6 
hrs. Whole-cell lysates were analyzed by immunoblots using antibodies against ORCA. 
Note the accumulation of the high-molecular-weight smear in lane 4 (the MG132-
treated sample compared to DMSO at the G1/S boundary). Tubulin serves as the 
loading control. The arrowhead represents unmodified ORCA and the asterisk 
represents the cross-reacting band. 
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Figure 24. ORCA ubiquitination occurs on multiple lysine residues in the WD 
domain. (A) Schematic representation of various truncation mutants of ORCA (adapted 
and modified from ((Shen et al., 2012)). T7 epitope was constructed at the N-terminus. 
(B) T7 immunoprecipitation of the ORCA mutants followed by T7 immunoblot 
analysis. Note that only the WD-containing mutants and the full-length protein display 
the high-molecular-weight smear. (C) Schematic representation of all the 14 lysine 
residues within the WD domain that were mutated into arginine residues. Individual 
point mutations, several combined mutations, and the mutants having all the lysines 
mutated (T7-ORCA.K-R or T7-ORCA.270-647.K-R) were tested for ubiquitination. 
(D) Immunoblot analysis of cell extracts expressing T7-vector control, T7-ORCA and 
T7-ORCA.K-R using T7 antibody. (E) Immunoblot analysis of cell extracts expressing 
T7-vector control, T7-ORCA.270-647 and T7-ORCA.270-647.K-R using T7 antibody. 
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Figure 25. ORCA polyubiquitin chain is formed through lysine-48 of the ubiquitin. 
(A) Immunoblot analysis of the whole-cell lysates of U2OS cells transfected with T7 
control vector or T7-tagged ORCA using antibodies against K48 ubiquitin. Short, non-
saturated exposure shows the high-molecular-weight smear in T7-ORCA expressing 
cells. (B) Immunoblot analysis of the whole-cell lysates of U2OS cells transfected with 
T7 control vector or T7-tagged ORCA (with (+) or without (-) MG132 treatment) using 
antibodies against K48 ubiquitin. Note the accumulation of the high-molecular-weight 
smear upon MG132 treatment. Long, saturated exposure was used to show the presence 
of K48 ubiquitin in all the samples (including controls). (C and D) HA 
immunoprecipitations in U2OS cells expressing HA-ORCA with (+) or without (-) 
Flag-Ub. Immunoblot analysis using K48-specific (C) or K63-specific (D) antibodies. 
Note the polyubiquitinated HA-ORCA is in the form of K-48 linkage. 
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Figure 26. Orc2 prevents ORCA from proteasome-mediated degradation. (A) 
Immunoblot analysis of whole-cell extracts from cells treated with Orc2 siRNAs in the 
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Figure 26 (cont.) absence (-) or presence (+) of proteasomal inhibitor MG132. Varying 
concentrations (25%, 50%, and 100%) of whole-cell extracts treated with luciferase 
siRNAs (control) are shown to provide information on the percentage of knockdown 
and reduction of protein levels. Note the destabilization of ORCA and Orc3 in Orc2-
depleted U2OS cells and the inhibition of ORCA degradation in the presence of 
MG132. Orc3 is destabilized upon Orc2 depletion, but cannot be stabilized upon 
MG132 treatment; whereas Cdt1 protein levels are elevated upon MG132 treatment. (B) 
Depletion of Orc2 in human WI38 cells. Note the degradation of ORCA and Orc3 in 
Orc2-depleted cells, but stabilization of ORCA as well as evidence of polyubiquitinated 
ORCA in the presence of MG132. (C) Depletion of ORCA and Orc2 in YFP-ORCA-
expressing cells. Immunofluorescence analysis was carried out using Trf2 antibody. 
The scale bar represents 30 µm. (D) Immunoprecipitation using Orc2, T7 or mouse IgG 
antibody in T7-ORCA-expressing cells. Note Orc2 associates with non-ubiquitinated 
ORCA. The arrowhead in unbound fractions denotes the absence of non-ubiquitinated 
form of ORCA in the Orc2 IP unbound sample. Note the enrichment of ubiquitinated 
forms of ORCA in the Orc2 IP unbound sample. (E) Immunoprecipitation using HA 
antibody in cells co-expressing HA-Orc2 and T7-ORCA. 
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Figure 27. The polyubiquitinated ORCA associates with detergent-resistant 
chromatin fraction. (A) YFP-ORCA-expressing U2OS cells were incubated with 
DMSO and MG132, and were then fixed directly by paraformaldehyde (PF) or pre-
extracted with detergent before fixation (PE) to remove soluble proteins. Note that 
YFP-ORCA localized in the form of aggregated foci upon MG132 treatment, which are 
resistant to detergent extraction. (B) Immunostaining of DMSO and MG132-treated 
YFP-ORCA-expressing cells with K48 ubiquitin antibody. (C) Immunostaining of 
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Figure 27 (cont.) DMSO and MG132-treated YFP-ORCA-expressing cells with 
Fibrillarin shows that the ORCA-containing foci do not localize to the nucleolar 
structures in the cells. (D) Biochemical fractionation of YFP-ORCA-expressing cells 
treated with DMSO or MG132 followed by immunoblot analysis using GFP antibody. 
(S) represents cytosolic fraction and (P) denotes chromatin-bound fraction. Note the 
high-molecular-weight smear of YFP-ORCA predominantly on the chromatin fraction 
(P) upon MG132 treatment. (E) Snap shots of the FRAP analyses on DMSO or MG132-
treated YFP-ORCA-expressing cells. The insets denote where the photobleach was 
conducted. (F) Quantitations of FRAP data show a highly dynamic rate of ORCA on 
chromatin, with the recovery time T(1/2) = 0.30 ± 0.07s to a 0.93 ± 0.04 recovery 
fraction, whereas in MG132-treated cells, no more than 20% recovery after photobleach 
was observed. Scale bars in A, B, C and E represent 10 µm. 
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Figure 28. ORCA is associated with Cul4A-Ddb1 E3 ligase. (A) ORCA 
immunoprecipitation in T7-ORCA and Myc-Cul4A-transfected cells followed by 
immunoblots with ORCA and Myc. Rabbit IgG serves as the control. (B) T7 
immunoprecipitation in cells transfected with T7-ORCA and Myc-Cul4A followed by 
immunoblots with T7 and Myc. Note that ORCA associates with Cul4A. Mouse IgG 
serves as the control. (C) ORCA immunoprecipitation in cells transfected with T7-
ORCA and Myc-Ddb1 followed by immunoblots with ORCA and Myc. Rabbit IgG 
serves as the control. (D) Myc immunoprecipitations in cells transfected with T7-
ORCA and Myc-Cul4A or Myc-Ddb1 followed by immunoblots with Myc and ORCA. 
Mouse IgG serves as the control. (E) Immunoprecipitations in cells expressing various 
T7-ORCA mutants and Myc-Cul4A were carried out using the T7 antibody, and Cul4A 
and the endogenous Ddb1 were analyzed by immunoblots. Note that only the WD-
containing constructs interact with Cul4A-Ddb1. (F) Depletion of Ddb1 or in 
combination with Orc2 followed by immunoblot analysis of ORCA. 
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CHAPTER V. CONCLUSIONS AND PERSPECTIVES 
 
DNA replication dictates duplication of the genetic material and therefore its 
accuracy is paramount to cell survival. ORC, being the initiator for replication, specifies 
the origin for DNA synthesis. How ORC is recruited to chromatin in higher eukaryotes 
had remained to be understood. In the search of novel ORC interactors, I identified 
ORCA/LRWD1 as a top hit. It co-localizes with ORC at heterochromatic sites and 
shows similar cell cycle dynamics to that of ORC in human cells. Tethering ORCA to 
an artificially generated chromatin region efficiently recruits ORC to that chromatin 
locus. Further, depletion of ORCA in human primary cells and embryonic stem cells 
results in the loss of ORC association to chromatin, the reduction of MCM binding to 
chromatin, and the subsequent accumulation of cells in G1 phase. These data establish 
ORCA as an essential factor for the stable association of ORC to chromatin. It is 
notable that these observations were made at the global chromatin levels, not individual 
chromatin locus. Interestingly, ORC has more molecules on chromatin than that of 
ORCA, and a fraction of ORC remains on chromatin upon ORCA depletion, indicating 
that ORCA interacts with only a subset of ORC. It is an intriguing possibility that this 
subset of ORCA-interacting ORC could be the origin-associating ORC. ORCA and 
ORC ChIPs in human cells followed by the analysis of identified human replication 
origins (e.g. Lamin B-2 (Abdurashidova et al., 1998), β-globin (Kamath and Leffak, 
2001), and c-myc (Waltz et al., 1996)) would address whether these ORCA-ORC 
occupied sites are indeed origins. If this is the case, ORCA ChIP combined with deep 
sequencing may resolve the chromatin occupancy of ORCA, and analysis of deep 
sequencing data may reveal consensus sequence or any specific sequence preference 
(e.g. AT-rich regions) as potential replication origin-firing sites in human cells. Further, 
ORC ChIP-deep sequencing in the presence and absence of ORCA can also be 
performed, and the comparison may reveal separate ORC occupancies for its 
replication-coupled function as well as non-pre-RC functions like heterochromatin 
silencing. 
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ORCA protein levels fluctuate throughout the cell cycle, peaking in G1 phase. 
In addition to ORC, ORCA also associates with other cell cycle-regulated proteins: 
Cdt1 and Geminin. All these interactions are cell cycle-dependent: ORCA associates 
with ORC core complex throughout the cell cycle, with Cdt1 in mitosis and G1, and 
with Geminin in post-G1 phases. Single-molecule analyses demonstrate that one 
molecule of ORCA binds to one ORC, one Cdt1 and/or two Geminin. Overexpression 
of Geminin in human cells results in the loss of interaction between ORCA and Cdt1, 
suggesting that increased levels of Geminin in post-G1 cells titrate Cdt1 away from 
ORCA. Taken together, these data suggest that ORCA modulates the stoichiometric 
assembly of the pre-RC components, and may serve as a novel licensing factor, in 
addition to its role in facilitating pre-RC assembly on chromatin. ORCA interacts with 
the C-terminus of Cdt1, the same region that interacts with MCM2-7. It is therefore 
speculated that ORCA may facilitate or inhibit MCM loading onto origins, as discussed 
in Chapter III. To test this hypothesis, MCM2-7 association levels to Cdt1 can be 
examined by in vivo and in vitro immunoprecipitation assays with the presence of 
increasing or decreasing amount of ORCA. Alternatively, if increasing Geminin levels 
and the concomitant loss of ORCA-Cdt1 interaction at the end of G1 permit the 
association of MCM with free Cdt1 (the exposed C-terminal domain of Cdt1), then 
inducible Geminin overexpression and ORCA knockdown will be utilized to assess this 
fine-tuned regulation at this specific time window. 
Others (Bartke et al., 2010; Chan and Zhang, 2012; Vermeulen et al., 2010) and 
I have revealed that the five WD repeats of ORCA are essential for its interaction with 
ORC, Cdt1, Geminin, as well as its association with chromatin. The WD domain forms 
a circular β-propeller structure, with each repeat unit as a blade in the form of a β sheet 
(Li and Roberts, 2001; Migliori et al., 2012; Neer et al., 1994; Smith et al., 1999). 
Therefore, the intact WD domain is important for these functional associations, as 
deletion of any repeat abolishes the interaction. The N-terminus of Orc2 interacts 
directly with the WD domain of ORCA. Upon Orc2 depletion, ORCA also undergoes 
rapid destruction, which can be rescued by the addition of proteasome inhibitor MG132, 
indicating that Orc2 protects ORCA from ubiquitin-mediated degradation. This is 
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further supported by the observations that K48 polyubiquitin chain can be formed on 
the WD domain of ORCA, and Orc2 only interacts with the non-ubiquitinated form of 
ORCA. Interestingly, ORCA exhibits elevated ubiquitination levels at the G1/S 
boundary. Both ORCA and ORC are released from chromatin sites and retain only at 
heterochromatic structures in post-G1 cells. These results suggest that ORCA may be 
degraded from origins in post-G1 cells by ubiquitin-mediated proteolysis. Together, I 
propose the model that at the end of G1 when ORCA accomplishes the loading of ORC, 
ORC is released from origins; the residual ORCA is detached from ORC (loss of 
interaction with Orc2) during the G1/S boundary and is degraded by ubiquitination. 
This would be a reasonable hypothesis in the context of replication licensing: when 
signals dictate ORC to come off the chromatin, ORCA is also instructed to undergo 
rapid destruction to prevent ORC from being re-stabilized on the chromatin. Then the 
question would be: what signals instruct ORC’s dissociation from chromatin? It is 
highly likely that S phase CDK phosphorylates one or more subunits of ORC and 
triggers the disassembly and/or destruction of ORC. It is also possible that a high 
affinity ORC interactor exists to compete with ORCA for ORC binding, or chromatin 
structure changes during replication to instruct ORC to dissociate from the origins. 
Furthermore, ORCA associates with Cul4/Ddb1, but knockdown of this E3 ligase 
doesn’t stabilize the protein levels of ORCA, suggesting other E3 ligase(s) may take 
over or compensate for the proteolytic pathway of ORCA. Therefore another question 
is: what are the other E3 ligases regulating ORCA levels? SCF
Skp2
 would be a top 
candidate, since Skp2 is responsible for the degradation of other pre-RC components 
like Orc1 (Kreitz et al., 2001; Mendez et al., 2002; Ohta et al., 2003) and Cdt1 (Li et al., 
2003; Liu et al., 2004; Nishitani et al., 2006; Sugimoto et al., 2004) at the G1/S 
transition. Immunoprecipitation analysis and co-depletion of both Cul4/Ddb1 and 
SCF
Skp2
 will test this hypothesis. Alternatively, a screen of E3 ligases and investigations 
of more ORCA-interacting proteins and modulators would be the necessary step 
forward. 
ORCA is likely to have multiple functions outside DNA replication. 
Interestingly, ORCA localizes to centromeres in MCF7 and other telomerase-positive 
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cell lines throughout the cell cycle, similar to that of ORC (Prasanth et al., 2004). A 
proteomic analysis of mitotic chromosome proteins also identified ORCA as a novel 
centromere protein (thus named CENP-33) (Ohta et al., 2010). On the other hand, 
ORCA localizes to telomeres in interphase U2OS cells, which utilize DNA 
recombination-mediated ALT mechanism to maintain telomeres (Reddel, 2003). In fact, 
the mouse ortholog of ORCA is highly expressed in the testis, the highly 
recombinogenic tissue, and is involved in spermatogenesis (Teng et al., 2010). 
Therefore, further investigation on the functional significance of ORCA at centromeres 
and telomeres may help us unveil the intrinsic connection between DNA replication, 
DNA recombination as well as chromosome segregation.  
Notably, in post-G1 phases of the cell cycle, ORCA is only restricted to 
heterochromatic regions in human cells as shown in Chapter II. One possibility is that 
ORCA involves in the late-origin replication, since it is generally known that late-
replication origins usually associate with heterochromatic regions (Bell and Dutta, 
2002; Diller and Raghuraman, 1994). This can be tested by examinations of the early-, 
mid-, and late-S phase replication patterns upon depletion of ORCA specifically in S 
phase when the involvement of ORCA in pre-RC assembly is accomplished. The other 
possibility is that ORCA plays a role in heterochromatin establishment and/or 
maintenance. In fact, ORCA has been shown to bind to repressive histone marks 
(Bartke et al., 2010; Chan and Zhang, 2012; Vermeulen et al., 2010). Particularly, 
ORCA associates with H3K9me3, H4K20me3, and H3K27me3 peptides and is 
recruited to pericentric heterochromatin through its association with H3K9me3 (Chan 
and Zhang, 2012). Moreover, ChIP-seq using the BAC ORCA-GFP cell line displays an 
enriched signal on satellite repeats (Vermeulen et al., 2010), and depletion of ORCA in 
MEF cells results in the up-regulation of major satellite repeat transcripts, suggesting its 
requirement for heterochromatin silencing (Chan and Zhang, 2012). Therefore, it is 
highly possible that ORCA works closely with histone modification enzymes to 
establish and maintain histone marks, and may function as an adaptor that links 
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replication to higher-order chromatin organization (Chakraborty et al., 2011). Hence, 
exploration of ORCA-interacting proteins will be critical to uncover the full spectrum 
of its function. 
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